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Background: Mobile health (mHealth) have shown promise for their potential to enhance 
clinical workflows, improve patient access to care, and the quality of that care. However, 
there remain persistent barriers to adoption, and some users continue to resist the use of 
these new tools.  
Objectives: This research investigated factors influencing clinicians’ mHealth adoption, and 
expounded these and the potential implications for their workflow and quality of patient care. 
Methods: A multiple-case study of three mHealth tools was conducted. Data were collected 
via 41 in-depth interviews with clinicians, technology providers, and medical informatics 
experts in 9 countries from April 2017 to March 2020. The case studies were examined in 
the context of relevant literature, identified by a systematic review that included171 studies 
published between 2008 and 2018. 
Results: Findings confirmed that the use of mHealth can provide numerous benefits such as 
efficacy and time-saving, improved safety and quality of patient care, improved accessibility, 
and better data security and validation. They can also positively impact workflow through 
better transparency and collaboration, empowerment, and efficiency. However, the factors 
impacting adoption go beyond material features such as usefulness, ease of use, privacy 
and security, interoperability and costs. Social factors like clinicians’ attitudes, awareness, 
experience, or culture are key. Organizational and policy factors are also vital and include 
user engagement, infrastructure, training, existing workload and resources, decision making, 
in addition to absence or ambiguity of regulations.  
Conclusions: Factors impacting clinicians’ adoption go beyond the material aspects of 
mHealth to also encompass substantial social and organizational elements. Therefore, from 
a practical perspective, mHealth providers should work together with clinicians and decision 
makers to address potential barriers and improve adoption. From a theoretical perspective, 
the study proposes an expansion of Leonardi’s methodological guidance to better account 
for user engagement; and a consolidated framework that better factors in the complexity of 
healthcare’s sociotechnical structure, and the interaction between the technical, social and 
organizational factors. 
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1 Introduction  
Healthcare organizations are facing some global and persistent challenges such as rising 
costs, inconsistent care, and increasing burden of chronic disease. Public health policy 
makers increasingly believe that transforming care through a patient-centric design and 
taking a more preventive and proactive method that focuses not only on treating disease but 
mainly on life quality can be a way of overcoming the current challenges (Pavel et al., 2013). 
Mobile devices can play a significant role in this context. The latest improvements in 
technology have enabled mobile devices to accomplish some increasingly advanced tasks 
because of their very sophisticated sensors and features (Putzer and Park, 2010); so much 
so that a new type of healthcare tools: mobile health (mHealth), has appeared (Gagnon et 
al., 2016). 
1.1 Research context 
mHealth is a significant medical technology innovation; previous research has shown that it 
holds promise for cost savings, better access to healthcare, and improved quality of care 
(Armstrong et al., 2012; Avey and Hobbs, 2013; Anderson et al., 2017; Bhatta, Aryal and 
Ellingsen, 2015; Mileski et al., 2017; Puszka et al., 2016). It can also support the 
transformation of healthcare and the shift towards a more patient-centric approach that 
doesn’t solely focus on treating disease but also adopts a more predictive approach that can 
help prevent disease (Pavel et al., 2013; Payne, Wharrad and Watts, 2012). It has also been 
reported to contribute to decreasing clinicians’ existing workload, and enhancing patient 
access to care (Kotronoulas et al., 2017b; Ruiz Morilla et al., 2017).  
The increasing adoption of health apps has also contributed to addressing patients’ 
information needs, and the myriad of information provided through these tools has helped 
make them feel more empowered (Kotronoulas et al., 2017a). Moreover, the data generated 
through mHealth can help practitioners personalize and adapt treatment plans 
correspondingly (Kotronoulas et al., 2018), resulting in a better quality of care via tailored 
treatments (Kotronoulas et al., 2018, 2017a). The structured and continuous data can help 
by prompting discussions of underreported and sensitive areas that can improve patient-
clinician communications (Kotronoulas et al., 2018), and help make patients feel more taken-
care-of (Kotronoulas et al., 2018). All these benefits encourage all patients, including older 
ones to adopt such apps (Bostrom et al., 2019) in defiance of the wide spread concept of a 
‘digital divide’, and can boost patients’ quality of life through personalized healthcare 




It is, however, important to note that one of the key factors that differentiate mHealth from 
other Information and Communication Technology (ICT) tools is its user-driven nature, 
particularly, their availability, convenience and affordability (Akter and Ray, 2010); hence, a 
good understanding of the factors affecting user acceptance and adoption is vital to the 
success of these tools. 
While previous studies indicate that practitioners generally have a favourable attitude 
towards mHealth, barriers to widespread adoption still persist (Connolly et al., 2020). For 
instance, the dynamic and liberal nature of the mHealth market makes the assessment of  
tools’ quality very challenging; making clinicians’ decision to choose which tool to adopt 
more difficult (Albrecht, Framke and von Jan, 2019). Moreover, the big data generated by 
these tools create a need for more comprehensive data privacy guidelines, particularly 
around the use of patient data that are clinically significant (Wernhart, Gahbauer and 
Haluza, 2019; Strotbaum et al., 2019). As well as existing workload, resource shortages, and 
essential workflow modifications were often raised as barriers to clinicians’ adoption 
(Anderson et al., 2017; Ariens et al., 2017; Avey and Hobbs, 2013; Bhatta, Aryal and 
Ellingsen, 2015; Bagot et al., 2017; Brewster et al., 2014). 
Many of the reported adoption factors go beyond the material features of technology to 
reflect the complexity of the healthcare context. Some of the barriers have slowed down the 
mHealth acceptance in certain healthcare settings (Kissi et al., 2019; Cowan et al., 2019), 
with some tools failing to advance beyond the pilot phase (Huang, Blaschke and Lucas, 
2017), or failing to become a part of standard care (Boonstra and van Offenbeek, 2010; van 
Dyk, 2014). Also, practitioners sometimes have negative perceptions of mHealth impact on 
their autonomy and credibility (Brewster et al., 2014). Therefore, it is vital to shift our focus 
past technology’s material features to address broader clinicians’ concerns, such as clinical 
workflow enhancement, and workload problems (Newbould et al., 2019; Doak, Schwager 
and Hensel, 2020; Cowan et al., 2019). 
These interconnected social, organizational, and technical factors, resulted in cases where 
users, predominantly clinicians, may resist mHealth adoption (Choi et al., 2018). This is 
especially relevant, considering that numerous studies, in developed and developing 
countries, indicated that clinicians’ adoption is the most significant factor in the success of 
health technologies (Hussein, Rada, Khalifa, 2012; Moffatt and Eley, 2011; Walter and 
Lopez, 2008; Xue et al., 2015; Gagnon et al., 2012a). Thus, the necessity and importance, 
of a better grasp of the different factors influencing clinicians’ adoption of mHealth in the 




1.2 Research questions and definitions 
Given that clinicians’ resistance is one of the key challenges for mHealth adoption, it is 
important to better understand the reasons why clinicians adopt, or do not adopt healthcare 
technology, and how such adoption decisions could impact and be impacted by contextual 
factors such as organizational practices and healthcare policies.  
Therefore, this research focuses on understanding the social and material factors impacting 
Clinicians’ adoption of mHealth tools and their implications for organizational practices and 
health care policies. The topic is investigated through the following questions: 
• What are the utilities and limitations of mHealth tools as perceived by clinicians? 
• What are the factors that constrain or afford clinicians’ adoption of mHealth? 
• What are the organisational and policy factors and implications of this adoption? 
In the context of this research, the World Health Organization’s Global observatory of 
eHealth definition of mHealth was used. It considers it a sub-category of eHealth and defines 
it as “medical and public health practice supported by mobile devices, such as mobile 
phones, patient monitoring devices, Personal Digital Assistants (PDAs), and other wireless 
devices”, and it considers Telemedicine a sub-category of mHealth and defines it as “the 
communication or consultation between health professionals about patients using the voice, 
text, data, imaging, or video functions of a mobile device. But it can be applied to other 
situations; the management of chronic diseases of patients living at home is one example.” 
(Kay, Santos and Takane, 2011). 
And the Merriam-Webster dictionary’s definition of the word ‘clinician’ was used: “a person 
qualified in the clinical practice of medicine, psychiatry, or psychology as distinguished from 





2 Literature review and theoretical framework 
This thesis uses the sociotechnical theory as a guide, specifically, employing the three step 
process in Leonardi’s methodological guidelines for the study of materiality and affordances 
(Leonardi, 2018). This section starts by explaining the logic behind choosing this theoretical 
framework, its context, and how it was used along the thesis; followed by a detailed and 
systematic review of the literature that was synthesised according to the theoretical 
framework by looking into technical, social, and organizational factors impacting clinicians’ 
adoption of mHealth tools. Furthermore, to avoid the overreliance on a single line of thinking, 
in the third part of this section the researcher also analysed the most used frameworks for 
studying clinicians’ adoption of mHealth tools and the factors that they encompass to ensure 
a more comprehensive thematic analysis. The section concludes with a summary and an 
aggregated view of the most used frameworks in studying mHealth adoption, identifying their 
gaps, and explaining how this research proposes to complement them. 
2.1 Theoretical framework: the sociotechnical theory as a guide 
User research investigating user choices, seeking a better understanding of how they 
interact with technology, and the relationship between work and technology was influenced 
by the appearance of the ‘post-humanist’ sociology of actor-network theory in the 1990s. 
This new turn proposed that users and new technologies are both equally regarded as 
'actants' defined by a network of relationships, an idea that started to develop into what is 
currently known as sociomateriality, advocating for the notion that social and material 
aspects of technology adoption are inseparable (Orlikowski, 2007, 2009; Orlikowski and 
Scott, 2015). However, this lack of distinction between the users (social factors) and the 
technology (material and technical factors) from this ontological standpoint makes it 
challenging to explain user choices (Mutch, 2013; Leonardi, 2013; McPhee and Canary, 
2013; Tunçalp, 2016).  
Therefore, other scholars explain that, from their perspective, social and material aspects 
are not inseparable but rather 'imbricating' to produce steady socio-material constructions 
over time, ensuing certain actions (Leonardi and Rodriguez-Lluesma, 2013). Here, the social 
and the material are viewed as independent factors, where users interact with certain 
features of technology to create particular 'affordances' (Leonardi, 2018; Mutch, 2013; 




This active role of the user (social factors) in technology adoption implies that understanding 
the technology is being used is key for recognising how it influences organizations and the 
process of organizing work. Since the way people interact with technology and tools 
influences how they organize their micro-level relations (Garfinkel, 1967), and also impacts 
the definition of their roles (Goffman, 1956; Pinch, 2010). Furthermore, the increasing 
digitalization of organizations pushed scholars to investigate how the technologies used at 
the workplace are vital to the enablement of new forms of organizing work and practice 
(Bélanger and Watson-Manheim, 2006; Chudoba et al., 2005). 
Consequently, to better comprehend clinicians’ adoption (the users) of mHealth (new 
technologies) and the implications for healthcare organizations (organizing), the research 
themes and questions were developed in light of Leonardi’s methodology and guidance 
“Methodological Guidelines for the Study of Materiality and Affordances” (2018) in order to 
crystallize the focus of the data collected in the interviews and subsequently the data 
analysis. 
According to the guidance (Leonardi, 2018), a solid analysis of the factors impacting 
adoption and its impact on organizations follows three main steps: 
• Step 1: Understanding and documenting the material aspects of technology and their 
limitations 
• Step 2: Linking the material aspects of technology to the tasks that they enable and 
facilitate  
• Step 3: Recognizing the processes resulting from these affordances and determining 
the consequential interactions taking place in the organization  
The following sub-sections give an explanation of how the research analysis stemmed from 
these three steps by detailing the research themes and the logic behind them. The three 
steps are kept in the same order defined in the guidance to respect their cumulative nature, 
and to allow each step to lead us into the next one.  
2.1.1 Step 1: ‘Accounting for materials’ 
This step focuses on investigating the limitations of technology and the types of uses that it 
allows. Understanding the material aspects of mHealth tools is vital because it allows us to 
recognise the different ways they can be used as well as things that cannot be done with 
them due to material limitations in their features. Technological features ‘can have various 




means that a good understanding of the technological features of the tool, recognizing what 
it can do versus what it cannot do, helps us understand not only the opportunities but also 
the limitations related to its use.  
That explains why the way a technological tool is built and its specific features matter, 
because based on that some uses might be very difficult or impossible to achieve, the same 
way that the material factors sometimes resist scientists’ efforts to control them, implying 
that materials have agency (Pickering, 1993). At the same time, the user’s ability to reshape 
or rearrange the material aspects of a tool impacts the way it is used (Kallinikos, 2012). That 
explains why researchers desiring to study digital technological artefacts listed all the 
features of a particular tool and described in detail what they were expected to achieve 
according to the developers, and detailed how all the features that form the final solution 
play a role in how it works (Poole and DeSanctis, 1992). The intangible nature of digital tools 
and the complexity of the ‘agency of the software routines’ that they are built on, however, 
might sometimes pose a challenge in understanding the limitations of their use (Leonardi, 
2010).  
Based on these arguments, the methodological guidance suggests that studying the material 
aspects and features of technological tools are the first step that will help us then understand 
the role of materiality in the organizing process (Leonardi, 2018). Figure 1 shows a mind 
map, reflecting the ideas discussed in this sub-section, of the notable scholars that shaped 
the understanding of the material aspects of technology and led Leonardi to outline this step 
that revolves around three questions aiming to help us understand the materials that form a 
specific technological tool, how they are organized into specific features, and what such 
features do or not do. Answering these questions is key to recognizing the utilities and 











Figure 1: Notable scholars shaping the understanding of the material aspects of technology 
 
Source: Author after (Leonardi, 2018) 
2.1.2 Step 2: ‘Accounting for materiality’ 
This second step aims to understand users’ perceptions of technology and how they intend 
to use it, because people’s views of technology can impact the way they utilize it in their 
everyday life (Leonardi, 2018). Exploring this idea requires an important differentiation 
between two key terms in the literature: sociomateriality and materiality, and how the 
different scholars have portrayed the way materiality becomes ‘entangled’ with users’ social 
practices. Inspired by agential realism (Barad, 2007) that theorizes the ‘entanglement’ of 
social and material aspects, sociomateriality is defined as: 
“The portmanteau ‘sociomaterial’ (no hyphen) attempts to signal [an] ontological fusion. Any 
distinction of humans and technologies is analytical only, and done with the recognition that 
these entities necessarily entail each other in practice.” (Orlikowski and Scott, 2008, p.456)  
However, this definition portrays a connection between the social and the material, which is 
only defined by researchers trying to make assertions about what counts or not from within a 
specific disciplinary view (Latour, 2005); this entails that sociomateriality as defined here is 
more of a way of being than a process that researchers can study (Leonardi, 2018). This 
concept of sociomateriality reminds us though that materials are continuously used, 




one when people start using it to achieve different tasks (Barley, 1981), it becomes part of 
their daily routine and the social and material aspects become imbricated (Leonardi, 2012), 
this is because materiality is triggered through users’ interactions with it making it difficult to 
argue that the social and material aspects are fundamentally independent leading to 
Leonardi’s differentiation between the concepts of sociomateriality and materiality: 
“So, if sociomateriality is an ontology, is there something out there called “sociomateriality” 
that we can also study empirically? I don’t think so. Technological artefacts cannot have 
sociomateriality, but they can have materiality” (Leonardi, 2018, p.284)  
He explains that claiming that a certain technology has materiality means that its materials 
are being ‘entangled’ or ‘imbricated’ with users’ experiences and culture in forms that make it 
hard to define the technological tool separately from its context of usage. Therefore, it is 
important to understand how materiality is produced by recognizing the constraints and 
affordances of technology to analyse materiality and the fusion of technology into social 
practices (Leonardi, 2018). This understanding acknowledges that users’ intentions and the 
goals that they want to achieve when using a specific technology have an impact on its 
affordances.  
Several academics believe that materiality is typically created through the understanding of 
the affordances and constraints of a specific tool (Leonardi, 2011, 2012, 2013), such 
understanding can clarify how materiality occurs at the junction between technology and its 
users (Faraj and Azad, 2012; Majchrzak et al., 2013). Affordances might arise when the 
existing material features of a certain technological tool are given a meaning based on its 
users’ perceptions and behaviour, bearing in mind that people typically will not interact with a 
technology unless they already recognize its utility (Gibson, 1986); this would entail that one 
technological tool might have different outcomes because materiality can offer various 
affordances depending on its users (Leonardi, 2018). Conversely, other scholars suggest 
that affordances are created by design and do not change depending on the contexts or 
users, but rather shaped by the designers  and ‘waiting to be perceived’ or discovered by the 
users (Norman, 1990, 1999). 
Hutchby (2001) takes a middle ground position between Norman (1990, 1999) and Gibson 
(1986) explaining that it is the relationship between the users and technology that results in 
specific affordances, meaning that affordances of a particular tool might change from one 
context to another even when its material features do not change (Hutchby, 2001). This is 
mainly due to the fact that users usually have different goals when approaching a tool 




also means that technology can have different uses, resulting in various ways in how work is 
organized (Fayard and Weeks, 2007; Zammuto et al., 2007). 
Based on these arguments, researchers studying materiality should investigate how the 
material aspects of technology blend with the users’ social context producing their 
perceptions about their constraints and affordances (Leonardi, 2018). Figure 2 shows a mind 
map, reflecting the ideas discussed in this sub-section, of the notable scholars that shaped 
the understanding of the materiality of technology and led Leonardi to outline this step that 
revolves around three questions aiming to help us understand what social factors shape the 
users’ objectives, how these objectives impact users’ understandings of what a specific 
technology can or cannot do, and what makes users perceive different constraints or 
affordances based on the tool’s features. Therefore, this step focuses on understanding 
users’ views of mHealth, their usage intentions, decision drivers and what they perceive as 
an affordance or constraint for its adoption.  
Figure 2: Notable scholars shaping the understanding of the materiality of technology  
 
Source: Author after (Leonardi, 2018) 
2.1.3 Step 3: ‘Accounting for materialization’ 
The third and last step concentrates on how the material aspects of technology change the 
ways of organizing work and its process. After understanding the limitations of a 




important to expand the analysis to comprehend the impact of technology adoption on the 
way people organize work. This step is about realizing the instances when particular 
affordances impact and transform users’ actions, hierarchies and relationships that 
constitute the organizing process (Leonardi, 2018).  
Not every technology will clearly impact the organizing process though, it is the enablement 
of certain affordances that helps a technological tool to materialize in a way that actually 
impacts how work is being organized in a specific organization (Leonardi, 2018). To better 
understand this idea, we can look at the example of a group of technicians who were given a 
new IT system; they started by using it for its initially defined feature of assigning jobs to 
others, and as they recognized its affordances, their use developed to use it for other uses 
such as documenting completed jobs, which further progressed to use this documentation to 
define who’s the best technician to be assigned a new task based on their previous 
experiences. This is how the system started to materialize as a crucial element in organizing 
and optimizing work in that department rather than merely assigning jobs to others as initially 
intended (Leonardi, 2007).   
The materialization of technology is an acknowledgement that it created specific and 
considerable outcomes that make it play a central role in the organizing process (Leonardi, 
2018). This can be understood linguistically by looking to the term “material” that stemmed 
from the Latin name ‘materia’ that can be defined as the “substance from which something is 
made”. Hence, when we want to understand what appears to be occurring in a certain 
situation we usually ask ‘what’s the matter’ to ask about the underlying cause of what’s 
happening (Cooren, 2015). 
Based on these arguments, researchers studying materialisation should investigate how 
technology impacts the organizing process (Leonardi, 2018). Figure 3 shows a mind map, 
reflecting the ideas discussed in this sub-section, of the notable scholars that shaped the 
understanding of the materialization of technology and led Leonardi to outline this step that 
revolves around three questions aiming to help us understand how the current patterns of 
organizing rely on the materiality of specific technologies, why some organizing processes 
create a social context in which technology can materialize in actions and interactions’ flows, 
and how have the affordances enabled by technology supported, changed, or transformed 
the way that people work or interact in a specific organization. Therefore, the focus in this 
final step is on understanding how mHealth impacts the way people interact and organize 





Figure 3: Notable scholars shaping the understanding of the materialization of technology 
 
Source: Author after (Leonardi, 2018) 
2.2 Systematic review of the literature  
The literature review aimed to systematically examine the published literature to better 
understand the different factors that may impact clinicians’ decision to adopt specific 
mHealth tools or not. Using Leonardi’s (2018) methodological guidance explained in the 
previous section, it synthesized the current understanding about the factors impacting 
clinicians’ adoption of mHealth not only from a technology perspective but also social and 
organizational perspectives. This sociotechnical approach was crucial for the researcher 
who had worked in the healthcare technology area for years and saw an overemphasis on 
the technical factors and aspects, therefore, she wanted to gain a more in-depth 
understanding of the complex and interrelated factors impacting technology adoption in 
healthcare by expanding her horizons using a sociotechnical approach that also takes 
individual, social, and organizational practices into account. The following sub-sections 
briefly summarize the methodology and high-level findings of the systematic review that was 
conducted in the context of this PhD thesis and published as: 
Jacob C, Sanchez-Vazquez A, Ivory C. Social, Organizational, and Technological 
Factors Impacting Clinicians’ Adoption of Mobile Health Tools: Systematic Literature 




2.2.1 Literature review methodology 
The methods for this systematic literature review were drawn from the Preferred Reporting 
Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines (Moher et al., 2009) 
and the Cochrane Handbook (Higgins and Green, 2011), both of which offer guidelines 
towards a reliable and rigorous methodology. These methods were defined beforehand and 
the review protocol was published in the PROSPERO international prospective register of 
systematic reviews, available online (Jacob, Ivory and Sánchez-Vázquez, 2018). The 
analysis didn’t necessitate any key deviation from the original protocol.  
2.2.1.1 Purpose, scope, and definitions  
The main purpose of the review was to examine the social, organizational and technological 
factors impacting clinicians' adoption of mHealth tools according to the published literature in 
a systematic manner. The scope was defined using the Participants, Intervention, 
Comparators, and Outcome (PICO) framework (PubMedHealth, 2018), and table 1 shows 
the corresponding inclusion and exclusion criteria.  
Table 1: Inclusion and exclusion criteria according to the PICO framework 
Population (P) 
Include: focused on healthcare professionals: e.g., physicians, nurses. 
Exclude: focused only on patients, caregivers or technology providers. 
Intervention (I) 
Include: focused on solutions involving a smart device: e.g., Mobile Health apps, Telehealth. 
Exclude: using other technologies: e.g., Virtual Reality, Machine Learning. 
Comparators (C) 
Does not apply. 
Outcome (O) 
Include: addresses factors impacting clinicians’ adoption, acceptance, use, experience, 
implementation, usability, or attitude of using Mobile Health for health care service delivery, 
regardless of the condition. 
Exclude: if focused only on mHealth success or development in general. 
Publication type  
Include: original, peer-reviewed, published paper. 
Exclude: editorials, interviews, comments, unstructured observations, and position papers, or 
similar. 




To define mHealth, the researcher used the World Health Organization’s Global observatory 
of eHealth definition as “medical and public health practice supported by mobile devices, 
such as mobile phones, patient monitoring devices, Personal Digital Assistants (PDAs), and 
other wireless devices”, Telemedicine is in turn a sub-category of mHealth and defined as 
“the communication or consultation between health professionals about patients using the 
voice, text, data, imaging, or video functions of a mobile device. But it can be applied to 
other situations; the management of chronic diseases of patients living at home is one 
example.” (Kay, Santos and Takane, 2011). This is the same definition used in this thesis 
from start to end.  
2.2.1.2 Outline of the search strategy 
Three databases were searched to identify the relevant studies in August and September 
2018: Medline PubMed, the Cochrane Library, and the SAGE database. The researcher 
narrowed the scope to articles published in the English language between January 2008 and 
August 2018. Hand searches of reference lists were not used because of the reasons 
summarized in the Cochrane Handbook: “positive studies are more likely to be cited” and 
“retrieving literature by scanning reference lists may thus produce a biased sample of 
studies” (Higgins and Green, 2011). Figure 4 shows the search string that was defined as 
per the Participants, Intervention, Comparators, and Outcome (PICO) framework 
(PubMedHealth, 2018) , there were no limitations on the types of health conditions qualified 
for inclusion and both qualitative and quantitative studies were included. As per the figure, 
the focus population for the study are clinicians, focus intervention are mHealth tools, focus 
outcome is the adoption of these tools; the search string included the possible synonyms or 
alternatives for each of the focus elements of the PICO framework.  




physician OR doctor OR nurse OR HCP  
OR “health care professional” OR oncologist  
OR clinician OR practitioner 




mHealth OR “mobile health” OR telehealth  
OR eHealth OR “mobile applications” OR “mobile apps”  
OR smartphone OR telemonitoring OR app 




Adoption OR Practice OR enable OR encourage  
OR foster OR acceptance OR use OR experience  
OR implementation OR usability OR attitude OR diffusion 




The databases’ search using the defined search string yielded 4993 results, of which 171 
met the inclusion criteria. Figure 5 shows the study selection flow diagram based on the 
PRISMA guidelines, clarifying the different levels of results starting with the identification 
phase, followed by the screening, then eligibility, and the inclusion results. As per the figure, 
the initial search yielded 4993 records, of which 3516 were identified in PubMed database, 
1296 in SAGE database, and 181 In the Cochrane database. As a first step 1156 were 
excluded because they were either dated before 2008 (1156 studies), or written in a 
language other than English (169 studies), leaving 3837 records to screen. After the initial 
screening of the study abstracts, 3458 records were excluded either because they did not 
involve mobile health or smart devices (493 studies), were focussed solely on e.g., patients, 
caregivers or technology providers and did not include clinicians (531 studies), were either 
non-peer-reviewed, editorials, interviews, comments, unstructured observations or position 
papers (271 studies), the full text was not available (2 studies), were not available in English 
(2 studies), did not address the factors impacting adoption (2119 studies), or were duplicates 
(40 studies). This left 338 full text articles to be assessed for eligibility, of which 161 were 
excluded either because they did not involve mobile health or smart devices (28 studies), 
were focused solely on e.g., patients, caregivers or technology providers and did not include 
clinicians (9 studies), were either non-peer-reviewed, editorials, interviews, comments, 
unstructured observations or position papers (6 studies), the full text was not available (4 
studies), or did not address the factors impacting adoption (120 studies). Therefore, this 
screening process resulted in 171 studies that met all the inclusion criteria and were 













Figure 5: Study selection flow diagram based on the PRISMA guidelines 
Identification 
 
4993 records identified  
- 3516 in PubMed 
- 1296 in SAGE 
- 181 In Cochrane 
  
    
Screening 
 
3837 records screened   
1156 records excluded as per the following criteria: 
- 987 studies dating before 2008 (older than 10 years) 
- 169 studies in languages other than English 
    
 
3796 records  
after removing 
duplicates  
Titles and abstract 
analyzed  
for inclusion or exclusion 
decision 
  
3458 articles excluded, for one or more of the following 
reasons: 
- 493 studies not involving mobile health or smart devices 
- 531 studies focusing solely on e.g. patients, caregivers 
or technology providers and not including clinicians 
- 271 studies are either non-peer-reviewed, editorials, 
interviews, comments, unstructured observations or 
position papers 
- 2 studies where the full text is not available, or not freely 
available 
- 2 studies not available in English 
- 2119 studies do not address the factors impacting 
adoption 
- 40 duplicates 
Eligibility 
    
 
338 full-text articles 
assessed for eligibility 
  
167 articles excluded, for one or more of the following 
reasons: 
- 28 studies not involving mobile health or smart devices 
- 9 studies focusing solely on e.g. patients, caregivers or 
technology providers and not including clinicians 
- 6 studies are either non-peer-reviewed, editorials, 
interviews, comments, unstructured observations or 
position papers 
- 4 studies where the full text is not available, or not freely 
available 
- 120 studies do not address the factors impacting 
adoption 
Inclusion 
    
 
171 studies included  
in qualitative synthesis 
  
Source: initially published in (Jacob, Sanchez-Vazquez and Ivory, 2020a) 
2.2.1.3 Outline of critical appraisal strategy 
The researcher used the Critical Appraisal Skills Programme (CASP) tool (Critical Appraisal 
Skills Programme, 2018) to assess the risk of study bias. The checklist and an Excel sheet 
with the appraisal of the included studies were both published in the paper that reports the 
detailed findings of the review as mentioned earlier (Jacob, Sanchez-Vazquez and Ivory, 
2020a).  In summary:  
- 38/171 studies did not include a clear participant recruitment strategy  
- 40/171 did not provide enough information on their data collection techniques  
- 76/171 did not report on how they addressed potential ethical considerations 




However, the researcher elected not to exclude articles based on their technical quality in 
order to capture both empirical and theoretical contributions from the published research. 
2.2.2 Thematic approach according to the theoretical framework   
The included studies encompassed a heterogeneous mixture of measures and outcomes 
that were not similar enough to allow a quantitative synthesis of the data. Thus, a narrative 
synthesis was used and structured around the different factors impacting clinician's adoption 
of mobile health solutions.  
The researcher was most interested in gaining an in-depth understanding of the technical, 
social, and organizational factors impacting adoption, therefore, the data coding began with 
an initial data extraction grid that included themes based on the theoretical framework, 
Leonardi’s “Methodological Guidelines for the Study of Materiality and Affordances” 
(Leonardi, 2018), as well as previous research and technology acceptance frameworks. 
Following Leonardi’s (2018) guidance, the researcher categorized the relevant adoption 
factors into technical, social, and organizational factors. Additional themes were added as 
they emerged during the review process. Braun and Clarke’s thematic analysis (Braun and 
Clarke, 2006) was used to identify and extract themes that met the review’s scope and 
purpose.  
2.2.3 Systematic review results  
As detailed in section 2.2.1.2. the review included 171 studies that met the selection criteria. 
Table 2 shows the characteristics of the studies included in the systematic literature review, 
including: study design, sample size, sample composition, clinical specialty or health 
condition, and location for each of the included studies.  





(Armstrong et al., 2011, 2012; Avey and Hobbs, 2013; Bagot et al., 2017; 
Beauregard, Arnaert and Ponzoni, 2017; Bello et al., 2017; Bhatta, Aryal 
and Ellingsen, 2015; Carlisle and Warren, 2013; Cary et al., 2016; Casey, 
Shaw and Swinglehurst, 2017; Catan et al., 2015; Chiang et al., 2015; 
Chung et al., 2015; de Souza et al., 2017; de Vries et al., 2017; Egerton et 
al., 2017; Esterle and Mathieu-Fritz, 2013; Fairbrother et al., 2014; Farrell, 
2016; Flynn et al., 2009; Giraldo et al., 2018; Goedken et al., 2017; 
Grünloh, Cajander and Myreteg, 2016; Han, Subramanian and Cameron, 
n.d.; Hanley et al., 2013; Hanna, May and Fairhurst, 2012; Hines et al., 
2015; James et al., 2016; Jarvis-Selinger et al., 2011; Jimbo et al., 2013; 




Kopanitsa and Yampolsky, 2016; Lacasta Tintorer et al., 2018; Levine et al., 
2014; Lord et al., 2016; MacNeill et al., 2014; McNally, Frey and Crossan, 
2017; Merchant et al., 2015; Moharra et al., 2015; Molfenter et al., 2015; 
Molleda et al., 2017; Moloczij et al., 2015; Morrow et al., 2017; Odeh et al., 
2014; Öberg et al., 2017; Puszka et al., 2016; Rothstein et al., 2016; 
Sandberg et al., 2009; Schneider et al., 2016; Seto et al., 2012; Sharma, 
Barnett and Clarke, 2010; Sharma and Clarke, 2014; Sinclair et al., 2013; 
Sturesson and Groth, 2018; Taylor and Coates, 2015; van Gaalen et al., 
2016; Varsi et al., 2015a; b; Vest et al., 2017; Wilhelmsen et al., 2014; 
Wynn et al., 2012; Zilliacus et al., 2010) 
Quantitative 
(n=58) 
(Abd Ghani and Jaber, 2015; Adenuga, Iahad and Miskon, 2017; Albrecht 
et al., 2017; El Amrani et al., 2017; Anderson et al., 2017; Asua et al., 2012; 
Ayatollahi et al., 2018; Mandirola Brieux et al., 2017; Dünnebeil et al., 2012; 
Duhm et al., 2016; Duplaga, 2016; Gagnon et al., 2012b; Hackl et al., 2014; 
Hao and Padman, 2018; Holderried et al., 2018; Jefee-Bahloul, Duchen and 
Barkil-Oteo, 2016; Jetty et al., 2018; Jury, Walker and Kornberg, 2013; Kato 
et al., 2015; Kifle et al., 2010; Kim et al., 2016; Klack et al., 2013; Kleinpell 
et al., 2016; Koval, Kim and Makhlouf, n.d.; Kowitlawakul, 2011; Kuhn et al., 
2014; Kuo et al., 2015; Lee et al., 2012; L’Esperance and Perry, 2016; Liu 
and Cheng, 2015; Ly et al., 2018; Mairesse et al., 2015; Miller et al., 2017; 
Moore et al., 2017; Ruiz Morilla et al., 2017; Moskowitz et al., 2010; 
O’Connor and Andrews, 2018; Okazaki et al., 2012; Orruño et al., 2011; 
Putzer and Park, 2012; Rho, Choi and Lee, 2014; Rogove et al., 2012; 
Sadoughi et al., 2017; Saigi-Rubió, Jiménez-Zarco and Torrent-Sellens, 
2016; Saigí-Rubió, Torrent-Sellens and Jiménez-Zarco, 2014; Sandholzer 
et al., 2015; Schmeer et al., 2016; Sezgin, Özkan-Yildirim and Yildirim, 
2017; Sims et al., 2016; Smith and Buzi, 2014; Steinschaden, Petersson 
and Astrand, 2009; Uscher-Pines and Kahn, 2014; van Houwelingen et al., 
2015; Villalba-Mora et al., 2015; Yaman et al., 2016; Zailani et al., 2014; 




(Alajlani and Clarke, 2013; Ariens et al., 2017; Bailey et al., 2017; Bidmead 
and Marshall, 2016; Bramley, Mangan and Conroy, 2018; Brown et al., 
2018; Chang et al., 2017; Charani et al., 2013; Cox et al., 2011; Ehrler et 
al., 2018; Iacono et al., 2016; Jamu, Lowi-Jones and Mitchell, 2016; Jeon et 
al., 2014; Loh, Flicker and Horner, 2009; Lapão, da Silva and Gregório, 
2017; Lygidakis et al., 2016; Mueller et al., 2014; Muigg et al., 2018; 
Nerminathan et al., 2017; Odnoletkova et al., 2016; Orchard et al., 2016; 
Payne, Weeks and Dunning, 2014; Possemato et al., 2017; Quanbeck et 
al., 2018; Ray et al., 2017; Shaw et al., 2013; Tahamtan et al., 2017; Taylor 
et al., 2016; Walker and Clendon, 2016; Williamson and Muckle, 2018; 
Zhang and Koch, 2015) 
Systematic 
Review (n=11) 
(Brewster et al., 2014; Davis et al., 2014; Gagnon et al., 2016; Hickson et 




2013; Lewis et al., 2012; Li and Cotton, 2018; Mileski et al., 2017; Penny, 
Bradford and Langbecker, 2018; Radhakrishnan et al., 2016) 
Others (n=5) (Daniel et al., 2018; Choi et al., 2018; Jungwirth and Haluza, n.d.; Ahmad, 
Norman and O’Campo, 2012; Mishori et al., 2017) 
Sample Size Less than 10 
(n=8) 
(Beauregard, Arnaert and Ponzoni, 2017; Cary et al., 2016; Casey, Shaw 
and Swinglehurst, 2017; Molfenter et al., 2015; Odeh et al., 2014; Taylor et 
al., 2016; Varsi et al., 2015a; Vest et al., 2017) 
10 - 20 (n=41)  (Armstrong et al., 2011, 2012; Avey and Hobbs, 2013; Bagot et al., 2017; 
Bailey et al., 2017; Bhatta, Aryal and Ellingsen, 2015; Brewster et al., 2014; 
Carlisle and Warren, 2013; Catan et al., 2015; Cox et al., 2011; 
Cunningham et al., 2013; Davis et al., 2014; de Souza et al., 2017; Duhm et 
al., 2016; Egerton et al., 2017; Ehrler et al., 2018; Esterle and Mathieu-Fritz, 
2013; Farrell, 2016; Grünloh, Cajander and Myreteg, 2016; Hanna, May and 
Fairhurst, 2012; Hines et al., 2015; Jamu, Lowi-Jones and Mitchell, 2016; 
Khan et al., 2015; Kim, Tiyyagura and Langhan, 2017; Lord et al., 2016; 
Lapão, da Silva and Gregório, 2017; McNally, Frey and Crossan, 2017; 
Merchant et al., 2015; Mishori et al., 2017; Moharra et al., 2015; Molleda et 
al., 2017; Öberg et al., 2017; Sandberg et al., 2009; Sharma, Barnett and 
Clarke, 2010; Sharma and Clarke, 2014; Sturesson and Groth, 2018; 
Uscher-Pines and Kahn, 2014; Varsi et al., 2015b; Wilhelmsen et al., 2014; 
Wynn et al., 2012; Zilliacus et al., 2010) 
21 - 40 (n=30)  (Abd Ghani and Jaber, 2015; Bishop et al., 2013; Bramley, Mangan and 
Conroy, 2018; Chiang et al., 2015; Chung et al., 2015; Fairbrother et al., 
2014; Gagnon et al., 2016; Giraldo et al., 2018; Goedken et al., 2017; Han, 
Subramanian and Cameron, n.d.; James et al., 2016; Jefee-Bahloul, 
Duchen and Barkil-Oteo, 2016; Jeon et al., 2014; Jimbo et al., 2013; Kayyali 
et al., 2017; Koval, Kim and Makhlouf, n.d.; Levine et al., 2014; MacNeill et 
al., 2014; Moloczij et al., 2015; Morrow et al., 2017; Payne, Weeks and 
Dunning, 2014; Possemato et al., 2017; Puszka et al., 2016; Rothstein et 
al., 2016; Sadoughi et al., 2017; Schmeer et al., 2016; Schneider et al., 
2016; Seto et al., 2012; Sinclair et al., 2013; Walker and Clendon, 2016) 
41 - 60 (n=11)  (Ahmad, Norman and O’Campo, 2012; Anderson et al., 2017; Hanley et al., 
2013; Iacono et al., 2016; Jarvis-Selinger et al., 2011; Kopanitsa and 
Yampolsky, 2016; Lacasta Tintorer et al., 2018; Loh, Flicker and Horner, 
2009; Mairesse et al., 2015; van Gaalen et al., 2016; Zhang and Koch, 
2015) 
61 - 80 (n=8)  (Bello et al., 2017; Bidmead and Marshall, 2016; de Vries et al., 2017; 
Jungwirth and Haluza, n.d.; Lee et al., 2012; L’Esperance and Perry, 2016; 
Putzer and Park, 2010; Sims et al., 2016) 
81 - 100 (n=5) (Charani et al., 2013; Gagnon et al., 2012b; Muigg et al., 2018; Saigi-Rubió, 
Jiménez-Zarco and Torrent-Sellens, 2016; Zhang, Cocosila and Archer, 
2010) 
More than 100 
(n=61) 
(Adenuga, Iahad and Miskon, 2017; Alajlani and Clarke, 2013; Albrecht et 




Mandirola Brieux et al., 2017; Brown et al., 2018; Chang et al., 2017; Choi 
et al., 2018; Daniel et al., 2018; Dünnebeil et al., 2012; Duplaga, 2016; 
Flynn et al., 2009; Asua et al., 2012; Hackl et al., 2014; Hao and Padman, 
2018; Holderried et al., 2018; Jetty et al., 2018; Jury, Walker and Kornberg, 
2013; Kato et al., 2015; Kifle et al., 2010; Kim et al., 2016; Klack et al., 
2013; Kleinpell et al., 2016; Kowitlawakul, 2011; Kuhn et al., 2014; Kuo et 
al., 2015; Liu and Cheng, 2015; Ly et al., 2018; Lygidakis et al., 2016; Miller 
et al., 2017; Moore et al., 2017; Ruiz Morilla et al., 2017; Moskowitz et al., 
2010; Mueller et al., 2014; Nerminathan et al., 2017; O’Connor and 
Andrews, 2018; Odnoletkova et al., 2016; Okazaki et al., 2012; Orchard et 
al., 2016; Orruño et al., 2011; Putzer and Park, 2012; Quanbeck et al., 
2018; Ray et al., 2017; Rho, Choi and Lee, 2014; Rogove et al., 2012; 
Saigí-Rubió, Torrent-Sellens and Jiménez-Zarco, 2014; Sandholzer et al., 
2015; Sezgin, Özkan-Yildirim and Yildirim, 2017; Shaw et al., 2013; Smith 
and Buzi, 2014; Steinschaden, Petersson and Astrand, 2009; Tahamtan et 
al., 2017; Taylor and Coates, 2015; van Houwelingen et al., 2015; Villalba-
Mora et al., 2015; Williamson and Muckle, 2018; Yaman et al., 2016; Zailani 







(Adenuga, Iahad and Miskon, 2017; Asua et al., 2012; Ayatollahi et al., 
2018; Mandirola Brieux et al., 2017; Cary et al., 2016; Charani et al., 2013; 
Chiang et al., 2015; Chung et al., 2015; Cox et al., 2011; Cunningham et al., 
2013; Esterle and Mathieu-Fritz, 2013; Gagnon et al., 2012b, 2016; 
Goedken et al., 2017; Hackl et al., 2014; Han, Subramanian and Cameron, 
n.d.; Jamu, Lowi-Jones and Mitchell, 2016; Jefee-Bahloul, Duchen and 
Barkil-Oteo, 2016; Jimbo et al., 2013; Jungwirth and Haluza, n.d.; Kato et 
al., 2015; Kayyali et al., 2017; Khan et al., 2015; Kim et al., 2016; Koval, 
Kim and Makhlouf, n.d.; Kuhn et al., 2014; Kumar, Merchant and Reynolds, 
2013; Levine et al., 2014; Lord et al., 2016; MacNeill et al., 2014; Mairesse 
et al., 2015; Merchant et al., 2015; Miller et al., 2017; Mishori et al., 2017; 
Moharra et al., 2015; Molfenter et al., 2015; Moloczij et al., 2015; Morrow et 
al., 2017; Mueller et al., 2014; Orchard et al., 2016; Orruño et al., 2011; 
Penny, Bradford and Langbecker, 2018; Puszka et al., 2016; Ray et al., 
2017; Rogove et al., 2012; Rothstein et al., 2016; Sadoughi et al., 2017; 
Sandberg et al., 2009; Sharma, Barnett and Clarke, 2010; Sims et al., 2016; 
Sinclair et al., 2013; Smith and Buzi, 2014; Sturesson and Groth, 2018; 
Taylor et al., 2016; Uscher-Pines and Kahn, 2014; Varsi et al., 2015a; b; 





(Ahmad, Norman and O’Campo, 2012; Alajlani and Clarke, 2013; Albrecht 
et al., 2017; Ariens et al., 2017; Avey and Hobbs, 2013; Bailey et al., 2017; 
Bello et al., 2017; Bhatta, Aryal and Ellingsen, 2015; Bidmead and Marshall, 
2016; Bishop et al., 2013; Bramley, Mangan and Conroy, 2018; Brown et 
al., 2018; Carlisle and Warren, 2013; Casey, Shaw and Swinglehurst, 2017; 
Catan et al., 2015; Chang et al., 2017; Choi et al., 2018; Davis et al., 2014; 




al., 2013; Hickson et al., 2015; Iacono et al., 2016; James et al., 2016; 
Jarvis-Selinger et al., 2011; Jeon et al., 2014; Jury, Walker and Kornberg, 
2013; Kopanitsa and Yampolsky, 2016; Lacasta Tintorer et al., 2018; 
L’Esperance and Perry, 2016; Lewis et al., 2012; Loh, Flicker and Horner, 
2009; Lapão, da Silva and Gregório, 2017; Lygidakis et al., 2016; Mileski et 
al., 2017; Molleda et al., 2017; Muigg et al., 2018; Odnoletkova et al., 2016; 
Possemato et al., 2017; Quanbeck et al., 2018; Radhakrishnan et al., 2016; 
Seto et al., 2012; Shaw et al., 2013; Taylor and Coates, 2015; van Gaalen 
et al., 2016) 
Physicians 
(n=41) 
(Abd Ghani and Jaber, 2015; El Amrani et al., 2017; Anderson et al., 2017; 
Armstrong et al., 2011, 2012; Daniel et al., 2018; de Souza et al., 2017; 
Dünnebeil et al., 2012; Duhm et al., 2016; Egerton et al., 2017; Grünloh, 
Cajander and Myreteg, 2016; Hanna, May and Fairhurst, 2012; Hao and 
Padman, 2018; Hines et al., 2015; Holderried et al., 2018; Jetty et al., 2018; 
Kifle et al., 2010; Klack et al., 2013; Kuo et al., 2015; Lee et al., 2012; Liu 
and Cheng, 2015; Ly et al., 2018; Moore et al., 2017; Ruiz Morilla et al., 
2017; Moskowitz et al., 2010; Nerminathan et al., 2017; Okazaki et al., 
2012; Payne, Weeks and Dunning, 2014; Putzer and Park, 2012; Rho, Choi 
and Lee, 2014; Saigi-Rubió, Jiménez-Zarco and Torrent-Sellens, 2016; 
Saigí-Rubió, Torrent-Sellens and Jiménez-Zarco, 2014; Sandholzer et al., 
2015; Schneider et al., 2016; Sezgin, Özkan-Yildirim and Yildirim, 2017; 
Steinschaden, Petersson and Astrand, 2009; Tahamtan et al., 2017; 
Villalba-Mora et al., 2015; Wilhelmsen et al., 2014; Yaman et al., 2016; 
Zhang and Koch, 2015) 
Nurses (n=21) (Beauregard, Arnaert and Ponzoni, 2017; Brewster et al., 2014; Duplaga, 
2016; Ehrler et al., 2018; Farrell, 2016; Giraldo et al., 2018; Kleinpell et al., 
2016; Koivunen and Saranto, 2018; Kowitlawakul, 2011; Li and Cotton, 
2018; McNally, Frey and Crossan, 2017; O’Connor and Andrews, 2018; 
Odeh et al., 2014; Öberg et al., 2017; Putzer and Park, 2010; Schmeer et 
al., 2016; van Houwelingen et al., 2015; Vest et al., 2017; Walker and 






(Ahmad, Norman and O’Campo, 2012; Armstrong et al., 2012; Asua et al., 
2012; Casey, Shaw and Swinglehurst, 2017; Davis et al., 2014; Farrell, 
2016; Flynn et al., 2009; Hanley et al., 2013; Hickson et al., 2015; Jury, 
Walker and Kornberg, 2013; Lacasta Tintorer et al., 2018; Lewis et al., 
2012; Molleda et al., 2017; Öberg et al., 2017; Rogove et al., 2012; Saigi-






(Brewster et al., 2014; Fairbrother et al., 2014; Gagnon et al., 2012b; Jarvis-
Selinger et al., 2011; Kato et al., 2015; Klack et al., 2013; Mairesse et al., 
2015; Odeh et al., 2014; Orchard et al., 2016; Seto et al., 2012; Sharma 






(Ayatollahi et al., 2018; Carlisle and Warren, 2013; de Vries et al., 2017; 
James et al., 2016; L’Esperance and Perry, 2016; Muigg et al., 2018; 
Odnoletkova et al., 2016; Okazaki et al., 2012; Sandberg et al., 2009; Vest 




(Albrecht et al., 2017; El Amrani et al., 2017; Egerton et al., 2017; Hanna, 
May and Fairhurst, 2012; Jetty et al., 2018; Moore et al., 2017; Sandholzer 




(Avey and Hobbs, 2013; Cunningham et al., 2013; Iacono et al., 2016; Kuhn 
et al., 2014; Possemato et al., 2017; Puszka et al., 2016; Sinclair et al., 
2013; Wynn et al., 2012) 
Dermatology 
(n=4) 




(Lord et al., 2016; Lygidakis et al., 2016; Molfenter et al., 2015; Quanbeck 





(Loh, Flicker and Horner, 2009; Radhakrishnan et al., 2016; Taylor et al., 




(Kim, Tiyyagura and Langhan, 2017; Ray et al., 2017; Rothstein et al., 
2016; Uscher-Pines and Kahn, 2014) 
Neurology, 
Stroke (n=4) 
(Duhm et al., 2016; Bramley, Mangan and Conroy, 2018; Moloczij et al., 
2015; Moskowitz et al., 2010) 
ICU (n=4) (Kleinpell et al., 2016; Kowitlawakul, 2011; Kumar, Merchant and Reynolds, 
2013; Li and Cotton, 2018) 
Asthma (n=3) (Morrow et al., 2017; Schneider et al., 2016; van Gaalen et al., 2016) 
Oncology 
(n=3) 




(Bailey et al., 2017; Brown et al., 2018; Smith and Buzi, 2014) 
Others (n=13) Ambulatory care (Dünnebeil et al., 2012), Cognitive behavioral therapy 
(Miller et al., 2017), Emergency (Mueller et al., 2014), Genetics (Zilliacus et 
al., 2010), Geriatrics (Esterle and Mathieu-Fritz, 2013; Levine et al., 2014), 
Hypertension (Mileski et al., 2017), Nephrology (Bello et al., 2017), Obesity 
and irritable bowel syndrome (Chung et al., 2015), Otolaryngology 
(Holderried et al., 2018), Radiology (Sadoughi et al., 2017), Speech-
language pathology (Hines et al., 2015), Tuberculosis (Kopanitsa and 
Yampolsky, 2016) 
Location USA (n=38) (Armstrong et al., 2011, 2012; Avey and Hobbs, 2013; Bishop et al., 2013; 
Cary et al., 2016; Chung et al., 2015; Cunningham et al., 2013; Goedken et 




Kim, Tiyyagura and Langhan, 2017; Kleinpell et al., 2016; Koval, Kim and 
Makhlouf, n.d.; Kowitlawakul, 2011; Kuhn et al., 2014; Levine et al., 2014; 
Lord et al., 2016; Miller et al., 2017; Molfenter et al., 2015; Molleda et al., 
2017; Moore et al., 2017; Moskowitz et al., 2010; Mueller et al., 2014; 
Possemato et al., 2017; Putzer and Park, 2012, 2010; Quanbeck et al., 
2018; Ray et al., 2017; Sandberg et al., 2009; Schneider et al., 2016; Shaw 
et al., 2013; Sims et al., 2016; Smith and Buzi, 2014; Uscher-Pines and 
Kahn, 2014; Vest et al., 2017; Williamson and Muckle, 2018) 
UK (n=22) (Bailey et al., 2017; Bidmead and Marshall, 2016; Bramley, Mangan and 
Conroy, 2018; Brewster et al., 2014; Casey, Shaw and Swinglehurst, 2017; 
Charani et al., 2013; Cox et al., 2011; Fairbrother et al., 2014; Flynn et al., 
2009; Hanley et al., 2013; Hanna, May and Fairhurst, 2012; Jamu, Lowi-
Jones and Mitchell, 2016; Kayyali et al., 2017; L’Esperance and Perry, 
2016; MacNeill et al., 2014; Morrow et al., 2017; O’Connor and Andrews, 
2018; Odeh et al., 2014; Payne, Weeks and Dunning, 2014; Sharma, 




(Carlisle and Warren, 2013; Egerton et al., 2017; Farrell, 2016; Hines et al., 
2015; Iacono et al., 2016; James et al., 2016; Jury, Walker and Kornberg, 
2013; Loh, Flicker and Horner, 2009; Moloczij et al., 2015; Nerminathan et 
al., 2017; Orchard et al., 2016; Puszka et al., 2016; Sinclair et al., 2013; 
Taylor et al., 2016; Zilliacus et al., 2010) 
Canada (n=9) (Ahmad, Norman and O’Campo, 2012; Anderson et al., 2017; Beauregard, 
Arnaert and Ponzoni, 2017; Bello et al., 2017; Chang et al., 2017; Jarvis-
Selinger et al., 2011; Jeon et al., 2014; Seto et al., 2012; Zhang, Cocosila 
and Archer, 2010) 
Germany 
(n=7) 
(Albrecht et al., 2017; Dünnebeil et al., 2012; Duhm et al., 2016; Holderried 
et al., 2018; Klack et al., 2013; Sandholzer et al., 2015; Schmeer et al., 
2016) 
Spain (n=7) (Asua et al., 2012; Gagnon et al., 2012b; Lacasta Tintorer et al., 2018; Ruiz 
Morilla et al., 2017; Orruño et al., 2011; Saigi-Rubió, Jiménez-Zarco and 
Torrent-Sellens, 2016; Villalba-Mora et al., 2015) 
Norway (n=4) (Varsi et al., 2015b; a; Wilhelmsen et al., 2014; Wynn et al., 2012) 
South Korea 
(n=4) 
(Choi et al., 2018; Kim et al., 2016; Lee et al., 2012; Rho, Choi and Lee, 
2014) 
Sweden (n=4) (Grünloh, Cajander and Myreteg, 2016; Öberg et al., 2017; Sturesson and 
Groth, 2018; Zhang and Koch, 2015) 
Austria (n=3) (Hackl et al., 2014; Jungwirth and Haluza, n.d.; Muigg et al., 2018) 
Iran (n=3) (Ayatollahi et al., 2018; Sadoughi et al., 2017; Tahamtan et al., 2017) 
Netherlands 
(3) 
(Ariens et al., 2017; van Gaalen et al., 2016; van Houwelingen et al., 2015) 




Others (n=39) Argentina (Giraldo et al., 2018), Australia-UK (Bagot et al., 2017), Austria-
Sweden (Steinschaden, Petersson and Astrand, 2009), Bangladesh (Khan 
et al., 2015), Belgium (Odnoletkova et al., 2016), Brazil (de Souza et al., 
2017), Congo (Mishori et al., 2017), Ethiopia (Kifle et al., 2010), Europe 
(Mairesse et al., 2015; Moharra et al., 2015), France (El Amrani et al., 2017; 
Esterle and Mathieu-Fritz, 2013), Ghana (Rothstein et al., 2016), Iraq (Abd 
Ghani and Jaber, 2015), Israel-Portugal (Catan et al., 2015), Italy (Lygidakis 
et al., 2016), Japan (Okazaki et al., 2012), Japan-Sweden (Kato et al., 
2015), Jordan-Syria (Alajlani and Clarke, 2013), Lebanon (Daniel et al., 
2018), Malaysia (Zailani et al., 2014), Nepal (Bhatta, Aryal and Ellingsen, 
2015), Netherlands-Spain-UK (de Vries et al., 2017), New Zealand 
(McNally, Frey and Crossan, 2017; Walker and Clendon, 2016), Nigeria 
(Adenuga, Iahad and Miskon, 2017), North America-Europe (Rogove et al., 
2012), Poland (Duplaga, 2016), Portugal (Lapão, da Silva and Gregório, 
2017), Russia (Kopanitsa and Yampolsky, 2016), Senegal (Ly et al., 2018), 
South-North America (Mandirola Brieux et al., 2017), Spain-Colombia-
Bolivia (Saigí-Rubió, Torrent-Sellens and Jiménez-Zarco, 2014), Sri Lanka 
(Han, Subramanian and Cameron, n.d.), Switzerland (Ehrler et al., 2018), 
Syria (Jefee-Bahloul, Duchen and Barkil-Oteo, 2016), Turkey (Sezgin, 
Özkan-Yildirim and Yildirim, 2017; Yaman et al., 2016), US-South Africa-
Thailand-Peru (Brown et al., 2018) 
Source: initially published in (Jacob, Sanchez-Vazquez and Ivory, 2020a) 
2.2.3.1 Technical and material factors 
The technical and material factors impacting clinicians’ mHealth adoption were categorized 
into 8 key themes: usefulness, ease of use, design, compatibility, technical issues, content, 
personalization and convenience; and these were sub-divided into 14 sub-themes. The most 
prominent factor group was technical issues, frequently linked to matters such as 
connectivity (17/171), system or tool reliability (21/171), the availability and efficacy of 
technical support (27/171), and technical difficulties in general (38/171). Factors defining 
usefulness, such as expected benefits, the tool’s performance expectancy and its added 
value were also prominent (64/171); while factors determining ease of use such as the tool’s 
usability and users’ effort expectancy were also central (55/171) (Jacob, Sanchez-Vazquez 
and Ivory, 2020a).  
Furthermore, some papers raised concerns related to the tools’ compatibility such as 
interoperability issues (31/171), Electronic Health Record (EHR) integration (20/171), and 
the tool’s competition with existing programs in the same clinic or hospital (1/171). Several 
design related aspects were also mentioned, such as the app’s layout, interface, and 




design to be patient centred (11/171). Convenience, often determined by the tool’s level of 
mobility and flexibility also played a role (17/171), plus the trustworthiness and quality of the 
content (15/171), and personalization opportunities through the app’s adaptability and 
customization (7/171) (Jacob, Sanchez-Vazquez and Ivory, 2020a). Figure 6 visualizes 
these technical and material factors, and their respective occurrence in the studied literature. 
Figure 6: Technical and material factors and their occurrence in the studied literature 
 
Source: initially published in (Jacob, Sanchez-Vazquez and Ivory, 2020a) 
2.2.3.2 Social and organizational factors 
The social and organizational factors were noticeably more numerous than the technical 
factors and were also sorted in 8 main themes: workflow related factors, patient related 
factors, health care policy and regulations, local and organizational culture as well as 
attitude and social influence, monetary and cost factors, evidence base proving the value of 
the tool, users’ awareness, and user engagement. These were in turn split into 41 sub-










Figure 7: Social and organizational factors and their occurrence in the studied literature 
 
Source: initially published in (Jacob, Sanchez-Vazquez and Ivory, 2020a) 
The workflow related factors were the most prominent in the included studies, with 17 sub-
themes. Training (80/171), workload (66/171), workflow fit (60/171), time and cost 
efficiencies (51/171), collaboration and coordination among clinicians (50/171), users’ 
technical skills and past experience (44/171), the impact of the tool’s use on clinicians’ roles 
and responsibilities (40/171), leadership support (35/171), the organizational or country level 
infrastructure (33/171), the standardization and planning of the clinical process (26/171), 
staff competence (26/171), health data access and management (25/171), potential changes 
to traditional clinical practice (24/171), job security of the care team (22/171), incentives 
(15/171), impact on clinicians’ career and potential knowledge expansion (13/171), and 
decision making (8/171) (Jacob, Sanchez-Vazquez and Ivory, 2020a). 
Patient related factors arose quite often, and were classified into 13 sub-themes. Quality and 
efficiency of patient care was the most prominent (77/171); followed by the quality and ease 
of communications between the care team and their patients (53/171), improving access to 
care (41/171), then the ease of getting an informed consent from the patients and their 
comfort with technology (30/171). Applicability and appropriateness, meaning the suitability 
of patients, based on their needs and characteristics arose frequently (24/171), and using 
mHealth to foster patient empowerment and engagement was also key (21/171). And in 
addition to patient safety (n=19); factors included: patient age, living standard, and access to 




support of their care team (8/171); also, patients’ worries associated with their data 
interpretation, or their feeling of being observed (6/171). The least frequent factors were 
those echoing concerns regarding patients’ long-term use (3/171), and protective attitudes of 
the practitioners (2/171) (Jacob, Sanchez-Vazquez and Ivory, 2020a). 
Other social and organizational factors included the external healthcare policies and 
regulations related to data privacy, security, and medico-legal issues (66/171), and the need 
for clearer policies and guidelines (44/171). Cultural and social factors were also central and 
were mostly linked to users’ attitudes towards technology (57/171), organizational culture 
and context (21/171), and peer influence and endorsement (21/171). Monetary factors such 
as reimbursement and funding (51/171), and cost (35/171) were also vital. Followed by the 
strength and quality of clinical evidence (22/171), lack of apps’ promotion and users’ 
awareness (20/171), and user involvement in the tools’ development and planning (12/171) 
(Jacob, Sanchez-Vazquez and Ivory, 2020a).  
2.2.4 Key findings: technical, social, and organizational factors 
The detailed discussion of the systematic literature review findings were published earlier 
(Jacob, Sanchez-Vazquez and Ivory, 2020a), therefore, this section only summarizes the 
key overall outcomes of the review to put them in the context of this thesis. These findings 
will be discussed in contrast with the outcomes of this multiple-case study in the discussion 
section of this thesis.  
2.2.4.1 Technological factors 
The most cited technical barrier was the different types of technical difficulties and 
limitations, examples included issues like failing to update the system or difficulties with 
testing and installing the tools (Avey and Hobbs, 2013; Brewster et al., 2014; James et al., 
2016), as well as poor video or audio quality (de Souza et al., 2017; Penny, Bradford and 
Langbecker, 2018; Sturesson and Groth, 2018; Zilliacus et al., 2010), and some log-in 
problems (Duhm et al., 2016; Farrell, 2016; Varsi et al., 2015b; Walker and Clendon, 2016). 
The availability and cooperation of technical support were also central; users reported 
concerns about technical service delivery due to shortage of technical support staff (Odeh et 
al., 2014; Öberg et al., 2017; Sharma and Clarke, 2014; Sharma, Barnett and Clarke, 2010; 
Wynn et al., 2012). System reliability is also key, as system failures and malfunctions may 
hinder adoption (Brown et al., 2018; Chiang et al., 2015; Steinschaden, Petersson and 




situation even when their patients are using the app on their own (Moloczij et al., 2015; 
Sharma, Barnett and Clarke, 2010).  
Usefulness clearly impacts the adoption and intention to use too, users are more likely to 
use an app when they understand its benefits (Catan et al., 2015; Seto et al., 2012; Varsi et 
al., 2015b), and when it is useful for their work (Charani et al., 2013; Duhm et al., 2016; 
Putzer and Park, 2012; Sandholzer et al., 2015; Varsi et al., 2015a; Wilhelmsen et al., 2014; 
Zhang, Cocosila and Archer, 2010).Perceived usefulness is also frequently linked to the 
tool’s ease of use and effort expectancy. Apps should be user friendly, so that every user 
can use them easily (Bhatta, Aryal and Ellingsen, 2015; Morrow et al., 2017; Penny, 
Bradford and Langbecker, 2018; Possemato et al., 2017; Puszka et al., 2016). Technical 
compatibility is also vital, clinicians prefer tools that integrate well with the other systems that 
they use in their daily work (Putzer and Park, 2012, 2010), and interoperability problems can 
raise user concerns (El Amrani et al., 2017; Bello et al., 2017). Equally, the lack of Electronic 
Medical Records (EMR) or EHR integration can cause similar issues (Davis et al., 2014; 
Gagnon et al., 2016),  mainly because of the resulting limitations in data integration and 
exchange between the different systems (Bidmead and Marshall, 2016; Catan et al., 2015; 
Chung et al., 2015; Loh, Flicker and Horner, 2009), often resulting in duplication of effort and 
an unnecessary increase in workload (Morrow et al., 2017; Öberg et al., 2017; Sharma and 
Clarke, 2014).  
Patient-centred and culturally appropriate design is also essential, cluttered and unorganized 
displays generally have a negative impact on user adoption (Jeon et al., 2014; Taylor and 
Coates, 2015; Taylor et al., 2016). Users should be able to adapt design elements according 
to their own preference (de Vries et al., 2017), to personalise the type of content according 
to their context and needs (Ehrler et al., 2018; O’Connor and Andrews, 2018), and to 
customise according to each patient’s medical condition (Morrow et al., 2017; van Gaalen et 
al., 2016). Furthermore, the convenience and mobility of mHealth apps impact perceived 
usefulness and ease of use positively (Liu and Cheng, 2015), and can improve the 
timeliness of care services (Mileski et al., 2017; Seto et al., 2012), as the portability of such 
apps facilitate information access and tasks accomplishment (Nerminathan et al., 2017; 
Odnoletkova et al., 2016; Puszka et al., 2016; Sadoughi et al., 2017; Sezgin, Özkan-Yildirim 
and Yildirim, 2017). Conversely, the small size of the mobile screen can be perceived as an 




2.2.4.2 Social and organizational factors 
The social and organizational factors impacting adoption were clearly more prominent in the 
included studies compared to the technical factors, highlighting the importance of taking the 
social and organizational contexts into account when studying adoption. This was a 
surprising as it was not anticipated that the social and organization factors would so vastly 
outnumber the technical ones.  
2.2.4.2.1 Workflow related factors 
Workflow related factors alone surprisingly included 17 sub-themes, and were the most 
prominent in the included studies, showing the importance of the implications of mHealth 
adoption for existing work practices. The availability of appropriate training programs is vital 
for adoption (Asua et al., 2012; Charani et al., 2013; Dünnebeil et al., 2012; Gagnon et al., 
2016, 2012b); whereas insufficient training (Alajlani and Clarke, 2013; Bhatta, Aryal and 
Ellingsen, 2015; Brewster et al., 2014; Farrell, 2016; Öberg et al., 2017; Sharma and Clarke, 
2014), the lack of time that must be invested in training (El Amrani et al., 2017; Davis et al., 
2014; Sinclair et al., 2013; Wilhelmsen et al., 2014), the necessary resources to sustain 
training programs (Loh, Flicker and Horner, 2009; Puszka et al., 2016), and training 
programs that are purely technical do not address the workflow changes associated with the 
use of these new tools (Casey, Shaw and Swinglehurst, 2017; Cunningham et al., 2013; 
Giraldo et al., 2018; Kato et al., 2015; Penny, Bradford and Langbecker, 2018; Taylor and 
Coates, 2015) were among the most important barriers. Training-related factors are of 
significant importance mainly because users need to develop new skills in order to be able 
to profit from these tools and embed them well in their clinical practice (Bagot et al., 2017; 
Carlisle and Warren, 2013; Jamu, Lowi-Jones and Mitchell, 2016; Ruiz Morilla et al., 2017; 
Morrow et al., 2017; Schneider et al., 2016).  
Resources availability and allocation were a key barrier (Ahmad, Norman and O’Campo, 
2012; Ariens et al., 2017; Catan et al., 2015; Davis et al., 2014; Ehrler et al., 2018; Gagnon 
et al., 2016; James et al., 2016; Jetty et al., 2018; Kato et al., 2015; Kayyali et al., 2017; 
Morrow et al., 2017; Varsi et al., 2015a), as adequate staffing is considered a requirement 
for effective adoption (Avey and Hobbs, 2013; Carlisle and Warren, 2013; Koivunen and 
Saranto, 2018; Lord et al., 2016; Penny, Bradford and Langbecker, 2018; Schneider et al., 
2016; Seto et al., 2012). Some papers recognized that mHealth triggered a surge in 
workload (Bhatta, Aryal and Ellingsen, 2015; Bishop et al., 2013; Fairbrother et al., 2014) 
mainly due to factors such as double data entry caused by lack of system integration 




of working (Hanley et al., 2013; Sharma, Barnett and Clarke, 2010; Sharma and Clarke, 
2014), and poor workflow adaptability (Radhakrishnan et al., 2016). Users may refrain from 
adopting the tools entirely if they think that they would result in an increased workload 
(Bidmead and Marshall, 2016; de Souza et al., 2017; Mileski et al., 2017). Other studies, 
however, suggested that mHealth can also alleviate workload in cases where clinicians’ 
recruitment and retention is challenging, through enhanced efficacy (Puszka et al., 2016), 
and support (Goedken et al., 2017; Koivunen and Saranto, 2018; Kumar, Merchant and 
Reynolds, 2013; Ruiz Morilla et al., 2017; Mueller et al., 2014). 
Adoption also depends on the fit into the workflow and compatibility with the clinical practice 
(Bailey et al., 2017; Ehrler et al., 2018; Gagnon et al., 2016; Hickson et al., 2015; Lacasta 
Tintorer et al., 2018; Lee et al., 2012; Miller et al., 2017; Possemato et al., 2017; Sezgin, 
Özkan-Yildirim and Yildirim, 2017; van Gaalen et al., 2016); therefore, appropriate 
integration (Brewster et al., 2014; Choi et al., 2018; Radhakrishnan et al., 2016; Lord et al., 
2016; Puszka et al., 2016), and an adept understanding of health care processes (Rho, Choi 
and Lee, 2014; Seto et al., 2012; Walker and Clendon, 2016) are indispensable to avoid 
potential disruption for clinical workflow. mHealth adoption can also result in workflow 
adjustments where a modification of working routines is necessary (Casey, Shaw and 
Swinglehurst, 2017; Chang et al., 2017; Molfenter et al., 2015), these changes are typically 
meant to complement standard clinical practice rather than replacing it (Cox et al., 2011; 
Morrow et al., 2017).  
Facilitators included factors such as improved competitiveness through efficacies and 
optimized work patterns (Ariens et al., 2017; Armstrong et al., 2012, 2011; Bishop et al., 
2013; Daniel et al., 2018; Kleinpell et al., 2016; Lacasta Tintorer et al., 2018; Li and Cotton, 
2018; Nerminathan et al., 2017; Rothstein et al., 2016; Varsi et al., 2015b), better access to 
care (Mueller et al., 2014; Odnoletkova et al., 2016; Sims et al., 2016; Zilliacus et al., 2010), 
and quick identification of patients that need urgent care due to the timely feedback enabled 
by tools such as remote patient monitoring (Bello et al., 2017; Han, Subramanian and 
Cameron, n.d.; Jarvis-Selinger et al., 2011; Kim, Tiyyagura and Langhan, 2017; L’Esperance 
and Perry, 2016; Lapão, da Silva and Gregório, 2017; Mileski et al., 2017). However, the 
efficiencies resulting from mHealth use are sometimes compromised by a greater overall 
workload when there’s no suitable reimbursement (Mairesse et al., 2015). Better multi-
disciplinary collaboration and coordination may also encourage adoption (Ariens et al., 2017; 
Armstrong et al., 2012; Duhm et al., 2016; Jarvis-Selinger et al., 2011; Kleinpell et al., 2016; 
Kumar, Merchant and Reynolds, 2013; Molleda et al., 2017), as such tools facilitate peer 




al., 2016; Esterle and Mathieu-Fritz, 2013; Iacono et al., 2016; Jetty et al., 2018; Kim, 
Tiyyagura and Langhan, 2017; Mueller et al., 2014; Penny, Bradford and Langbecker, 2018; 
Sims et al., 2016). Inversely, some papers stated that this can also result in more pressure 
on clinicians, as the additional coordination and communication with other staff members 
adds to their already high workload (Grünloh, Cajander and Myreteg, 2016), and as multi-
disciplinary cooperation can be challenging (Varsi et al., 2015a) occasionally resulting in 
conflicting opinions or lack of trust (Li and Cotton, 2018; Moloczij et al., 2015).  
Users familiarity with mHealth technology may generate confidence that may encourage 
adoption (Hanna, May and Fairhurst, 2012; Saigí-Rubió, Torrent-Sellens and Jiménez-
Zarco, 2014; Sandholzer et al., 2015; Tahamtan et al., 2017; Zailani et al., 2014), while the 
lack of previous experience or poor technical skills may create uncertainties about how the 
tools work (Charani et al., 2013; de Souza et al., 2017; Hickson et al., 2015; Iacono et al., 
2016; Jungwirth and Haluza, n.d.; Kayyali et al., 2017; Lacasta Tintorer et al., 2018; 
Molfenter et al., 2015; Putzer and Park, 2012; Sinclair et al., 2013; Villalba-Mora et al., 
2015). Previous IT-related experience also lowered users’ expected effort related to the use 
of these new tools, positively impacting their intention to use them (Dünnebeil et al., 2012; 
Duplaga, 2016; Gagnon et al., 2016; Rho, Choi and Lee, 2014).  
Some changes in staff’s roles and responsibilities are sometimes necessary to enable a 
smooth mHealth integration (Bagot et al., 2017; Khan et al., 2015; MacNeill et al., 2014; 
Molfenter et al., 2015; Öberg et al., 2017) , this could take the form of alignment of duties 
(Ariens et al., 2017; Hanley et al., 2013; Varsi et al., 2015b), redistribution of roles (Avey and 
Hobbs, 2013; Casey, Shaw and Swinglehurst, 2017), an expansion of job responsibilities 
(Varsi et al., 2015a), or even the creation of new functions to cover some of the new tasks 
connected to the management of the new technologies (Esterle and Mathieu-Fritz, 2013; 
Jury, Walker and Kornberg, 2013; Molleda et al., 2017; Odeh et al., 2014; Rothstein et al., 
2016; Schneider et al., 2016; Sharma, Barnett and Clarke, 2010; Vest et al., 2017; Wynn et 
al., 2012). The new roles resulting from the use of mHealth can be related to data analysis 
and interpretation (Bramley, Mangan and Conroy, 2018; Levine et al., 2014; Rothstein et al., 
2016), patient monitoring and triage (Quanbeck et al., 2018), in addition to some non-clinical 
tasks such as equipment installation and troubleshooting (Penny, Bradford and Langbecker, 
2018; Sharma and Clarke, 2014; Sturesson and Groth, 2018).  
Leadership support is also essential (Abd Ghani and Jaber, 2015; Ahmad, Norman and 
O’Campo, 2012; Gagnon et al., 2016; Li and Cotton, 2018; Lapão, da Silva and Gregório, 




Rubió, Jiménez-Zarco and Torrent-Sellens, 2016; Sandholzer et al., 2015), as it can 
facilitate potential organizational changes entailed by mHealth use, like roles and 
responsibilities (Esterle and Mathieu-Fritz, 2013), or workflow changes (Farrell, 2016; Öberg 
et al., 2017; Orchard et al., 2016), training and education (Kowitlawakul, 2011), and 
allocation of resources (Puszka et al., 2016; Sadoughi et al., 2017; Tahamtan et al., 2017). It 
can be challenging at times to get the required senior management support (Bidmead and 
Marshall, 2016; Catan et al., 2015; Smith and Buzi, 2014), mainly due to a lack 
understanding of mHealth (Chang et al., 2017), or a false perception that it would detract 
clinicians from their actual work (Loh, Flicker and Horner, 2009), which can result in a lack of 
recognition of staff’s activities performed using these new tools (Lacasta Tintorer et al., 
2018). Another precondition for mHealth success is the presence of a suitable organizational 
infrastructure (Bello et al., 2017; Charani et al., 2013; Liu and Cheng, 2015; Orruño et al., 
2011; Zilliacus et al., 2010), including a reliable internet access, the availability of the 
necessary equipment, and a suitable space to perform the necessary tasks (Bailey et al., 
2017; Bhatta, Aryal and Ellingsen, 2015; Cary et al., 2016; Ehrler et al., 2018; Han, 
Subramanian and Cameron, n.d.; Iacono et al., 2016; James et al., 2016; Jamu, Lowi-Jones 
and Mitchell, 2016; Lewis et al., 2012; Moloczij et al., 2015; O’Connor and Andrews, 2018; 
Putzer and Park, 2012; Schneider et al., 2016; Shaw et al., 2013).  
Implementation planning, and process standardization are also vital (Dünnebeil et al., 2012; 
Goedken et al., 2017; Puszka et al., 2016; Varsi et al., 2015b; Vest et al., 2017). Streamlined 
procedures (Egerton et al., 2017; Muigg et al., 2018; Sharma and Clarke, 2014), and clear 
protocols and guidelines (Esterle and Mathieu-Fritz, 2013; Koivunen and Saranto, 2018; Ray 
et al., 2017), are key for a successful adoption. A lack of such planning can result in 
workflow challenges that hinder adoption (Giraldo et al., 2018; Grünloh, Cajander and 
Myreteg, 2016; Jeon et al., 2014; Mileski et al., 2017; Molfenter et al., 2015; Penny, Bradford 
and Langbecker, 2018; Quanbeck et al., 2018; Sturesson and Groth, 2018; Taylor and 
Coates, 2015; van Gaalen et al., 2016). Furthermore, staff non-technical competence is also 
relevant (Avey and Hobbs, 2013; Koivunen and Saranto, 2018; Loh, Flicker and Horner, 
2009; Orchard et al., 2016; Puszka et al., 2016; van Gaalen et al., 2016; Zilliacus et al., 
2010); considerations such as familiarity with clinical terminology, a decent command of the 
language in which the tool is offered, and the capability to review and process the large 
amounts of data generated by mHealth tools are vital for successful adoption (Bhatta, Aryal 
and Ellingsen, 2015; Bramley, Mangan and Conroy, 2018; Chung et al., 2015; Kleinpell et 




competence of other mHealth collaborators (James et al., 2016; Egerton et al., 2017); and 
the fear of showing knowledge gaps (Kifle et al., 2010; Klack et al., 2013; Sims et al., 2016).  
Some data related issues such as information overload (Levine et al., 2014; MacNeill et al., 
2014; Öberg et al., 2017), and data integration into the existing clinical workflow (Jimbo et 
al., 2013; Quanbeck et al., 2018; Radhakrishnan et al., 2016), can hinder adoption (Brown et 
al., 2018; James et al., 2016); especially because some of the available mHealth tools do 
not offer users the flexibility to tailor data reporting according to their individual needs 
(Chung et al., 2015; Davis et al., 2014; Miller et al., 2017). At the same time, availability and 
access to health care data (Duhm et al., 2016; Holderried et al., 2018; Moharra et al., 2015; 
Schneider et al., 2016), greater efficacy of data analysis (Klack et al., 2013; Rothstein et al., 
2016), and improved quality of care resulting from the timely availability of data (L’Esperance 
and Perry, 2016; Lapão, da Silva and Gregório, 2017; Sandberg et al., 2009; Seto et al., 
2012) can encourage adoption.  
Clinical practice adjustments are sometimes necessary for a successful mHealth 
implementation (Ahmad, Norman and O’Campo, 2012; Bagot et al., 2017; Carlisle and 
Warren, 2013; Hanley et al., 2013; Kumar, Merchant and Reynolds, 2013; Lacasta Tintorer 
et al., 2018; Penny, Bradford and Langbecker, 2018), mainly due to the introduction of new 
paradigms such as patients’ self-monitoring and reporting, which entail new care 
approaches (Brewster et al., 2014; Koivunen and Saranto, 2018; Odnoletkova et al., 2016; 
Öberg et al., 2017). Such changes can be challenging (Casey, Shaw and Swinglehurst, 
2017; de Souza et al., 2017; Radhakrishnan et al., 2016); for example, clinicians can 
perceive mHealth as an interference with standard clinical practice when a tool allows 
patients to access their test results before their treating physician (Grünloh, Cajander and 
Myreteg, 2016). Additionally, clinicians’ perceptions of the impact of such new tools on their 
autonomy and job security are also pertinent (Bramley, Mangan and Conroy, 2018; Brewster 
et al., 2014; Gagnon et al., 2016; Koivunen and Saranto, 2018; Li and Cotton, 2018; Öberg 
et al., 2017; Radhakrishnan et al., 2016); for example if they perceive that mHealth makes 
their patients’ treatment plans and outcomes more accessible to others and accordingly 
more susceptible to external control or criticism, this may be a barrier to adoption (Li and 
Cotton, 2018; Liu and Cheng, 2015; MacNeill et al., 2014; Steinschaden, Petersson and 
Astrand, 2009; Uscher-Pines and Kahn, 2014; Kumar, Merchant and Reynolds, 2013; 
Rogove et al., 2012).  
mHealth use can also positively impact clinicians’ empowerment especially for nursing staff 




al., 2016; Öberg et al., 2017; Penny, Bradford and Langbecker, 2018; Shaw et al., 2013), the 
educational benefits of these tools can encourage adoption (Nerminathan et al., 2017; Sims 
et al., 2016), as they are perceived as enablers that support clinical decisions, expand 
knowledge, and encourage best practices (Puszka et al., 2016; Rothstein et al., 2016; 
Sadoughi et al., 2017; Varsi et al., 2015b). Adoption can also be encouraged through proper 
incentives (Adenuga, Iahad and Miskon, 2017; Bhatta, Aryal and Ellingsen, 2015; Ruiz 
Morilla et al., 2017; Orchard et al., 2016; Vest et al., 2017). Financial incentives and better 
reimbursement schemes are not the only form of incentives though; awarding Continuing 
Medical Education (CME), adding the tools’ use as a goal in the care team appraisals, and 
providing clarity around medico-legal issues may also increase adoption (Armstrong et al., 
2011; Bello et al., 2017; Bramley, Mangan and Conroy, 2018; Jungwirth and Haluza, n.d.; 
Lacasta Tintorer et al., 2018; Lapão, da Silva and Gregório, 2017; Rho, Choi and Lee, 2014; 
Uscher-Pines and Kahn, 2014; Zhang and Koch, 2015). 
The highly fragmented nature of the healthcare sector can result in decision making issues, 
especially in the absence of a dedicated accountable decision maker(s) for digital health 
programs in healthcare organizations (Bhatta, Aryal and Ellingsen, 2015; Jungwirth and 
Haluza, n.d.; Muigg et al., 2018; Jetty et al., 2018). This can also be a barrier when the 
official decision makers do not include clinicians in the selection and implementation of an 
mHealth tool (Flynn et al., 2009; Odeh et al., 2014; Öberg et al., 2017).  
2.2.4.2.2 Patient related factors 
Quality of care enhancements can encourage adoption (Anderson et al., 2017; Giraldo et al., 
2018; Holderried et al., 2018; Jarvis-Selinger et al., 2011; Kim et al., 2016; Klack et al., 
2013; Kleinpell et al., 2016; Kumar, Merchant and Reynolds, 2013; Lord et al., 2016; 
McNally, Frey and Crossan, 2017; Merchant et al., 2015; Mileski et al., 2017; Moharra et al., 
2015; Miller et al., 2017; Moloczij et al., 2015; Ruiz Morilla et al., 2017; Okazaki et al., 2012; 
Possemato et al., 2017; Putzer and Park, 2010, 2012; Radhakrishnan et al., 2016; Ray et 
al., 2017; Steinschaden, Petersson and Astrand, 2009; Taylor and Coates, 2015; Varsi et 
al., 2015b; Zhang and Koch, 2015), such improvements are typically the result of  enhanced 
information access, better disease control, tailored treatment plans, and more proactive 
patient care (Bidmead and Marshall, 2016; Avey and Hobbs, 2013; Carlisle and Warren, 
2013; Cary et al., 2016; Chung et al., 2015; Daniel et al., 2018; de Souza et al., 2017; 
Esterle and Mathieu-Fritz, 2013; Farrell, 2016; Han, Subramanian and Cameron, n.d.; 
Hanley et al., 2013; Hickson et al., 2015; Jury, Walker and Kornberg, 2013; Kayyali et al., 




and Perry, 2016; Li and Cotton, 2018; Lapão, da Silva and Gregório, 2017; Mairesse et al., 
2015; Mueller et al., 2014; Muigg et al., 2018; Odnoletkova et al., 2016; Öberg et al., 2017; 
Rogove et al., 2012; Seto et al., 2012; Sharma and Clarke, 2014; Vest et al., 2017). 
However, some practitioners raised concerns about the quality of patient self-reporting, the 
risk of overtreatment, or the reporting of false positives (Davis et al., 2014; de Vries et al., 
2017). The desire for a better patient-clinician communication may also encourage adoption 
(El Amrani et al., 2017; Bailey et al., 2017; Bishop et al., 2013; Han, Subramanian and 
Cameron, n.d.; Koivunen and Saranto, 2018; Vest et al., 2017), this is in cases where the 
tool improves communication (Anderson et al., 2017; Bidmead and Marshall, 2016; Duhm et 
al., 2016; Hines et al., 2015; Kopanitsa and Yampolsky, 2016; Lacasta Tintorer et al., 2018; 
L’Esperance and Perry, 2016; Mileski et al., 2017; Moharra et al., 2015; Molfenter et al., 
2015; Penny, Bradford and Langbecker, 2018; Radhakrishnan et al., 2016; Sandberg et al., 
2009; Schneider et al., 2016; Seto et al., 2012; Sturesson and Groth, 2018; Walker and 
Clendon, 2016; Zhang and Koch, 2015), however, it can be a barrier when practitioners 
perceive the tool as an hindrance to their communications with their patients (Brewster et al., 
2014; Cox et al., 2011; Flynn et al., 2009; Grünloh, Cajander and Myreteg, 2016; Kayyali et 
al., 2017; Wilhelmsen et al., 2014). Communications related concerns are mainly about loss 
of human interaction, potential privacy breaches, medico legal matters, unprofessional 
image, and risks of patient’s overreliance on the tool (Daniel et al., 2018; Fairbrother et al., 
2014; Loh, Flicker and Horner, 2009; Muigg et al., 2018; Öberg et al., 2017; Sharma, Barnett 
and Clarke, 2010; Sharma and Clarke, 2014; Wynn et al., 2012).  
Improving access to care is another facilitator (Anderson et al., 2017; Armstrong et al., 2012; 
Bidmead and Marshall, 2016; Choi et al., 2018; Daniel et al., 2018; Flynn et al., 2009; 
Hickson et al., 2015; Loh, Flicker and Horner, 2009; Merchant et al., 2015; Mileski et al., 
2017; Odnoletkova et al., 2016; Puszka et al., 2016; Radhakrishnan et al., 2016; Rho, Choi 
and Lee, 2014; Rogove et al., 2012; Sturesson and Groth, 2018), especially when mHealth 
allows healthcare access to underserved patients (Armstrong et al., 2011; Bhatta, Aryal and 
Ellingsen, 2015; Cary et al., 2016; Catan et al., 2015; Chang et al., 2017; Cunningham et al., 
2013; Egerton et al., 2017; Han, Subramanian and Cameron, n.d.; Jetty et al., 2018; Kayyali 
et al., 2017; Molfenter et al., 2015; Moskowitz et al., 2010; Mueller et al., 2014; Sandberg et 
al., 2009; Sinclair et al., 2013). Digital tools may enhance access by reducing or even 
eliminating travel costs (Avey and Hobbs, 2013; Bhatta, Aryal and Ellingsen, 2015; Bishop et 
al., 2013; Levine et al., 2014; Lewis et al., 2012; MacNeill et al., 2014; Seto et al., 2012; 
Shaw et al., 2013; Zilliacus et al., 2010). Also, patient preferences, comfort, and consent 




2013; Egerton et al., 2017; Gagnon et al., 2016; Hanna, May and Fairhurst, 2012; Iacono et 
al., 2016; Kato et al., 2015; Koivunen and Saranto, 2018; Ruiz Morilla et al., 2017; 
Moskowitz et al., 2010; Saigi-Rubió, Jiménez-Zarco and Torrent-Sellens, 2016; Wynn et al., 
2012),  these preferences are influenced by several elements such as patients’ age, the 
complexity of their health condition, technical skills, access to technology, or data privacy 
concerns (Armstrong et al., 2012; Bidmead and Marshall, 2016; Bishop et al., 2013; 
Bramley, Mangan and Conroy, 2018; Cox et al., 2011; Flynn et al., 2009; Hickson et al., 
2015; Jarvis-Selinger et al., 2011; Jimbo et al., 2013; Jungwirth and Haluza, n.d.; Levine et 
al., 2014). Additionally, practitioners believe that these tools may not be suitable to all 
patients (Gagnon et al., 2016; Jury, Walker and Kornberg, 2013; Lord et al., 2016; Molleda 
et al., 2017; Penny, Bradford and Langbecker, 2018; Vest et al., 2017; Wynn et al., 2012; 
Zilliacus et al., 2010), therefore, the presence of a clear selection criteria is very important 
(Odeh et al., 2014; Odnoletkova et al., 2016; Radhakrishnan et al., 2016; Sharma, Barnett 
and Clarke, 2010; Wilhelmsen et al., 2014). Conversely, some clinicians believe that 
mHealth is more suitable for chronic patients, or those with an unstable health conditions 
because they require more attention (Fairbrother et al., 2014; Moharra et al., 2015); while 
others believed it is not appropriate for severely ill patients, or those with health impairments 
(Kato et al., 2015; Koivunen and Saranto, 2018; MacNeill et al., 2014; Puszka et al., 2016; 
Sandberg et al., 2009; Sinclair et al., 2013; Varsi et al., 2015b).  
Tools that promote patient engagement and empowerment, offering them more autonomy 
and assurance about their health condition are more likely to be adopted (Catan et al., 2015; 
Cox et al., 2011; Giraldo et al., 2018; Hanley et al., 2013; L’Esperance and Perry, 2016; 
Lapão, da Silva and Gregório, 2017; MacNeill et al., 2014; Mileski et al., 2017; Possemato et 
al., 2017; Puszka et al., 2016; Schneider et al., 2016; Seto et al., 2012; Vest et al., 2017; 
Wilhelmsen et al., 2014; Zhang and Koch, 2015). Similarly, mHealth tools that enhance 
patient safety through early symptom detection, timely reporting, and structured 
documentation are more accepted by clinicians (Bishop et al., 2013; Bramley, Mangan and 
Conroy, 2018; Giraldo et al., 2018; Kleinpell et al., 2016; Li and Cotton, 2018; Moharra et al., 
2015; Penny, Bradford and Langbecker, 2018; Seto et al., 2012; Steinschaden, Petersson 
and Astrand, 2009; Varsi et al., 2015b). However, practitioners are concerned about the 
digital divide, and those patients that might be marginalized because their lack of technology 
access or skills, those who have literacy problems, or a lower living standard (Hanna, May 
and Fairhurst, 2012; Jimbo et al., 2013; Jungwirth and Haluza, n.d.; Kayyali et al., 2017; 




Puszka et al., 2016; Sandberg et al., 2009; Sharma, Barnett and Clarke, 2010; Sinclair et al., 
2013; Smith and Buzi, 2014; van Gaalen et al., 2016).  
Adoption is also positively impacted by tools that improve patient awareness and education 
(Daniel et al., 2018; Davis et al., 2014; Jarvis-Selinger et al., 2011; Jimbo et al., 2013; 
Levine et al., 2014; Odnoletkova et al., 2016; Orchard et al., 2016; Ray et al., 2017; 
Sandberg et al., 2009; Oudshoorn, Rommes and Stienstra, 2004; Varsi et al., 2015b; Vest et 
al., 2017); but some practitioners’ fear that the convenience of mHealth might raise the risk 
of patients’ overreliance on their care team’s support (Anderson et al., 2017; Fairbrother et 
al., 2014; Radhakrishnan et al., 2016; Seto et al., 2012), and that they may over-utilize the 
tool or attempt to contact their treating practitioner after hours (Loh, Flicker and Horner, 
2009; Shaw et al., 2013). However, surveillance and data related anxiety may be a barrier to 
adoption (Daniel et al., 2018; Steinschaden, Petersson and Astrand, 2009), especially in 
cases where patients might get extremely anxious or overwhelmed by the vast amounts of 
data offered through these tools (El Amrani et al., 2017; Grünloh, Cajander and Myreteg, 
2016), or might feel constantly watched due to their use of digital patient monitoring tools 
(MacNeill et al., 2014; Seto et al., 2012). 
2.2.4.2.3 Other social and organizational factors 
There were also some other social and organizational factors impacting mHealth adoption. 
Fears related to health data privacy and security issues may hinder clinicians’ adoption (Abd 
Ghani and Jaber, 2015; Ahmad, Norman and O’Campo, 2012; Albrecht et al., 2017; 
Bidmead and Marshall, 2016; Brown et al., 2018; Egerton et al., 2017; Gagnon et al., 2016; 
Jungwirth and Haluza, n.d.; Klack et al., 2013; Koivunen and Saranto, 2018; Lygidakis et al., 
2016; Molfenter et al., 2015; Saigi-Rubió, Jiménez-Zarco and Torrent-Sellens, 2016; van 
Gaalen et al., 2016; Villalba-Mora et al., 2015). The main data-related barriers were the 
potential medico-legal risks, healthcare data anonymity, and risks of inappropriate data 
use(El Amrani et al., 2017; Anderson et al., 2017; Ariens et al., 2017; Avey and Hobbs, 
2013; Bailey et al., 2017; Brewster et al., 2014; Chang et al., 2017; Davis et al., 2014; de 
Souza et al., 2017; Hackl et al., 2014; Han, Subramanian and Cameron, n.d.; Hanna, May 
and Fairhurst, 2012; Hickson et al., 2015; Holderried et al., 2018; Jarvis-Selinger et al., 
2011; Jetty et al., 2018; Jimbo et al., 2013; Koval, Kim and Makhlouf, n.d.; Lacasta Tintorer 
et al., 2018; Mishori et al., 2017; Moskowitz et al., 2010; Muigg et al., 2018; Penny, Bradford 
and Langbecker, 2018; Quanbeck et al., 2018; Radhakrishnan et al., 2016; Rogove et al., 
2012). Remarkably, some papers concluded that concerns related to data privacy are 




mHealth tools despite their privacy concerns (Dünnebeil et al., 2012; Okazaki et al., 2012; 
van Houwelingen et al., 2015). Additionally, healthcare policy and regulations related to 
reimbursement, malpractice protection, credentialing, and licensing can definitely impact 
adoption (Abd Ghani and Jaber, 2015; Alajlani and Clarke, 2013; Brewster et al., 2014; de 
Souza et al., 2017; Gagnon et al., 2016; Lord et al., 2016; Moore et al., 2017; Moskowitz et 
al., 2010; Puszka et al., 2016; Rogove et al., 2012; Uscher-Pines and Kahn, 2014). Factors 
such as incompatible regulations (Charani et al., 2013; Chiang et al., 2015; Jeon et al., 
2014; McNally, Frey and Crossan, 2017; Mileski et al., 2017; Mueller et al., 2014), 
restraining directives (Jetty et al., 2018; Merchant et al., 2015), absence of suitable health 
policies and clinical protocols (Catan et al., 2015; Han, Subramanian and Cameron, n.d.; 
James et al., 2016; Kato et al., 2015; Molfenter et al., 2015; Nerminathan et al., 2017; 
Odnoletkova et al., 2016), can negatively impact adoption.  
Clinicians’ attitudes towards technology in general (Chiang et al., 2015; Kim et al., 2016; Ly 
et al., 2018; Mileski et al., 2017; Moloczij et al., 2015; Putzer and Park, 2012; Sandholzer et 
al., 2015; Sezgin, Özkan-Yildirim and Yildirim, 2017; Smith and Buzi, 2014; Williamson and 
Muckle, 2018) or mHealth specifically (Abd Ghani and Jaber, 2015; Ayatollahi et al., 2018; 
Brewster et al., 2014; Chang et al., 2017; Kleinpell et al., 2016; Koivunen and Saranto, 2018; 
Kowitlawakul, 2011; Li and Cotton, 2018; Rogove et al., 2012; Saigi-Rubió, Jiménez-Zarco 
and Torrent-Sellens, 2016; Saigí-Rubió, Torrent-Sellens and Jiménez-Zarco, 2014) may also 
impact adoption. Users who are resistant to change or unfamiliar with mobile technologies 
may refrain from using health apps (Albrecht et al., 2017; Bidmead and Marshall, 2016; 
Bishop et al., 2013; Catan et al., 2015; Klack et al., 2013; Kumar, Merchant and Reynolds, 
2013; Levine et al., 2014; Molfenter et al., 2015; Varsi et al., 2015a). Some negative cultural 
views on mobile use at work can also be a barrier (Daniel et al., 2018; McNally, Frey and 
Crossan, 2017; O’Connor and Andrews, 2018), as well as some individual traits such as the 
person’s degree of adaptability and the willingness to try new things (Holderried et al., 2018; 
Lacasta Tintorer et al., 2018; Lapão, da Silva and Gregório, 2017). Other social factors such 
as endorsement and peer influence may influence adoption (Avey and Hobbs, 2013; 
Gagnon et al., 2016; Okazaki et al., 2012; Putzer and Park, 2010; Radhakrishnan et al., 
2016; Tahamtan et al., 2017; van Houwelingen et al., 2015; Zhang and Koch, 2015); for 
example, recommendations by senior colleagues, opinion leaders, prominent healthcare 
organizations, or scientific societies can foster adoption (El Amrani et al., 2017; Bailey et al., 
2017; de Vries et al., 2017; Hao and Padman, 2018; James et al., 2016; Kifle et al., 2010; 
Lord et al., 2016; Molfenter et al., 2015; Nerminathan et al., 2017; Zhang, Cocosila and 




Adoption is also influenced by the internal context and culture of the healthcare organization 
(Abd Ghani and Jaber, 2015; Alajlani and Clarke, 2013; Ray et al., 2017), for example, 
adoption would be clearly discouraged in the case restrictive or unclear expectations around 
the use of smartphones at work (Beauregard, Arnaert and Ponzoni, 2017; Charani et al., 
2013; Farrell, 2016; McNally, Frey and Crossan, 2017; Nerminathan et al., 2017; O’Connor 
and Andrews, 2018; Payne, Weeks and Dunning, 2014; Tahamtan et al., 2017). Also, 
organizations that are resistant to change may oppose the introduction of new technologies 
(Bramley, Mangan and Conroy, 2018; Mandirola Brieux et al., 2017; Goedken et al., 2017; 
Varsi et al., 2015b). Financial aspects are also vital (Ariens et al., 2017; Jefee-Bahloul, 
Duchen and Barkil-Oteo, 2016; Morrow et al., 2017; Ray et al., 2017); factors such as lack of 
funding (Alajlani and Clarke, 2013; Chung et al., 2015; Loh, Flicker and Horner, 2009; Muigg 
et al., 2018; Odeh et al., 2014; Orchard et al., 2016; Quanbeck et al., 2018; Varsi et al., 
2015b; Villalba-Mora et al., 2015), and reimbursement issues (El Amrani et al., 2017; 
Anderson et al., 2017; Armstrong et al., 2011; Avey and Hobbs, 2013; Chiang et al., 2015; 
Gagnon et al., 2016; Hickson et al., 2015; Holderried et al., 2018; James et al., 2016; Khan 
et al., 2015; Kumar, Merchant and Reynolds, 2013; Levine et al., 2014; Lord et al., 2016; 
Mairesse et al., 2015; Mileski et al., 2017; Moskowitz et al., 2010; Rho, Choi and Lee, 2014; 
Rogove et al., 2012; van Gaalen et al., 2016) are typical barriers to adoption. A suitable 
reimbursement scheme and health insurance policy can accelerate adoption (Bishop et al., 
2013; Carlisle and Warren, 2013; Choi et al., 2018; Molfenter et al., 2015; Molleda et al., 
2017; Ruiz Morilla et al., 2017; Radhakrishnan et al., 2016; Sadoughi et al., 2017; Schneider 
et al., 2016). Similarly, a tool that reduces costs and helps achieve budget efficiencies is 
more likely to be adopted (Armstrong et al., 2012; Avey and Hobbs, 2013; Ayatollahi et al., 
2018; Mileski et al., 2017; Mueller et al., 2014; Radhakrishnan et al., 2016; Saigi-Rubió, 
Jiménez-Zarco and Torrent-Sellens, 2016; Zilliacus et al., 2010). Yet, ambiguities around 
cost-effectiveness (Catan et al., 2015; Fairbrother et al., 2014; Lee et al., 2012; Puszka et 
al., 2016; Seto et al., 2012), and mHealth affordability (Ayatollahi et al., 2018; de Vries et al., 
2017; Egerton et al., 2017; Gagnon et al., 2016; James et al., 2016; Jimbo et al., 2013; 
Jungwirth and Haluza, n.d.; Kayyali et al., 2017; Koval, Kim and Makhlouf, n.d.; Levine et al., 
2014; Loh, Flicker and Horner, 2009; Lord et al., 2016; McNally, Frey and Crossan, 2017; 
Merchant et al., 2015; Molfenter et al., 2015; Moskowitz et al., 2010; van Gaalen et al., 2016; 
van Houwelingen et al., 2015) may negatively impact adoption. 
Clinical evidence generation through mHealth data may increase clinicians’ intention to use 
these tools (Klack et al., 2013; Kleinpell et al., 2016; L’Esperance and Perry, 2016; Mueller 




perceived lack of evidence is a barrier (Flynn et al., 2009; Levine et al., 2014; Li and Cotton, 
2018; Mileski et al., 2017; Moloczij et al., 2015; Muigg et al., 2018; Odnoletkova et al., 2016; 
Puszka et al., 2016; van Gaalen et al., 2016; Zhang and Koch, 2015), which emphasises  
the need for more research about the clinical efficacy of mHealth to help promote adoption 
(Jeon et al., 2014; Kayyali et al., 2017; Kumar, Merchant and Reynolds, 2013). Moreover, 
clinicians’ lack of awareness of these tools may also be a challenge (Alajlani and Clarke, 
2013; Miller et al., 2017; Puszka et al., 2016; Zhang and Koch, 2015); therefore, an active 
promotion of mHealth objectives (Duhm et al., 2016; Gagnon et al., 2016; Kayyali et al., 
2017; Khan et al., 2015; Loh, Flicker and Horner, 2009), as well as its benefits and impact 
on quality of care may increase adoption (Avey and Hobbs, 2013; Cox et al., 2011; de Vries 
et al., 2017; Dünnebeil et al., 2012; Flynn et al., 2009; Lord et al., 2016; Radhakrishnan et 
al., 2016; Ray et al., 2017; Sadoughi et al., 2017; Wilhelmsen et al., 2014). 
Another vital facilitator is user engagement, as clinicians are more likely to adopt mHealth 
tools when they were engaged in their development, planning and implementation (Davis et 
al., 2014; Molleda et al., 2017; Schmeer et al., 2016; Shaw et al., 2013; Varsi et al., 2015b; 
Walker and Clendon, 2016). Involving practitioners in the development and co-design of 
these tools  (Brewster et al., 2014; Lord et al., 2016), and encouraging user feedback can 
positively impact adoption (de Vries et al., 2017; Jarvis-Selinger et al., 2011). Unfortunately, 
some studies reported that clinicians are barely engaged in mHealth development even 
though it is one of their work tools (Öberg et al., 2017; Radhakrishnan et al., 2016).  
2.2.5 Summary: Adoption is about more than a tool’s technical features 
The systematic literature review allowed the researcher to have a very good overview of 
what has been previously published about the factors impacting clinicians’ adoption of 
mHealth. Looking at the prevalence of the different categories, it is unexpected and very 
clear that the social and organizational factors are such a key driver for adoption. This was 
an important finding to the researcher, because in her practical experience, many people 
working on mHealth technologies tend to focus more on the technical and material factors 
when developing and implementing such novel tools, often overlooking some of the crucial 
social and organizational aspects - perhaps not surprisingly - leading to considerable issues 
with subsequent widespread adoption.    
These key findings should help future researchers to shift their focus from only assessing 
the tool’s features and technical aspects to widen their scope and make sure to incorporate 
the social factors (such as experiences, skills, culture…), and the organizational factors (like 




stakeholders in defining the needed actions in order to foster adoption. The practical 
recommendations for policy makers, technology providers, and clinical decision makers are 




2.3 Review of the most used frameworks in studying mHealth adoption 
With Leonardi’s methodological guidelines in mind, the researcher wanted to also make sure 
that she has a good understanding of the different theoretical frameworks used in studying 
clinicians’ mHealth adoption, to ensure a comprehensive analysis of the collected data, to 
have a better overview of the factors that are pre-defined in the most used frameworks, and 
any potential gaps that might need to be addressed, so that they can be complemented by 
the work in this research. Therefore, this section is an in-depth sub-analysis of the 
systematic literature review to reflect more deeply on the most common theoretical 
frameworks used in studying adoption. The following sub-sections briefly summarize the 
high-level findings of the review of the most used frameworks that was conducted in the 
context of this PhD thesis and published as: 
Jacob C, Sanchez-Vazquez A, Ivory C. Understanding Clinicians' Adoption of Mobile 
Health Tools: A Qualitative Review of the Most Used Frameworks. JMIR Mhealth 
Uhealth. 2020;8(7):e18072. DOI: 10.2196/18072 
2.3.1 Overview of the most used frameworks 
While the complete systematic literature review yielded 171 studies, only 50 of those used a 
theoretical framework in their research design. The most commonly used frameworks were 
diverse forms of extensions of the Technology Acceptance Model (TAM), the Diffusion of 
Innovation theory (DOI), and diverse forms of extensions of the Unified Theory of 
Acceptance and Use of Technology (UTAUT) (Jacob, Sanchez-Vazquez and Ivory, 2020b). 
TAM extensions were employed in 34% of the studies (n=17) and sometimes added factors 
stemming from the literature and the research context (Asua et al., 2012; Jetty et al., 2018; 
Kowitlawakul, 2011; Orruño et al., 2011; Rho, Choi and Lee, 2014; Saigi-Rubió, Jiménez-
Zarco and Torrent-Sellens, 2016; Schmeer et al., 2016; Tahamtan et al., 2017; Williamson 
and Muckle, 2018; Wynn et al., 2012; Zhang, Cocosila and Archer, 2010), or factors from 
other frameworks such as Chau and  Hu’s model of telemedicine acceptance and Theory of 
Interpersonal Behaviour (TIB) (Gagnon et al., 2012b), the Organizational Readiness for 
Change Model (Ray et al., 2017), Theory of reasoned action (TRA) and Theory of Planned 
Behaviour (TPB) (Saigi-Rubió, Jiménez-Zarco and Torrent-Sellens, 2016), and in 
combination with the UTAUT (Dünnebeil et al., 2012; Kim et al., 2016).  
DOI was used in 16% of the included papers (n=8) (Abd Ghani and Jaber, 2015; Han, 




Miller et al., 2017; Puszka et al., 2016; Smith and Buzi, 2014; Zhang and Koch, 2015), and 
UTAUT extensions in 12%; some of these UTAUT extensions were founded on other 
published literature or the specific research context (Adenuga, Iahad and Miskon, 2017; 
Ehrler et al., 2013; van Houwelingen et al., 2015), and other included expansions from other 
theoretical frameworks such as De Lone and McLean Information Success Model (Hackl et 
al., 2014), Use of Technology (de Vries et al., 2017), and a combination of TAM, TPB and 
DOI (Sezgin, Özkan-Yildirim and Yildirim, 2017). Moreover, 6% used a combination of the 
TAM and DOI frameworks (n=3) (Putzer and Park, 2010, 2012; Sandholzer et al., 2015); 6% 
used the Consolidated Framework for Implementation Research (CFIR) (n=3) (Lord et al., 
2016; Possemato et al., 2017; Varsi et al., 2015b), and 4% used the Sociotechnical Theory 
(n=2) (Ahmad, Norman and O’Campo, 2012; Casey, Shaw and Swinglehurst, 2017). 
Other frameworks were used in 22% of the studies(n=11), including the APEASE 
(Affordability, Practicability, Effectiveness, Acceptability, Side-effects/Safety and equity) 
framework (Egerton et al., 2017), an extended De Lone and McLean Information System 
Success Model (Okazaki et al., 2012), Giddens’s structuration theory (Sharma, Barnett and 
Clarke, 2010), Normalisation Process Theory (Bagot et al., 2017), Organizational Theory of 
Implementation Effectiveness (Shaw et al., 2013), Reach, Effectiveness, Adoption, 
Implementation, and Maintenance (RE-AIM) framework (Quanbeck et al., 2018), 
Technological Frames (Grünloh, Cajander and Myreteg, 2016), the Design Science 
Research Methodology (DSRM) (Lapão, da Silva and Gregório, 2017), Theory of Change 
(Bramley, Mangan and Conroy, 2018) , and Theory of Planned Behaviour (TPB) (Kuo et al., 
2015). An overview of these most used frameworks as detailed in this sub-section is 













Figure 8: Overview of the most used frameworks 
 
Source: initially published in (Jacob, Sanchez-Vazquez and Ivory, 2020b) 
2.3.2 Gap analysis of framework-based versus additional factors from technical, 
social and organizational perspectives 
Having defined the theoretical frameworks that are most frequently used in studying 
clinicians’ mHealth adoption, it was important to move on to analyse the framework-based 
versus additional factors to better recognise potential gaps in the mostly used theories and 
give suggestions based on the specificities of the healthcare context as reported in the 
included studies. The detailed analysis of the different factors was published earlier (Jacob, 
Sanchez-Vazquez and Ivory, 2020b), therefore, this section only summarizes the key overall 
outcomes of the gap analysis to put them in the context of this thesis.  
The factors impacting adoption were categorized according to the theoretical framework into 
technical, social, and organizations factors. The majority of factors could be connected to 
one framework or another, however, unexpectedly no single framework could cover all the 
adoption factors resulting from the analysis unless modified or combined with other models, 
highlighting the pre-existing gaps in these mostly used frameworks. Figure 9 visualizes the 
gap analysis of framework-based versus additional factors to make it clear to the reader 
which constructs could be traced back to one or the other framework, and which ones were 
not predefined but emerged from the data. In the figure, factors pre-defined in one of the 
included frameworks comprise the name of the framework following the name of the specific 




not identified as pre-defined constructs in any of the used frameworks are not followed by 
brackets and are marked in blue font. These added factors typically stemmed from papers 
that used a qualitative methodology, or were pre-defined by researchers’ analysis of earlier 
studies rather than established frameworks (Jacob, Sanchez-Vazquez and Ivory, 2020b). 
Factors with similar meaning were grouped together in the analysis to avoid an overcrowded 
factors scheme. For instance, when we talk about mHealth usefulness, it can be expressed 
as perceived usefulness if the research is using TAM, or performance expectancy if the 
UTAUT is employed, or relative advantage if CFIR or DOI are used. Likewise, the factor 
ease of use, can be referred to as perceived ease of use if the research is employing TAM, 
or effort expectancy if using the UTAUT, or complexity if employing CFIR or DOI.  
Figure 9: Gap analysis of framework-based versus additional factors 
Source: initially published in (Jacob, Sanchez-Vazquez and Ivory, 2020b) 
Researchers in most of the included papers expanded pre-existing technology acceptance 
models to be able to examine potentially significant additional factors; however, some 
academics have criticized such a method of subjectively adding constructs, as it can lead to 
an inconsistent use of established frameworks (Benbasat and Barki, 2007), highlighting the 
need for an aggregated framework that covers all these factors in one overview and 
complements any pre-existing gaps, in order to allow future researchers to have a more 





One of the reasons that might have led some of these researchers to add supplementary 
constructs to pre-existing theories is that some of these frameworks appear oversimplified or 
not specific enough (Jacob, Sanchez-Vazquez and Ivory, 2020b). For instance, some 
frameworks stated that usefulness is a key factor, yet, we need to better recognize the 
aspects that influence the user’s perception of usefulness, without this specificity it is hard to 
take precise actions. For this reason, many of the included research papers operationalized 
such overgeneralized factors by breaking them down into more precise constructs, for 
example by asking whether the mHealth app was useful to the job, or if it has improved job 
efficiency (Jacob, Sanchez-Vazquez and Ivory, 2020b). 
2.3.3 Reflection on the frequently used theoretical frameworks 
The following sub-sections discuss each of the used frameworks in more detail by giving 
some background on the frameworks themselves, and some examples of how other 
researchers used or expanded them. It is followed by another section that discusses a 
potential consolidated framework that aggregates all these most used frameworks and 
complements their pre-existing gaps according to the findings of this research. 
2.3.3.1 TAM and UTAUT expansions 
The TAM was used in 34 % of the included papers; the model was developed by Davis in 
the late 1980s (Davis, 1989) based on Fishbein and Ajzen’s Theory of Reasoned Action 
(TRA) (Ajzen and Fishbein, 1977). The TAM assumes that users’ perceived usefulness, and 
perceived ease of use of technology are the key predictors of their attitude towards using a 
new tool, which in turn governs the factor called behavioural intention to use that can be 
interpreted into technology acceptance. Numerous researchers proposed extensions of the 
initial TAM model to overcome some of its limitations; for example, Holden suggested adding 
constructs such as individual user aspects, organizational readiness, and trust (Holden and 
Karsh, 2010); Venkatesh and Davis also expanded the model and called it TAM2, by adding 
job relevance, subjective norm, voluntariness of use, and image; because these factors were 
considered to impact perceived usefulness (Venkatesh and Davis, 2000). Venkatesh and 
Bala stretched the model even more to TAM3 by adding enjoyment and computer anxiety 
(Venkatesh and Bala, 2008).  
The TAM and UTAUT have several resemblances, basically because the latter was based 
on the former. UTAUT was employed in 12 % of the included studies; it was first published 
by Venkatesh and Davis (Venkatesh et al., 2003); when they analysed and compared TAM, 




outcome was a new model with four key constructs: 1- performance expectancy, which 
indicates job usefulness (to match perceived usefulness in TAM); 2- effort expectancy, which 
indicates the tool’s user friendliness and ease of use, (to match perceived ease of use in 
TAM); 3- social influence, which indicates the degree to which a user’s deems that 
significant others believe they should use the tool and 4- facilitating conditions, which 
indicates the existence of an organizational and technical infrastructure that can support the 
tool’s use. The revised framework also adds some moderating aspects such as users’ age, 
experience, gender and voluntariness of use. And, behavioural intention to use the new 
technology is influenced by the three constructs effort expectancy, performance expectancy, 
and social influence; while the actual tool’s usage is then determined by this overall 
behavioural intention to use together with the construct facilitating conditions.  
The majority of the researchers that employed TAM or UTAUT in the included studies, have 
either added some constructs or expanded the original models to make them more suitable 
to the specific health care context. This establishes that despite their attractiveness, both 
frameworks often need some kind of extension to be more appropriated to complex health 
care contexts. The following lines include the most significant extension examples from the 
included papers to highlight the constructs that researchers added to these two models.  
Two papers added factors from the TIB and TRA to account for the influence of the social 
context and external factors (Orruño et al., 2011; Gagnon et al., 2012a);  they also used 
Chau and Hu’s model (Chau and Hu, 2002) to further segment elements into technical, 
individual, and organizational factors. They augmented the original framework with factors 
proposed by TIB, such as compatibility and technical context to account for automatized 
behaviour, and habit and facilitators to account for the organizational infrastructure. 
Furthermore, they incorporated the factor subjective norms from the TRA to evaluate if users 
believe that significant others will support their decision to adopt mHealth. Results from both 
studies indicated that facilitators were the most important factor in the adapted model, 
therefore stressing the significance of the organizational context for adoption. 
Two other papers extended the TAM with features from the TPB and TRA, with one of them 
additionally adding factors from the DOI and TR (Saigi-Rubió, Jiménez-Zarco and Torrent-
Sellens, 2016; Saigí-Rubió, Torrent-Sellens and Jiménez-Zarco, 2014). The first paper 
(Saigí-Rubió, Torrent-Sellens and Jiménez-Zarco, 2014) included three additional factors: 
the propensity to innovate (users’ inclination to innovate); optimism (the degree to which 
users consider that mHealth will allow them to gain benefits or reduce effort); and the level of 




paper (Saigi-Rubió, Jiménez-Zarco and Torrent-Sellens, 2016) additionally includes 
personal technology use (calling it ‘ICT user profile’) and added other constructs such as 
data confidentiality and security, costs reduction, and quality improvement. They also 
considered other factors like the impact of clinicians, patients, and management by 
assessing their influence on subjective norm. Their results revealed that the most important 
factors impacting adoption are the resulting cost savings, healthcare data security, and 
clinicians’ technology use in their personal lives. 
Another TAM expansion used factors from the DOI and TIB to take into account facilitating 
conditions, as they were shown in previous research to be among the most significant 
factors (Asua et al., 2012). Their results established that the facilitators in the organisational 
setting are the most important factors for mHealth adoption. Similarly, Ray (Ray et al., 2017) 
extended the model with the Organizational Readiness for change model (Weiner, 2009) by 
incorporating contextual aspects. Their results confirmed that patient-specific education, 
detailed clinical protocols, and response times reduction are key factors for adoption. 
The Dual-Factor model was also used to extend the TAM, as it incorporates constructs that 
might hinder adoption, unlike the TAM that focuses more on positive factors such as the 
tool’s ease of use and usefulness (Liu and Cheng, 2015). The study was guided by Walter 
and Lopez (Walter and Lopez, 2008) who proposed that the perceived threat to professional 
autonomy may negatively influence mHealth adoption. Furthermore, they added the aspect 
of perceived mobility as suggested by Huang (Huang, Lin and Chuang, 2007); and their 
findings confirmed its significance. Other TAM expansions were based on previous research 
(Rho, Choi and Lee, 2014) and added factors such: accessibility of medical records, self-
efficacy, and incentives.  
The UTAUT was also extended with various factors; for example, one paper expanded it 
with reinforcement factors to incorporate the potential impact of incentives on adoption 
(Adenuga, Iahad and Miskon, 2017). Their results particularly showed the relevance of 
financial incentives on mHealth use. Another paper combined UTAUT and TAM, and 
extended them with some additional factors that can influence mHealth ease of use and 
usefulness (Dünnebeil et al., 2012). Their additional factors included health data security, 
the intensity of IT use, eminence of documentation, previous mHealth knowledge and 
process standardization.  Comparably, Sezgin (Sezgin, Özkan-Yildirim and Yildirim, 2017) 
combined UTAUT and TAM, and extended them with factors from TPB and DOI. They 
incorporated the constructs personal innovativeness and compatibility, as well technology 




2.3.3.2 DOI, CFIR, and Sociotechnical Theory 
Rogers’ DOI theory advocates for the idea that technology adoption goes beyond a tool’s 
technical aspects to also incorporate the usage context (Rogers, 2003);  the theory was 
used in 16% of the included studies, and used in combination with TAM in another 6%. The 
DOI specifies five features of a technological tool that will foster its adoption: 1- relative 
advantage (if users believe that it is better than the processes that they currently use), 2- 
compatibility with users’ needs and past experiences, 3- complexity (whether it is difficult to 
use), 4- trialability (whether it can be piloted on a limited basis), and 5- the observability of 
the results of its usage. These factors complement the TAM well, as they counterbalance its 
contextual gaps.  
Putzer et al combined elements from DOI and TAM (Putzer and Park, 2010, 2012), following 
Kwon and Zmund’s guidance on the DOI adaptation (Kwon and Zmud, 1987). Their 
extension included the removal of the trialability construct to avoid potential confusion with 
observability, and the addition of internal and external environmental factors, in addition to 
some moderating factors such as demographics. Another DOI expansion was employed by 
Han et al (Han, Subramanian and Cameron, n.d.) that used Berwick’s model (Berwick, 2003) 
to add three groups of factors: 1- the perception of whether the innovation is helpful, 2- the 
‘types’ of users (e.g. innovators, early adopters…), 3- contextual factors  (e.g. social setting). 
Furthermore, Abd Ghani et al (Abd Ghani and Jaber, 2015) expanded the DOI with the 
technology-organization-environment (TOE) model (Tornatzky and Fleischer, 1990) to also 
incorporate individual contexts, as well as the social exchange theory (SE) (Emerson, 1976) 
to include factors related to power and trust, and implications of aspects such as 
management support.  
The Consolidated Framework for Implementation Research (CFIR) (Damschroder et al., 
2009; Damschroder and Hagedorn, 2011), was employed in 6% of the included papers. This 
framework also takes into account implementation factors, and comprises 39 constructs, 
clustered in 5 main areas: features of the technological tool, users’ characteristics, 
organizational context, the social setting, as well as the implementation process. Because of 
its extensive nature, the papers that used this framework did not expand it, they chose it 
because of its multidimensional nature (Possemato et al., 2017), and its exhaustiveness that 
allows it to capture the complexity of healthcare settings (Varsi et al., 2015b). However, our 
findings indicate that the model still has some gaps, like the lack of some specific factors like 




The Sociotechnical Theory (STS) (Trist and Bamforth, 1951; Morgan, Trist and Murray, 
1992) was employed in 4% of the included papers, and it focuses on the fit between the 
technical and social factors of a workplace. It deals with organizations as systems 
incorporating interrelated social and technical subsystems, and necessitate the integration 
and coordination of these subsystems to achieve optimization. The theory was employed by 
researchers that aimed to examine the factors that come into play when technology is put 
into practice  (Ahmad, Norman and O’Campo, 2012; Casey, Shaw and Swinglehurst, 2017).  
2.3.3.3 Less frequently used Frameworks 
Some frameworks only appeared in one of the included publications. However, many of 
them show the importance of social and organizational factors, and go beyond personal or 
individual aspects to also integrate the organizational context and its implications for 
implementation issues that can impact adoption. Several frameworks accounted for the 
interactions that occur between the social, technical or organizational factors, emphasizing 
the entanglement between those different facets. 
The Normalisation Process Theory (NPT) (May and Finch, 2009; May et al., 2009) 
addresses the success factors that are needed for the implementation of novel healthcare 
interventions into routine work or ‘normalisation’, and proposes a nonlinear understanding of 
technology acceptance and use, in view of the interdependent connections within 
organizations. It focuses on four factors: 1- coherence (the course that users undertake 
when trying to comprehend new practices); 2- cognitive participation (the work that users do 
to maintain a new practice); 3- collective action (the operational work that users do to 
endorse a new practice) and 4- reflexive monitoring (the appraisal work undertaken to the 
effect of new practices). And even though this is one of the few healthcare-specific 
technology adoption frameworks, it was, surprisingly, the main model used by only one 
study in this systematic literature review. Bagot (Bagot et al., 2017) employed the NPT in 
their study, and their results showed – in alignment with what NPT theory proposes – that 
mHealth implementation requires changes in work practice and the development of new 
skills in order to succeed. 
The Technological Frames (TF) model (Orlikowski and Gash, 1994) focuses on the 
‘assumptions, expectations, and knowledge’ individuals use to better understand new 
technologies in their organizational setting. The framework encompasses three frames: 1- 
the nature of technology (people’s understanding of the new technology and its features); 2- 
the technology strategy (the motivation behind user adoption and its value to the 




implication of this use). Grünloh (Grünloh, Cajander and Myreteg, 2016) used the TF to 
better understand how new technologies impact clinicians’ work environment; they could 
identify relevant work-related factors like the significance of work processes, the existing 
workload, and control (worries that the new tools may lead to patients controlling the 
practitioners). 
Bidmead (Bidmead and Marshall, 2016) wanted to better investigate the role of the users in 
the adoption and to make sure that all relevant stakeholders are included; therefore, they 
employed the stakeholder empowered adoption model (StEAM) (Marshall, 2013). It 
classifies stakeholders in four groups: professional users (clinicians and care teams), patient 
users, organisational management (leadership), and technology providers. The study 
findings showed that the key barriers for adoption are risk averseness, data privacy 
concerns, and issues related to data integration into the hospital information system.  
The theory of planned behaviour (TPB) (Ajzen, 1991) includes three main constructs: 1- 
users’ attitude (their feelings about using the new technology); 2- subjective norms (whether 
the individual should or should not adopt the new tool) and 3- perceived behavioural control 
(the availability of the skills, and resources necessary for adoption). It was used by Kuo (Kuo 
et al., 2015) who’s findings confirmed that all three factors can influence technology 
adoption. Whereas, researchers wanting to address matters like trust and security, which 
are not truly tackled in most other models, used Gidden’s structuration theory (Parsons and 
Giddens, 1980; Giddens, 2012, 1984). Sharma (Sharma, Barnett and Clarke, 2010) 
employed the theory in combination with Kouroubali’s concept that a better comprehension 
of social aspects can help resolve possible conflict, and allow an efficacious implementation 
(Kouroubali, 2002). Their outcomes highlighted the significance of gaining the trust of care 
teams and promoting a sense of security to foster the adoption of new technologies in 
healthcare organizations.  
The theory of change (W.K. Kellogg Foundation, 2004)  takes a different approach, and 
helps researchers investigate the aspects that would help participants be less resistant to 
change. Bramley (Bramley, Mangan and Conroy, 2018) used it to examines three 
stakeholder levels: 1- the macro level (how authorities work with technology providers); 2- 
the meso level (providers working with practitioners); and 3- the micro level (co-creation and 
spread of care packages). Their results confirmed that factors like workforce buy-in, 
leadership engagement, organizational culture, data privacy and safety issues are key for 
adoption. Similarly, Shaw (Shaw et al., 2013) tackled the matter from an organizational 




(Weiner, Lewis and Linnan, 2009; Weiner, 2009). The model can help identify the factors 
impacting an organization’s readiness for change, which depends on two main concepts: 1- 
change valence (the organization’s perception of advantages, fit, and need for change) and 
2- informational assessment (information about the requirements and availability of 
resources necessary to implement the change). The research showed the relevance of 
some organizational barriers like the potential additional workload, shortage of resources, 
and lack of workflow integration. 
Some theories focused more on the design process itself. For example, the APEASE 
(affordability, practicability, effectiveness, acceptability, side-effects/safety and equity) 
framework (Michie, Atkins and West, 2014), which is typically used to assess the design of 
new technologies was employed by Egerton (Egerton et al., 2017). They identified some 
barriers that may result in resistance to the new tools, such as lack of familiarity with the 
technology, sense of loss of control, or absence of information and support. Other studies, 
like Lapao (Lapão, da Silva and Gregório, 2017) used the Design Science Research 
Methodology (DSRM) (Peffers et al., 2007; Hevner et al., 2004) to investigate the relation 
between theory and practice by designing, executing and assessing a health tool that 
addressed a particular need. Their results illustrate that the main barriers for the new 
technology implementation are the lack of clear role definition, skills and time.  
Quanbeck (Quanbeck et al., 2018) examined the implementation process itself, and 
employed the Reach, Effectiveness, Adoption, Implementation, and Maintenance 
Framework (RE-AIM) (Glasgow, Vogt and Boles, 1999) to accomplish that. Their outcomes 
showed that the main barriers are system integration, data management, and the involved 
costs. Similarly, Okazaki (Okazaki et al., 2012) used an extension of the DeLone and 
McLean Information System Success Model (DeLone and McLean, 1992) to assess the 
success of new intervention in a particular organizational setting. They used the original 
factors of user satisfaction, system and service quality, information quality, and net benefits; 
and added some supplementary constructs such as data security and privacy risks, 
ubiquitous control (meaning time and place flexibility), and subjective norms from TPB. They 
concluded that adoption is most impacted by perceived value and net benefits of the new 
technology.  
2.3.4 Consolidated framework to aggregate and complement the most used models 
The review of the most used frameworks in studying mHealth adoption showed that the 
majority of factors can be related to one model or another, but surprisingly no framework 




many of them do not break them down into their specific constituents to allow researchers to 
assess the precise causes behind specific adoption or implementation challenges, which 
doesn’t help them identify appropriate solutions.  
These gaps could be due to that fact that healthcare tools are largely more complex than 
other technologies that address a single precise need, as they are typically used with 
patients with comorbidities that are normally treated by interdisciplinary healthcare teams - 
possibly working in several healthcare organizations. The particular features of how the 
healthcare sector functions (highly regulated, usual budget deficits, interdependence 
amongst healthcare organisations) require critical expansions to the current frameworks. 
This confirms the suitability of the sociotechnical approach, that looks beyond technology 
itself to also take into account other contextual elements such as social factors, individual 
characteristics, and organizational setting.  
Due to these existing gaps in the mostly used technology acceptance models, researchers 
in most of the included papers expanded the frameworks that they employed in their 
research, in order to be able to examine potentially significant additional factors; however, 
some academics have criticized such a method of subjectively adding constructs, perhaps 
not surprisingly, as it can lead to an inconsistent use of established frameworks (Benbasat 
and Barki, 2007), highlighting the need for an aggregated framework that covers all these 
factors in one overview, and allows future researchers to have a more consistent approach 
to the topic, making sure that they do not overlook any of the important adoption factors. 
This frameworks’ review helped shed light on gaps in the most used frameworks, as well as 
many specificities of healthcare, helping the researcher identify the important factors that 
should not be overlooked when studying mHealth adoption. Therefore, the researcher 
proposes a consolidated model that aggregates all the most used frameworks and 
complements them with the additional factors that emerged from the gap analysis discussed 
in section 2.3.2. These recommendations are discussed in more detail in the findings and 
implications section and visualised in figure 21. This consolidated framework should help 
future researchers adopt a more consistent approach when studying the topic, and cover all 
the relevant factors in their studies related to mHealth adoption and implementation. 
It is worth noting that other researchers identified the same need for an aggregated and 
healthcare-specific technology adoption framework, hence similar efforts were done in 
parallel to this research. For instance, the nonadopting, abandonment, scale-up, spread, and 
sustainability (NASSS) framework (Greenhalgh et al., 2017) had a similar objective, but most 




was published in November 2017, and the systematic review conducted for this thesis 
included studies published between January 2008 and August 2018. The NASSS framework 
not only addresses adoption factors, but also the non-adoption and abandonment of 
healthcare technologies. It encompasses 7 key factors: the condition or disease, the tool or 
technology, the value proposition, the adopter system (including healthcare professional, 
patients, and caregivers), the healthcare organization, the broader context (institutional and 
societal), and the interplay between all these factors over time. Even though it is quite 
extensive, the NASSS framework does not call out some of the prominent healthcare-
specific technology adoption factors such as EMR integration and harmonization, or 
reimbursement policies, without which widespread adoption is virtually impossible. The 
consolidated framework in this thesis calls out such specific and prevalent factors to ensure 
that future researchers will consider them when studying technology adoption in healthcare.  
Furthermore, given the importance of social and organizational factors as reflected in the 
data, the researcher also suggests an expansion to Leonardi’s methodological guidance, to 
include a fourth step that accounts for user engagement. It was surprising to the researcher 
that the initial methodological guidelines would stop at understanding how the interaction 
between the social and the technical materialize at the workplace, without looking into how 
to ensure that the identified barriers and affordances are taken into account for the further 
development of the studied technologies. Therefore, this suggested additional fourth step 
should focus on the mechanisms to engage users, capture their feedback, prioritize it, and 
take it into account in the tool’s constant development. This is discussed in more detail in the 






This section provides a description and justification of the paradigm and methods used in the 
research design, data collection, analysis and interpretation. It starts with a summary of the 
research question to explain why the qualitative paradigm was chosen. Then the study 
design is described in detail starting with the multiple-case study rationalization, followed by 
sample selection, data collection techniques, timeframe and location. It concludes with a 
detailed account of the data analysis method and an explanation of the different phases of 
thematic analysis.  
3.1 Using qualitative research to investigate mHealth adoption 
The choice of paradigm is closely related to the questions that the research is addressing; 
therefore, it is important to remind the reader of the main research questions that this study 
focuses on. This research, as mentioned earlier, focuses on understanding the factors 
impacting Clinicians’ adoption of MHealth tools and their implications for social and 
organizational practices. The topic is investigated through the following sub-questions: 
• What are the utilities and limitations of mHealth tools as perceived by clinicians? 
• What are the factors that constrain or afford clinicians’ adoption of mHealth? 
• What are the social and organisational implications of this adoption? 
Qualitative techniques have become more common in research concerned with the 
assessment of health technologies as well as health services; this was reflected in the rising 
numbers of qualitative research published in medical journals (Mays and Pope, 2000). 
Catherine Pope and Nick Mays wrote five articles in healthcare and health services research 
explaining why qualitative methods are more suitable than quantitative methods whenever 
the research is addressing questions such as 'What is Y, how does it vary in different 
contexts, and why/how?" as opposed to "How many Xs are there?" (Pope and Mays, 1995). 
According to Pope and Mays (1995), one of the reasons behind the growing importance of 
qualitative methods in healthcare research is its ability to address questions that are more 
concerned with the organization and culture of healthcare professionals, which makes 
qualitative research crucial for studying health services and understanding the context 
around them. It enables us to understand the complexities of today’s healthcare by touching 
on complex social aspects such as Clinicians’ attitudes and behaviours in ways that cannot 




The researcher chose this paradigm because it clearly gives precedence to ‘the voices of 
participants’ and the individual and unique ‘reflexivity of the researcher’ (Creswell and Poth, 
2018, p.8); and because of the rich insights it offers, which will help understand the 
experiences and perceptions of healthcare professionals in different ways than quantitative 
methods (Clarke and Braun, 2013; Braun and Clarke, 2014). The clearest argument for the 
Qualitative paradigm is that it fundamentally pictures the complexity, and sometimes even 
the contradiction of the real world, and at the same time allows the researcher to identify and 
understand patterns of meaning (Clarke and Braun, 2013). 
In the case of this research, understanding the factors impacting Clinicians’ adoption of 
mHealth tools requires a complex and detailed understanding of their perceptions, which can 
only be established by having in-depth and detailed discussions with them. Additionally, 
investigating the implications of this adoption to social and organizational practices 
necessitates an understanding of the contexts in which these Clinicians operate because 
their adoption of these tools cannot be separated from their daily work practices. 
Within the qualitative paradigm, it is important to differentiate between five key approaches. 
As shown in Figure 10, these approaches are narrative research, phenomenological 
research, grounded theory research, ethnographic research, and case study research 
(Creswell and Poth, 2018). Each one of the five approaches has a specific focus that 
addresses a particular problem; understanding the research problem for each approach 
helps the researcher to define their choice of method according to their respective research 
questions.   
Narrative research as a qualitative method can be defined as the procedure of analysing the 
stories that individuals - the study participants - tell the researcher (Chase, 2008; Clandinin 
and Connelly, 2000), it focuses on the individual’s specific experience but also on exploring 
the cultural and social contexts that help shape these experiences (Clandinin, 2016). In 
contrast, the phenomenological research method focuses more on the shared experiences 
of a group of individuals that lived a shared phenomenon, it investigates what all participants 
experienced in common facing this specific phenomenon and describes what and how they 
lived it  (Moustakas, 1994; Creswell and Poth, 2018; van Manen, 1990). 
Grounded theory research, unlike narrative and phenomenological research, goes beyond 
description to create or generate a new theory, a “unified theoretical explanation”  
addressing a specific action or defined process (Corbin and Strauss, 2007, p.107). This 
approach aims at explaining what happens in practice and creating relevant frameworks 




steps that occur over time, enabling the theory to emerge from the data collected from the 
field (Strauss and Corbin, 1998; Creswell and Poth, 2018); this approach is particularly 
relevant when there is not an existing theory or framework that can help the researcher 
understand that studied process (Creswell and Poth, 2018). 
While study participants involved in the grounded theory approach are not necessarily 
located in the same area or frequently interacting together, an ethnographic research on the 
other hand would rather focus on describing and interpreting the shared patterns of 
elements such as shared language, culture, belief systems, and individuals’ common 
behaviours (Harris, 1968; Creswell and Poth, 2018), to be able to achieve this, 
ethnographers engage in extensive fieldwork and typically immerse themselves in the 
participants’ daily lives to gain deeper insights through observation and be able to develop a 
complex and complete description of the participants’ culture and experiences (Creswell and 
Poth, 2018).  
Even though an ethnographic research of a specific culture could be considered a case, the 
focus of ethnography is on determining how this specific culture functions rather than using it 
as a case study to investigate a specific problem or question (Creswell and Poth, 2018). In 
contrast, a single or multiple case study approach would focus on investigating a predefined 
contemporary issue in a real-life setting of a bounded system (the case, or cases) (Yin, 
2017). The case study approach is typically used for “current, real-life cases that are in 
progress so that they can gather accurate information not lost by time” (Creswell and Poth, 
2018, p.97), which makes it a very good fit for a contemporary topic such mHealth adoption, 













Figure 10: Five qualitative approaches to inquiry  
 
Source: (Creswell and Poth, 2018) 
The following section explains in more detail why the multiple-case study approach is 
chosen for this research, and how the researcher addressed the concerns related to this 
approach to ensure rigor and reliability. 
3.2 Multiple-case study as a formal research method 
Given the contemporary nature of the topic of mHealth, being a relatively new technology 
used in healthcare, and the research questions that are focusing not only on the “what” but 
also on the “how”, case study research is deemed appropriate for this study.  It has a long 
history in many disciplines; it is a familiar method to social scientists because of its 
popularity in areas like psychology, legal cases, case reports in political sciences, as well as 
case analysis in medicine and healthcare studies (Creswell and Poth, 2018). 
Yin (Yin, 2017) explains that there are three main factors that impact the choice of method: 
The research question itself, and whether it is focused on the “why”, the “how” or the “what”, 
the researcher’s control over social measures, and the focus on recent versus historical 




The study’s research questions focus on explaining the contemporary topic of mHealth tools 
usage by clinicians, understanding the “why” behind this usage, and “how” its usage could 
impact social and organization practices  makes the case study method very relevant as it is 
advantageous when studying contemporary topics that are focused on explaining “why” and 
“how” certain phenomena happen (Creswell and Poth, 2018; Yin, 2017). 
To better understand the uniqueness and richness of the case study method, it is worth 
looking at this twofold definition: 
1. “A case study is an empirical method that investigates a contemporary phenomenon 
in depth and within its real-world context, especially when the boundaries between 
phenomenon and context may not be clearly evident.  In other words, you would want 
to do a case study because you want to understand a real-world case and assume that 
such an understanding is likely to involve important contextual conditions pertinent to 
your case. 
2. A case study copes with the technically distinctive situation in which there will be 
many more variables of interest than data points, and as one result benefits from the 
prior development of theoretical propositions to guide design, data collection, and 
analysis, and as another result relies on multiple sources of evidence, with data 
needing to converge in a triangulating fashion.” (Yin, 2017). 
This definition shows how choosing the case study method would benefit this research, as it 
takes the context into account, which is very important for the topic of the usage of mHealth 
tools by Clinicians because it could potentially impact not only users and how they use 
technology but also social practices such as roles and hierarchies in healthcare 
organizations. Therefore, taking the real-world context into account is crucial for an in depth 
understanding of the topic. 
Multiple-case study is a variation of case study research design; it is defined as a case 
study that includes multiple cases, it allows the researcher to compare the findings of each 
case, and to identify cross-case patterns to conclude some common patterns and intergroup 
differences (Bryman and Bell, 2017; Yin, 2017; Creswell and Poth, 2018). 
The researcher chose this variation because in most cases, multiple-case studies are likely 
to be more solid compared to vulnerable single cases where you put all your eggs in one 




anticipates similar results between the cases “literal replication” or contrasting results for 
predictable reasons “theoretical replication” (Yin, 2017). 
Several of the earlier methodology texts did not consider case studies as a formal 
research method, but rather as a step in the exploratory phase of another research 
method(Yin, 2017). However, the method gained considerable acknowledgment in the last 
few decades, as shown by the growing body of published research and references that 
successfully applied case study approaches (Creswell and Poth, 2018). 
Traditionally, there have been many concerns raised around case study research for 
several reasons such as lack of rigour, non-research case studies that lack a solid 
methodology, the ability to generalise from a case study, the massive amount of data and 
documents resulting from them and their comparative advantage when compared to other 
methods as explained by Yin (2017); however, it is possible to overcome each of them, and 
the researcher took this into account: 
 Rigour: as explained later in this section, there are ways and procedures that can be 
taken by the researcher to ensure the highest possible level of rigor and quality. 
 Non-research case studies: the researcher will overcome this concern by providing 
a rich account of the method used to conduct the research, including a clear 
description of the procedures, with detailed documentation and a fair reporting of the 
evidence.  
 Generalizability: the ability to generalize from a case study has always been a 
concern, but the same concern can also apply to experimental research, “how would 
it be possible to generalize from one experiment?” The same generalization 
approach used with experimental research can also be used here; even though 
population generalization is not possible in case study research, it is possible to 
achieve theoretical or analytic generalizations by expanding and generalizing 
theories.  
 Required effort: the researcher designed the study in a way that puts clear 
boundaries to the timeframe and the kind of data to be collected to make its planning 
and realization easier. 
 Comparative advantage: the researcher argues that case study research can 
potentially offer insights that cannot be achieved with methods like randomized 
controlled trials especially when try to investigate the “how “and the “why” certain 




3.3 Study design 
This section includes the explanation and justification of the study design, starting with the 
case studies’ selection criteria and reasoning, followed by details about the pilot case study 
selection and handling, then the sample selection method, data collection approach and the 
timeframe and location. 
At a glance, and as shown in figure 11, this is a multiple-case study research focusing on 
three mHealth tools and their adoption by Clinicians: an oncology decision support app, a 
clinical trial matching app, and a clinical photo and wound documentation app. Participant 
profiles varied between clinicians, mHealth developers, and medical informatics experts. The 
study spanned over a period of 36 months, from April 2017 to March 2020. The researcher 
conducted 41 in-depth interviews, and analysed them using NVivo qualitative data analysis 
software. The following sub-sections clarify each of these design elements in detail. 
Figure 11: Study design at a glance 
 
3.3.1 Defining the Cases 
Defining the cases to be studied is a critical step in the study design and is considered one 
of the key challenges of this approach, as the researcher recognizes that there are many 
cases that are potential candidates for the study, and it is important to select the ones that 
are worth studying (Creswell and Poth, 2018). Selecting cases in multiple-case study 
designs usually follows a replication logic rather than a sampling one to enable comparison; 
furthermore, the choice of cases depends on their relevance to the research questions and 




At the time of case selection for this research, there were more than 325 000 mHealth apps 
in the app store, however, a deeper look shows that only 45% of these apps get downloaded 
more than 5000 times, and only 16% have more than 10 000 monthly active users 
(Research2Guidance, 2017). This information helped the researcher to narrow down the 
selection to only include apps with a solid user base and an acceptable level of monthly 
active users to ensure that the selected app is relevant and used often enough for her to 
recruit an acceptable number of participants.  
Bearing in mind that researchers usually pick no more than four or five cases (Creswell and 
Poth, 2018), the researcher was able to identify three mHealth tools providers, two of them 
mainly operating in Europe, and one operating in the US with a customer base in Europe as 
well. She started by researching the available apps in the app store and in peer reviewed 
journals reporting on relevant apps such as the Journal of Medical Internet Research, then 
filtered the ones with a clinician interface, and a solid user base. The selected tools were 
apps that are mainly driven by the clinicians, either because they were primarily created for 
them, or because they include highly specialized information that cannot be processed and 
interpreted by the patient alone.  These were deemed most suitable for the research 
question because it focuses on clinician adoption of those apps, making them a decisive 
element as the gatekeeper to the adoption of these tools.  
The operational criteria for case purposeful sampling and selection were: 
- An mHealth tool with a clinician interface (excludes tools with patient-only interface) 
- The tool has a user base in Europe (even if the tool provider is based elsewhere) 
- Willingness to share and collaborate, enabling smooth access 
Contacts were identified then contacted first through email or LinkedIn, the professional 
social platform, to allow for full transparency about the researcher and her background. 
Almost all the people contacted responded, some declined the request, and a few agreed to 
discuss further. The novelty of mHealth tools and the competitiveness of this new area in 
healthcare explain the reason behind many rejections of the researcher’s request for 
collaboration, as it can be challenging to build trust with mHealth providers that have no 
previous knowledge of the researcher. The case recruitment efforts continued until the 
researcher successfully recruited three cases, at this point she stopped searching further.  
The digital health tools companies that were selected for the study were chosen because, as 
well as their suitability to the research question, they showed an openness for research 




findings of the research. This solves access issues and enables an open in-depth and two-
way dialogue between the researcher and the key informants, letting the research shape the 
existing solution, paving the way to a more solid and refined research themes and protocol. 
Given the very innovative and competitive nature of the mHealth development sphere a 
mutual non-disclosure agreement (NDA) was signed with the research partners to facilitate 
the collaboration and enable access. In two of the three cases the involved parties confirmed 
an NDA waiver to enable the publishing of the results, the third case remains anonymous 
and is only included in the aggregated findings in this thesis.  
The cases were selected using the replication logic that is suitable for case study research 
as shown in figure 12. The extensive literature review and theoretical framework are the first 
and crucial step in identifying the suitable cases and designing the data collection method; 
subsequently, each case is studied and its results are sought to be replicated in the other 
cases, concluding with a summary report that highlights the replication logic, and cross-case 
differences and similarities (Yin, 2017). The feedback loop represented by the dashed-line 
denotes the case where the research yields an important discovery that necessitates a 
redesign, a revision of the studied cases or the case study protocol (Yin, 2017). 
One way to analyse and report on multiple-case study research is to follow the steps 
suggested in figure 12, starting by creating an individual report for each case separately 
conducting a within-case analysis, then have an additional section detailing the cross-case 
analysis and findings (Yin, 2017; Creswell and Poth, 2018). Alternatively, the researcher 
could choose not to dedicate separate sections to the individual cases, and rather have a 
more extensive cross-case analysis section with sub-sections focusing on the different 
cross-case themes or issues, where the information from the individual cases is spread 
across these different sub-sections (Yin, 2017). 
Given that the researcher has published the individual reports of the two largest cases 
separately in peer reviewed journals as referenced in the results section, she elected to 









Figure 12: Multiple case study procedure 
 
Source: (COSMOS, 1983) as cited in (Yin, 2017)  
3.3.2 The case studies 
This research included three case studies, starting with a pilot case study that served as a 
foundational tool that helped the researcher in refining the research protocols, the interview 
themes, and sometimes offering conceptual clarifications that can be useful for the research 
design (Yin, 2017). This is aligned with the approach that other researchers adopted, 
studying a specific case or cases to investigate mHealth experiences, implementation and 
adoption (Bidmead and Marshall, 2016; Casey, Shaw and Swinglehurst, 2017; Flynn et al., 
2009; Lygidakis et al., 2016; Moharra et al., 2015; Molleda et al., 2017; Rothstein et al., 
2016; Wilhelmsen et al., 2014).  
The digital health tools company that was selected as a pilot was chosen because, as well 
as their suitability to the research question, they showed an openness for research 
engagement and willingness to collaborate and even adapt their application based on the 
findings of the research. This solves access issues and enables an open in-depth and two-
way dialogue between the researcher and the key informants, letting the research shape the 
existing solution, paving the way to more solid and refined research themes and protocol.  
Feedback, both verbally and in the form of a written report was shared with the key 
informants in return for serving as pilot; the researcher’s feedback to them, as an external 




their needs, and explicitly explaining the lessons learned from the pilot, indicating any 
adjustments that will be applied in the next cases (Clarke and Braun, 2013; Yin, 2017). 
3.3.2.1 Case study 1 (pilot): an oncology decision support app 
The first case study, that also served as the pilot study, examined an oncology decision 
support app created in 2012. It is freely available to oncologists and oncology nurses, with 
the aim of supporting their decision making at point of care, and it did not comprise a patient 
interface at the time of the research.  
Its key features include adjuvant tools that may be used to get an overall survival of patients 
with and without chemotherapy in an adjuvant setting, this helps clinicians inform their 
patients their decision of prescribing chemotherapy or not, this prediction algorithm 
estimates survival rates for different types of cancer based upon risk factors and treatment. 
It also includes interactive formulas, also available offline, to allow clinicians to make the 
essential calculations at point of care (e.g., body surface area / chemotherapy dose 
calculator to adjust the chemo dosage if a patient’s weight changes since the last dosage). 
Clinicians may also use the tool to check common toxicity criteria for the standardized 
classification of adverse effects of cancer therapy drugs, as well as drug information, and a 
drug interaction checker that allow them to check combinations of drug interactions to 
identify if they are safe to use. Furthermore, the tool includes prognostic scores that allow 
clinicians to, for example, predicting survival in patients with a specific type of cancer based 
on a few questions and patient characteristics. And the AJCC TNM staging feature assists 
users in their cancer reporting and classification, for example tumour size, affected lymph 
nodes, and metastases.  
3.3.2.2 Case study 2: a clinical trial matching app 
The second case study covered a clinical trial matching tool. It is mainly aimed at 
oncologists and oncology nurses, and it incorporated a patient interface in addition to the 
clinicians’ interface at the time of the research.  
Virtual tumour boards and second opinion is one of the tool’s key functionalities that aims at 
bridging the gap between community oncologists and academic oncologists. And their 
clinical trial matching system uses Artificial Intelligence (AI) to pre-screen the patients to 
specific clinical trials and aims at helping the patients gain access to trials faster, easing the 
stress of clinical trial enrolment process and giving the clinicians more time to focus on other 




Additionally, the tool may be integrated into the hospital or clinic’s internal information 
system and Electronic Medical Record (EMR).  
3.3.2.3 Case study 3: a clinical photo and wound documentation app 
The third case study assessed a clinical photo and wound documentation app created in 
2016. It has a solid user base in Europe, mainly in Switzerland and Germany, and it did not 
encompass a patient interface at the time of the research.  
The app’s key features include secure clinical photo and wound documentation, direct 
patient identification via barcode, precise measurement of the area (but also length, width, 
circumference) of wounds and specimens, timelines to better understand the patient’s 
progress, classification of images using hashtags to enable photo search, as well as team 
collaboration via the chat function for second opinions. 
3.3.3 The interview guide design  
The interview themes and questions were developed in light of Leonardi’s methodology and 
guidance in his paper “Methodological Guidelines for the Study of Materiality and 
Affordances” in order to crystallize the focus of the data collected in the interviews (Leonardi, 
2018).  
According to Leonardi’s guidance, a solid analysis of the role of technology in organizing and 
its impact on organizations follows three main steps: 
• Understanding and documenting the material aspects of technology and their 
limitations 
• Linking the material aspects of technology to the tasks that they enable and facilitate  
• Recognizing the processes resulting from these affordances and determining the 
consequential interactions taking place in the organization  
These three steps are reflected in the research questions, and the following lines give an 
explanation of how the interview questions stemmed from these three steps by detailing the 
interview themes and their respective questions.  The three steps are kept in the same order 
defined by Leonardi to respect their cumulative nature, and to allow each step to lead us 
smoothly into the next one.  
The following questions were used in the clinicians’ interviews, and were slightly amended 




background and role. The complete interview guides for the three participants profiles are 
included in Appendix 1.  
3.3.3.1 Background questions 
In addition to the main themes’ questions as per Leonardi’s guidance, the general 
background questions below were used at the beginning of the interviews to have a better 
understanding of the participants’ profiles and their experience with mHealth tools. 
1. Participant introduction 
- Tell me about your role in the organization 
- How long have you worked in healthcare? 
- How long have you been using mHealth? 
- How would you define your level of technical awareness on a scale of 1 to 10? 
2. How would you define mHealth in one sentence? 
3.3.3.2 Theme 1: accounting for materials 
This theme focuses on understanding the types of technology uses and as well as its 
limitations.  It is crucial to understand the material aspects of mHealth tools because it 
allows us to identify their utilities as well as things that cannot be done with them due to their 
material limitations.  
Technological features “can have various degrees of utility based on the forms into which 
they are cast” (Leonardi, 2018, p.286), that explains why a good understanding of an app’s 
features, identifying what it can do versus what it cannot do, should help avoid the delusion 
that users can accomplish limitless tasks with the tools that they use in their daily work. 
Thus, recognizing not only the utilities but also the limitations of mHealth tools is 
fundamental for the analysis.  
The questions in this section aim at investigating this theme in the context of mHealth tools. 
3. Tell me about the mHealth tool that you are using 
- What are its main features? 
- Are there any limitations to its features?  
- If you would add one feature what would it be? 




3.3.3.3 Theme 2: accounting for materiality 
This theme evolves around understanding users’ perceptions of technology and how they 
intend to use it, because people’s views of technology can influence the way they utilize it in 
their routine practice (Leonardi, 2018).  
Using the lens of sociomateriality, and according to Barley (1981), this is the step where 
technology is converted from a material object into a social one when people start using it to 
achieve different tasks, Leornardi (2012) adds that it becomes part of their daily routine and 
the social and material aspects become imbricated and can hardly be separated any 
anymore (Leonardi, 2012; Barley, 1981).  
Recognizing the constraints and affordances of technology should help the researcher to 
analyse materiality and the fusion of technology into social practices since “material 
properties afford different possibilities for action based on the contexts in which they are 
used” (Leonardi, 2018, p.290). This understanding acknowledges that users’ intentions and 
the goals that they want to achieve when using a specific technology has an impact on its 
affordances.  
Hutchby (2001) adds that such affordances go beyond users and technology’s properties, 
and are established based on the kind of relationship formed between people and the 
technology that they use; accordingly, a tool’s affordances can change depending on the 
context even when its material features remain the same (Hutchby, 2001).  
Therefore, questions in this section focus on understanding users’ views of mHealth, their 
usage intentions, decision drivers and what they see as an affordance or a constrain when 
using it.  
5. Tell me about what you wanted to achieve when you decided to use mHealth 
6. What were the factors that influenced your decision to adopt mHealth?  
- Which would you consider a barrier and which an opportunity? 
7. Who made the decision to implement it? And are there any assessment/selection criteria 
for such new technologies in your workplace? 
3.3.3.4 Theme 3: accounting for materialization 
The third and last theme concentrates on how the material aspects of technology change the 
ways of organizing work and its process. Once the researcher understands a tool’s 




important to expand the analysis to understand the impact of technology on the process of 
organizing (Leonardi, 2018). This focuses on analysing and realizing the cases when 
particular affordances impact and alter the actions, and relationships that form the 
organizing process.      
The questions in this final section focus on understanding how mHealth impacts the way 
people interact and organize work and processes in healthcare.  
8. What influence did mHealth have on your work/the work of others?  
- Did it improve it? 
- Was the previous practice better for some things? 
9. Have these tools led to changes in how the organization works, its rules or the use of 
other tools / technologies? 
10. How have the uses of these tools sustained, altered, or transformed the way that people 
interact in your organization? 
11. In your opinion, what does the future hold for mHealth? And what role could clinicians 
play in that future? 
3.3.4 Sample selection and characteristics  
Unlike quantitative research that is dominated by random sampling with the objective of 
generalizing the results to the wider population, however, the most appropriate technique for 
this research as in most qualitative research is purposive sampling with the objective of 
rich insights generation (Clarke and Braun, 2013). Therefore, qualitative researchers select 
potential participants based on their ability to provide rich and in-depth information about the 
research topic; essentially, they have to be individuals who have personal experience with 
the topic being studied so they can articulate their real life experiences (Clarke and Braun, 
2013; Creswell and Poth, 2018).  
Nowadays, the Internet and social media sites offer many opportunities for participant 
recruitment (Clarke and Braun, 2013). After shortlisting the app cases of interest as per the 
criteria explained earlier in this thesis, the researcher started contacting key informants in 
these companies via the professional social media site LinkedIn. She chose this platform 
because it transparently informs the potential participant about her professional experience, 
background and it also allows them to check others’ endorsement of the researcher. It 
allows the contacted key informant to put a face on the name of the researcher and makes 




response to her enquiry even when the potential participant declined the collaboration 
request.  
After connecting with the key informants in the selected cases of the study, the researcher 
worked with them to identify suitable participants in their tools’ user base. This technique is 
called snowballing, where the researcher builds the sample through the network of other 
participants, in this case the key informants (Clarke and Braun, 2013). The main selection 
criteria were that participants must be either healthcare professionals – e.g. physicians, 
nurses – and are active users of one of the mHealth tools subject of this study, or medical 
informatics experts supporting the implementation of these tools.  
In order to avoid the possible selection bias that might result from the key informants 
selectively connecting the researcher to users with positive inclination towards the studied 
solution, the researcher agreed with the key informants that she would ask the users they 
connected her with if they can in turn connect her to other colleagues that are using the 
solution and are willing to participate.   
As for the satisfactory amount of interviews, there isn’t a well-defined cut-off point for data 
collection in case study method, however, the researcher recognizes an acceptable level of 
saturation when confirmatory evidence is reached for the key themes, and at the same time 
this evidence incorporates efforts to examine main rival theories or accounts (Yin, 2017). 
A common sample size in research aiming to identify patterns throughout data is somewhere 
between 15 and 30 interviews; whereas a sample of 50 or more interviews is considered 
large in qualitative research (Clarke and Braun, 2013). The researcher must be sure to 
collect enough data to allow her to conduct a rich analysis, but at the same not to collect too 
much data in a way that makes a deep analysis impossible in the available timeframe; 
reaching saturation is usually a signal that enough data has been collected, this is when new 
data does not generate new insights anymore (Braun and Clarke, 2014).  
With this in mind, and an overall number of 41 interviews, ranging from 17 to 110 minutes, 
the researcher is confident that she has reached an acceptable level of saturation. Table 3 
shows an overview of the sample characteristics. Most participants were interviewed once, 
those that were interviewed more than once were members of the providers’ teams, and 
these additional interviews were either introductory interviews to talk in detail about the 
features and context of the app they provide, or as follow-up interviews to give more detail 




The researcher initially intended to conduct a similar number of interviews per case, she 
succeeded in that with case 1 (n=17) and case 3 (n=20), however, case 2 (n=4) was very 
challenging as the mHealth provider started some strategic initiatives after starting the 
research, and due to the confidentiality of the process they were reluctant to refer the 
researcher to their users at the time, resulting in a limited number of interviews. After 
discussing with the supervisory team, the researcher decided to still include the 4 interviews 
from case 2 in the aggregated analysis, despite their small number, because of the rich 
insights they provide and how they complement the findings from the other two cases.  
Table 3: Sample characteristics 
 Case 1 Case 2 Case 3 Overall Sample 
Number of 
interviews*  
17 4 20 41 
Number of 
participants 
13 3 18 34 
Function  
 
11 clinicians (one of 
them is also team 
member of the tool’s 
provider) 
2 more members of 
the tool’s provider 
team 
2 clinicians (both 
team members of the 
tool’s provider) 
1 more member of 
the tool’s provider 
team 
9 clinicians (one of 
them is also team 
member of the tool’s 
provider) 
5 medical informatics 
experts  
4 more members of 
the tool’s provider 
team 
22 clinicians 
5 medical informatics 
experts 
7 mHealth providers 










AVG 7.25 AVG 7.5 AVG 7.5  AVG 7.3 
Healthcare 
experience 
AVG years 14.5 AVG years 12.3 AVG years 13.4 AVG years 13.4 
mHealth 
experience 




Ireland, France, Italy, 
Spain, and Portugal 
United States Switzerland and 
Germany 
United Kingdom, 





* may include preparatory or follow-up interviews with the same participant ** on a scale of 1 to 10 
There was no reward or incentive offered other than the benefit of the study results. This is 




tempting the participants to expose themselves to any harm that they wouldn’t otherwise be 
exposed to (Braun and Clarke, 2014). 
3.3.5 Data collection  
In accordance to the research paradigm, the researcher decided to use qualitative data 
collection techniques, emphasizing words rather than numbers while collecting and 
analysing data; the selected techniques are mainly descriptive with a focus on 
understanding the world through the eyes of the participants (Bryman and Bell, 2017).  
The researcher collected the data mainly through interviews. Case study interview has 
interchangeably been called an “intensive interview,” “in-depth interview,” or “unstructured 
interview” and is more of a guided dialogue than structured enquiries where the researcher 
follows a general topic and its themes, using a more fluid flow of questions (Braun and 
Clarke, 2014; Yin, 2017). 
Due to the fact that participants were in many different locations, not all interviews were held 
face to face, most of them were conducted electronically via Skype, Google Hangout, or 
telephone conferencing, and 4 participants sent their responses electronically via email as 
they did not have the time for a live call. It is worth noting that digital communication forms 
are becoming more and more embedded in our daily lives, therefore, the perceptions about 
them are changing and they are no longer perceived as weaker substitutes to face-to-face 
interviews, but rather a different format of interview method (Braun and Clarke, 2014).  
The researcher made sure to always balance between following the case study protocol and 
its line of questions with verbalizing the actual interview questions in a conversational and 
unbiased manner. So, for instance, even though the researcher may want to understand 
“why” do Clinicians choose to adopt or not adopt an mHealth solution, she was careful with 
verbalizing the question because “why” questions can easily create defensiveness on the 
side of the participant; alternatively, verbalizing the question as a “how” question can be 
perceived as more friendly and nonthreatening, leading to much better results (Yin, 2017). 
She developed the interview protocol based on the guidance in Braun and Clarke (2014) 
and Creswell and Poth (2018) to detail the procedures for preparing and conducting the 
interview as shown in table 4. Before the interview she designed the interview questions, 
sent the information sheet to the participant along with the consent form, then scheduled the 
interview according to the participants’ availability; she made sure not to schedule more than 




a suitable and comfortable location or tool for the interview (face-to-face, Skype, 
teleconference, Google Hangout). 
During the interview she explained the purpose of the research again, and reminded the 
interviewees that they can skip any questions they do not wish to answer, she showed 
interest in what the participant is saying, and made sure not to be judgmental, and made 
sure to use recording equipment to have a precise record of the interview. 
After the interview she made sure to send a thank you note to the participant, to 
acknowledge their time and effort, transcribed the interview within 2-3 weeks from the date 
of the interview itself to capture all the details while they are still fresh in her memory, and 
took note of early reflections. 
Table 4: Interview protocol guide: procedures for preparing and conducting interviews 
  
Before the Interview • Designed the interview questions according to the research questions 
• Sent the information sheet to the participant 
• Sent the consent form to the participant  
• Scheduled the interview according to the participants’ availability 
• Did not schedule more than one interview per day 
• Allowed enough time for transcription between interviews 
• Picked a suitable and comfortable location or tool for the interview (face-
to-face, Skype, teleconference, Google Hangout) 
During the Interview • Explained the purpose of the research again, and reminded the 
interviewees that they can skip any questions they do not wish to answer 
• Showed interest in what the participant is saying, and made sure not to 
be judgmental  
• Made sure to use recording equipment to have a precise record of the 
interview 
After the Interview • Sent a thank you note to the participant, to acknowledge their time and 
effort 
• Transcribed the interview within 2-3 weeks from the date of the interview 
itself to capture all the details while they are still fresh in her memory 
• Took note of early reflections 





The researcher made sure to follow the protocol, provide a thick description of each step 
taken in the research and keep a chain of evidence by documenting all procedures in order 
to allow the readers to follow the derivation of evidence from research questions to findings.  
In addition to the interviews, documentary analysis was performed to obtain a solid and 
clear background about the mHealth tools included, and any related studies and known 
results or impact (Bryman and Bell, 2017). Public documents and explanatory documents 
provided on the websites were thoroughly studied as well as the non-public documents 
provided by the participants and explaining what the apps are designed to do, how they are 
meant to be used and the consequences expected from their usage. 
Furthermore, the researcher collected and analysed physical artefacts such as 
screenshots of how the app looks like, the devices it can be used on, and example written 
feedback to the developers (e.g. app reviews on the app store) in order to develop a broader 
perspective about the tools subject of the study (Yin, 2017). 
3.3.6 Timeframe and location 
In Creswell’s (2018) definition of case studies, he explains that multiple case studies are 
“contemporary bounded systems over time” (Creswell and Poth, 2018, p.96); he explains 
that the boundaries that the researcher put around the case(s) are crucial in defining the 
study. 
When defining the study’s timeframe, the researcher took into account Leonardi and Barley’s 
recommendations about the importance of tracking technology adoption over longer 
timeframes to have a better understanding of its implications. The studies that they reviewed 
covered no more than 24 months (Leonardi and Barley, 2010); therefore, the researcher 
defined a timeframe of 36 months for this study.  
The geographical location was initially meant to be focused on Europe, and the second case 
provider was selected because they have an active user base in Europe; however, due to 
recruitment difficulties it was only possible to interview the provider’s team members that are 
located in the United States. The researcher still decided to include the data collected from 
second case because of the rich insights gained from the participants and the fact that two 
of them are clinicians, and accordingly also presenting the users’ perspective not only the 
providers’ side.  
Eventually, the research took place in a time period of 36 months, with the research itself 




March 2020. Participants were located in United Kingdom, Ireland, France, Italy, Spain, 
Portugal, United States, Switzerland, and Germany.  
3.4 Data analysis  
This section explains the data analysis method choice and the steps taken to analyse the 
collected data. It starts with an introduction to thematic analysis, explaining what it is and 
why it was selected for the data analysis. Then, it details the steps taken to do the analysis 
starting with the audio data preparation for transcription and analysis, followed by 
familiarization and coding, and concluding with the procedures followed for identifying, 
analysing and interpreting patterns. 
3.4.1 Thematic analysis  
After collecting the data, the researcher used thematic analysis to make sense of it by 
identifying and extracting themes that address the research questions, and explain what 
each theme could mean as well as the links between themes (Braun and Clarke, 2006). 
Thematic Analysis was chosen because of its flexibility and its many advantages such as 
permitting the process of contrasting data similarities versus differences, generating 
unforeseen insights and enabling social and psychological data analyses (Braun and Clarke, 
2006). It is also extensively adopted in health research since the publication of Braun & 
Clarke work in 2006 titled “Using thematic analysis in psychology” (Braun and Clarke, 2014). 
Furthermore, Thematic Analysis is particularly valuable for researchers working on more 
applied research aiming at generating results that go beyond academia and benefit the 
policy or practice domains, which can very well encompass health research. It enables 
researchers to conduct thorough qualitative analysis that has the potential to get the most 
out of the data and at the same time present them in a digestible manner to audiences 
outside the academic body (Braun and Clarke, 2014). 
And because thematic analysis is a rather flexible method, the researcher made sure to be 
explicit and clear about every step in the research and to apply the steps of rigorous 
research (Braun and Clarke, 2006). To achieve the highest level of accuracy, the researcher 
decided to follow the systematic method explained by Braun and Clarke (2006), adapted and 
detailed in table 5. She started by familiarizing herself with the data, transcribing data, 
reading and re-reading the data, noting down initial ideas. She generated the initial codes by 




collating data relevant to each code. Then collated codes into potential themes, gathering all 
data relevant to each potential theme, and checked if the themes work in relation to the 
coded extracts (Level 1) and the entire data set (Level 2), generating a thematic ‘map’ of the 
analysis. She kept an on-going analysis to refine the specifics of each theme, and the overall 
story the analysis tells, generating clear definitions and names for each theme; then linked 
the themes to explanatory frameworks, models and concepts. Finally, she proceeded with 
producing the report.  
Table 5: Phases of thematic analysis after Braun & Clarke 
Familiarizing yourself with 
your data 
Transcribing data, reading and re-reading the data, noting down initial ideas.    
Generating initial codes Coding interesting features of the data in a systematic fashion across the 
entire data set, collating data relevant to each code. 
Searching for themes Collating codes into potential themes, gathering all data relevant to each 
potential theme. 
Reviewing themes Checking if the themes work in relation to the coded extracts (Level 1) and the 
entire data set (Level 2), generating a thematic ‘map’ of the analysis. 
Defining and naming 
themes 
On-going analysis to refine the specifics of each theme, and the overall story 
the analysis tells, generating clear definitions and names for each theme. 
Linking themes to 
explanatory frameworks, 
models and concepts 
Making a contribution to theory, reflecting on the validity of different 
sociomaterial approaches. Building new approaches and theoretical categories 
and concepts.  
Producing the report The final opportunity for analysis. Selection of a vivid, compelling extract 
examples, final analysis of selected extracts, relating back of the analysis to 
the research question and literature, producing a scholarly report of the 
analysis. 
Source: After (Braun and Clarke, 2006, p.87).  
The following sub-sections explain each of these steps in detail. 
3.4.2 Audio data preparation for transcription and analysis 
There are different types of transcription explained in the literature; there is orthographic or 
verbatim transcription where the researcher transcribes everything that was said in the 
recording, while the other type of transcription includes more paralinguistic descriptions 




2014). The researcher used orthographic transcription for this study. She also made sure to 
schedule enough time for transcribing after each interview to minimize any errors resulting 
from forgetting what was captured in the recorded data, especially if the recording was not 
very clear for any reason ranging from technical issues to the un-clarity of the participant’s 
voice or pronunciation.  
An exception to transcribing everything that was said verbatim is the crucial necessity of 
anonymizing data for ethical consideration; the researcher made sure to apply this rule, as 
explained in the transcription notation system recommended by Braun and Clarke (2013), by 
altering or eliminating any data that could identify the participants, such as their names or 
the names of other people that they mention.  
3.4.3 Familiarization and coding 
Unlike quantitative analysis, qualitative analysis is not a linear process, it is a continuous and 
on-going process of “Noticing, collecting and thinking about interesting things”; this 
progressive process keeps turning in a sequence until saturation, it starts by observing 
things and noticing them, we then start giving them codes and naming them based on their 
sense and finally we group them the same way we do with a puzzle, in a way that make 
them meaningful and emphasizes the differences as well as the patterns (Seidel, 1998). 
Therefore, it is not necessary to wait until all data has been collected to start the analysis in 
qualitative studies; the researcher immersed herself in the data by reading and re-reading 
transcripts and documents, and started noticing interesting things and casually taking note of 
them as the research progresses (Braun and Clarke, 2014). 
After the data familiarization, the coding – which is a more systematic process – starts. 
Braun and Clarke (2014) distinguish between two methods of coding: the first is “selective 
coding” where the researcher identifies a body of interesting instances in a selective 
manner; and the second is “complete coding” where anything and everything that is relevant 
to the research questions is identified and given a code. The researcher used the “complete 
coding” method, working systematically through the data, coding data chunks that are 
relevant to the research questions, and refining codes as the analysis evolved.  
In multiple case studies, it is important to structure the coding in a way that helps the 
researcher to cluster the data by themes within each case, and also by themes that 





Codes can be a word or a brief phrase that explain why a piece of data is relevant to the 
research question, and they form the building blocks of the analysis. The same data extract 
can be given as many codes as fits the purpose (Creswell and Poth, 2018; Braun and 
Clarke, 2014). It is also important to differentiate between codes that reflect the data’s 
semantic content, and those that reflect more theoretical or conceptual explanations. 
According to Braun and Clarke (2014): 
• Data-driven or semantic codes offer a concise summary of the explicit content of 
the data; they are grounded in the semantic sense of the data reflecting the 
participants’ language and ideas. 
• Researcher-driven or latent codes go beyond data’s explicit content; they 
represent the researcher’s theoretical frameworks and concepts to distinguish the 
implicit assumptions that underpin what is found in the data.   
Table 6 shows the codes used for the analysis, and whether they are data-derived or 
researcher-derived, as well as the theoretical frameworks where the researcher driven 
themes originated. These codes were used to group the different issues, and compare the 
different input about the same point from different participants. The first cluster of themes 
reflects the tools’ utilities versus limitations, the second cluster reflects the technical and 
material adoption factors, the third cluster reflects the social and individual factors, and the 
fourth cluster reflects the organizational and policy implications.  
Table 6: Researcher driven vs. data driven coding scheme 
Theme Sub-theme Researcher/ Data 
Driven 
Theoretical frameworks where the 
researcher driven themes 
originated 
Utilities versus Limitations 
Utilities Accessibility and 
compact overview 
Data driven __ 
Patient safety and 
quality of care 
Researcher driven Output quality (TAM2) 
Saving time and 
efficacy 
Researcher driven Effectiveness (APPEASE) 
Security and 
validation 
Data driven __ 




Design related Data driven __ 
System related Data driven __ 
Resources related Data driven __ 
Technical and material factors 
Data Related Data management 
and overload 
Data driven __ 
Privacy, security, 
and liability 
Data driven __ 
Ease of Use Researcher driven Perceived ease of Use (TAM)-Effort 
expectancy (UTAUT)-Complexity 
(CFIR-DOI) 




Data driven __ 
Technical and 
connectivity issues 
Data driven __ 
Monetary factors Researcher driven Cost (CFIR)-Affordability (APPEASE) 
Usefulness Efficacy and time 
saving 
Researcher driven Effectiveness (APPEASE) 
Evidence base Researcher driven Evidence (CFIR) 
Quality of care Researcher driven Output quality (TAM2) 
Usefulness  Researcher driven Perceived usefulness (TAM)-
Performance Expectancy (UTAUT)-
Relative Advantage (CFIR-DOI) 
User experience Design, and 
content 
reliability/neutrality 
Researcher driven Design Quality (CFIR)- Source (CFIR) 
Social and individual factors 
Personal 
characteristics 
Attitude  Researcher driven Attitude (TAM-TPB) 
Awareness  Data driven __ 
Experience and 
habits 
Researcher driven Self-Efficacy (CFIR)- Habit (TIB) 
Preference for 
personal devices 
Data driven __ 




Social and cultural 
factors 
Endorsement Researcher driven Social Influence (UTAUT)-
Observability (DOI)-Subjective Norm 
(TRA) 
Organizational and policy implications 
Inner setting Apps replacing 
traditional tools 
Data driven __ 
Decision maker Data driven __ 
Innovation and 
tension for change 
Researcher driven Tension for change (CFIR) 
Reinforcement 
factors/incentives 
Researcher driven Incentive (CFIR) 
Training and 
education 
Data driven __ 
Trialability/piloting  Researcher driven Trialability (CFIR) 
Workflow related  Clinical practice 
and infrastructure 





Data driven __ 
Empowerment  Data driven __ 
Made the work 
easier 
Data driven __ 
Roles and 
responsibilities 
Data driven __ 
Workflow fit and 
location flexibility 
Data driven __ 
Workload and 
resources 
Researcher driven Resources (CFIR) 
Policy and 
regulations 
Regulations Researcher driven External Policies (CFIR) 
Reimbursement 
and funding 
Data driven __ 
Patient related Accessibility and 
availability 








User engagement  Data driven __ 
The coding was done using NVivo that allows a clean and organized coding process and 
make the grouping and pattern identification easier than what it would be if it were done 
using printed papers. 
3.4.4 Identifying, analysing and interpreting patterns 
Pattern identification is not a passive process; the researcher develops themes from the 
coded data by actively examining the codes and the data in order to generate possible 
patterns. These themes usually cover clustered codes and have “central organizing 
concepts” capturing data patterns that are relevant to the research questions (Braun and 
Clarke, 2014; Clarke and Braun, 2013). 
As Braun and Clarke (2013) explain, some themes, might not include codes but rather other 
themes, they are called overarching themes and they help in structuring and organizing the 
analysis. At the same time, some themes might include sub-themes that capture certain 
features of the “central organizing concept” of a specific theme. It is important to remember 
that the most important themes are not necessarily the most frequent, but rather the ones 
that inform us about something meaningful and significant to address the research question 
(Braun and Clarke, 2014, 2006). 
Figure 13 illustrates a visual thematic map that shows the relationships between overarching 
themes, themes and sub-themes used in this research. The three main umbrella themes 
follow Leonardi’s (2018) methodological guidance, by categorizing the data according to his 
three key steps 1- accounting for the materials: useful features and limitations, 2- accounting 
for materiality: constraints and affordances for adoption, and 3-accounting for 
materialization: organizational and policy implications. The umbrella theme (accounting for 
the materials: useful features and limitations) was split into two themes, on one hand 
limitations, and on the other hand useful features. The second umbrella theme (accounting 
for materiality: constraints and affordances for adoption) was also split into two themes, on 
one hand the technical and material factors, and on the other hand the social and individual 
factors. Lastly, the third umbrella theme (accounting for materialization: organizational and 
policy implication) was split into five categories: inner setting of the organization, workflow fit 




The researcher (CJ) conducted the interviews, and did the analysis and coding, then the 
second supervisor (ASV) reviewed the coding; any cases of disagreement were discussed in 

































The researcher defined each theme to clarify its scope. An overview of these definitions is 
presented in the table 7, reflecting pre-existing definitions when relevant, e.g., for constructs 
that were pre-defined in some of the most used frameworks. The first cluster defines the 
different codes used to express the tools’ utilities versus limitations, the second cluster 
defines the different codes used to express the technical and material adoption factors, the 
third cluster defines the different codes used to express the social and individual factors, and 
the fourth cluster defines the different codes used to express the organizational and policy 
implications.  
Table 7: Themes’ definitions 
Theme Sub-theme Definition 
Utilities versus Limitations 
Utilities Accessibility and 
compact overview 
The perception that the tool has an impact on data 
accessibility due to the compact overview it gives the users  
Patient safety and 
quality of care 
The perception that the tool has an impact on patients’ 
safety and the quality of patient care. This theme embraces 
the pre-defined construct ‘output quality’ (TAM2) which 
refers to the perceived system’s output 
Saving time and 
efficacy 
The perception that the tool helps the user save time and 
achieve the task at hand more efficiently. This theme 
embraces the pre-defined construct ‘effectiveness’ 
(APPEASE) which refers to the degree to which the tool is 
successful in producing a desired result; success 
Security and 
validation 
The perception of the level of data security and validation of 
the tool 
Limitations Data related Limitations related to data factors 
Design related Limitations related to the tool’s design  
System related Limitations related to information systems’ factors 
Resources related Limitations related to the available resources  
Technical and material factors 
Data Related Data management 
and overload 
The perception of how easy or complex is the management 
of the data resulting for the tool’s use and whether it may 
pose an information overload 
Privacy, security, 
and liability 
Medico-legal issues related to health data privacy, security 
and any liability that this might entail 
Ease of Use This theme embraces the pre-defined constructs ‘perceived 
ease of use’ (TAM) which refers to the perceived ease of 




refers to the perception a user has that the technology is 
easy to use, and ‘complexity’ (CFIR-DOI) which refers to the 
perceived difficulty of the intervention, reflected by duration, 
scope, radicalness, disruptiveness, centrality, and intricacy 
and number of steps required to implement. The degree to 
which the innovation is perceived as being difficult to 
understand and use 




The extent to which the tool is interoperable with the 
hospital’s information system, and whether the tool supports 
EMR/EHR integration or not 
Technical and 
connectivity issues 
Any technical issues, such as wi-fi and connectivity issues, 
network issues, login issues…etc 
Monetary factors This theme embraces the pre-defined constructs ‘cost’ 
(CFIR) which refers to the costs of the intervention and costs 
associated with implementing the intervention including 
investment, supply, and opportunity costs, as well as 
‘affordability’ (APPEASE) which refers to elements such as 
cost and funding 
Usefulness Efficacy and time 
saving 
The perception that the tool helps the user save time and 
achieve the task at hand more efficiently. This theme 
embraces the pre-defined construct ‘effectiveness’ 
(APPEASE) which refers to the degree to which the tool is 
successful in producing a desired result; success 
Evidence base This theme embraces the pre-defined construct ‘evidence’ 
(CFIR) which refers to stakeholders’ perceptions of the 
quality and validity of evidence supporting the belief that the 
intervention will have desired outcomes 
Quality of care The perception that the tool enhances the quality of patient 
care. This theme embraces the pre-defined construct ‘output 
quality’ (TAM2) which refers to the perceived system’s 
output 
Usefulness  This theme embraces the pre-defined constructs ‘perceived 
usefulness’ (TAM) which refers to the usefulness the 
individual sees in using the technology, ‘performance 
expectancy’ (UTAUT) which refers to the perception a user 
has that the technology has inherent benefits, and ‘relative 
advantage’ (CFIR-DOI) which refers to stakeholders’ 
perception of the advantage of implementing the intervention 
versus an alternative solution. The degree to which the 




User experience Design, and 
content 
reliability/neutrality 
This theme embraces the pre-defined constructs ‘design 
quality’ (CFIR) which refers to perceived excellence in how 
the intervention is bundled, presented, and assembled; and 
‘source’ (CFIR) which refers to the perception of key 
stakeholders about who developed the intervention 
Social and individual factors 
Personal 
characteristics 
Attitude  This theme embraces the pre-defined construct ‘attitude’ 
(TAM-TPB) which refers to the perception of the positive or 
negative consequences related to adopting the technology; 
and the positive or negative feelings about using mHealth 
Awareness  The level of users’ awareness of the existence of the tool in 
general, or in their hospital/clinic specifically, as well as their 
awareness of its features and capabilities  
Experience and 
habits 
This theme embraces the pre-defined constructs ‘self-
efficacy’ (CFIR) which refers to the individual belief in their 
own capabilities to execute courses of action to achieve 
implementation goals, and ‘habit’ (TIB) which refers to users’ 
behavior that has become automatized (out of habit)  
Preference for 
personal devices 
This theme refers to users’ preference for using their 
personal devices at work, which may impact mHealth 
adoption  
Social and cultural 
factors 
Culture This theme embraces the pre-defined construct ‘culture’ 
(CFIR) which refers to norms, values, and basic 
assumptions of a given organization (or person, or society) 
Endorsement This theme embraces the pre-defined constructs ‘social 
influence’ (UTAUT) which refers to the influence of others on 
a prospective technology adopter, ‘observability’ (DOI) which 
assumes that the easier it is for individuals to see results of 
the innovation, the more likely they will be to adopt it, and 
‘subjective norm’ (TRA) which refers to the extent to which 
an individual believes that people who are important to him 
or her will approve his or her adopting of a particular 
behavior 
Organizational and policy implications 
Inner setting Apps replacing 
traditional tools 
Users’ perception of how new technologies such as mHealth 





Decision maker The clarity of the decision makers and the decision-making 
process, when it comes to decisions about the adoption of 
specific mHealth tools in a healthcare organization 
Innovation and 
tension for change 
This theme embraces the pre-defined construct ‘tension for 
change’ (CFIR) which refers to the degree to which 




This theme embraces the pre-defined construct ‘incentive’ 
(CFIR) which refers to the extrinsic incentives such as goal-
sharing awards, performance reviews, promotions, and 
raises in salary, and less tangible incentives such as 
increased stature or respect 
Training and 
education 
The availability and quality of the relevant training material 
and educational programs that help train the users on how to 
successfully and efficiently use the tool 
Trialability/piloting  This theme embraces the pre-defined construct ‘trialability’ 
(CFIR) which refers to the ability to test the intervention on a 
small scale in the organization, and to be able to reverse 
course (undo implementation) if warranted 
Workflow related  Clinical practice 
and infrastructure 
This theme embraces the pre-defined constructs 
‘compatibility’ (CFIR-DOI) which refers to the degree of 
tangible fit between meaning and values attached to the 
intervention by involved individuals, how those align with 
individuals’ own norms, values, and perceived risks and 
needs, and how the intervention fits with existing workflows 
and systems, ‘adaptability’ (CFIR) which refers to the degree 
to which an intervention can be adapted, tailored, refined, or 
reinvented to meet local needs, ‘practicability’ (APPEASE) 
which refers to the quality of being practicable, viability, and 
‘job relevance’ (TAM2) which refers to the importance of the 
technology for the job 
Collaboration and 
transparency 
The perception that the tool has an impact on team 
collaboration and transparency 
Empowerment  The perception that the tool enhances the users’ feeling of 
enablement  
Made the work 
easier 




The perception that the tool had an impact on the team 
members’ roles and responsibilities (e.g. altered some roles, 




Workflow fit and 
location flexibility 
The perception of the tool’s fit into the daily workflow, and 
how this is impacted by the resulting location flexibility 
Workload and 
resources 
This theme embraces the pre-defined construct ‘resources’ 
(CFIR) which refers to the level of resources dedicated for 
implementation and on-going operations, including money, 
training, education, physical space, and time 
Policy and 
regulations 
Regulations This theme embraces the pre-defined construct ‘external 
policies’ (CFIR) which is a broad concept that includes 
external strategies to spread interventions, including policy 
and regulations (governmental or other central entity), 
external mandates, recommendations and guidelines, pay-




The existence of clear and relevant reimbursement policies 
that ensures the team’s compensation for the tool’s use, and 
the existence of relevant funding for this adoption 
Patient related Accessibility and 
availability 
The perception that the tool enhances access to and 




The perception that the tool enhances patients’ engagement 
in their care process, and improves their safety 
User engagement  The extent to which the users are involved and engaged in 
the development, planning and implementation of such new 
tools 
Subsequently, the researcher started to select the excerpts that were used to explain the 
aspects of each theme, and create an account that tells the narrative of each theme in a way 
that helps the reader to smoothly understand the analysis. And even though it is not 
necessary to identify patterns in each data item (Braun and Clarke, 2006), the researcher 
made sure to balance the data excerpts and drew them unselectively from across the data.  
There are two ways to treat such data excerpts in qualitative analysis as explained by Braun 
and Clarke (2013): 
• Treating data excerpts illustratively: where the analytic account offers a 
comprehensive narrative and explanation of the theme, and the included data 
excerpts are merely used as illustrations of the analytic arguments that the 




• Treating data excerpts analytically: where the analytic account offers an analysis 
of the content of the excerpt itself. 
In this research, the researcher treated data excerpts as illustrative examples, which means 
that the excerpts included in the analysis part do not include all possible data excerpts 
related to a specific theme but rather examples to help the reader understand the story 
behind each theme and how it relates to the research questions.  
3.5 Ensuring the study’s quality 
In quantitative research, validity and reliability are used as the criteria for quality 
assessment; however, in qualitative research, there is a debate about whether the same 
criteria would be relevant; and even so, those who used validity and reliability as criteria 
suggested that different definitions should apply for qualitative research (Bryman and Bell, 
2017; Braun and Clarke, 2014; Clarke and Braun, 2013).  
Consequently, there have been alternative criteria suggested in the literature in order to 
assess the quality of qualitative research; those are “trustworthiness and authenticity” as 
explained in Bryman & Bell (2017). Table 8 shows the alternative criteria and how they were 
taken into account in this research. As shown in the table, credibility in qualitative research, 
is the equivalent of internal validity in quantitative studies. Its basis is to ensure that the 
research was done according to ‘the canons of good practices’ and supports submission of 
findings to the participants with the aim of confirming that the research has the correct 
understanding of what the participants intended, the latter is called ‘respondent validation’ 
(Bryman and Bell, 2017). Therefore, at different stages of the research, the researcher 
shared the analysis with the key informants to get their feedback. 
Transferability in qualitative research, is the equivalent of external validity in quantitative 
studies. To allow the judgment of the transferability of the finding to other cases, qualitative 
researchers are always encouraged to provide ‘thick descriptions’ that can be explained as 
‘rich accounts of the details of a culture’ (Bryman and Bell, 2017). Therefore, the researcher 
paid attention to providing a clear description of each step in the research process. 
Dependability in qualitative research, is the equivalent of reliability in quantitative studies. It 
means that the researcher has to ensure the documentation of all phases of the research to 
obtain a complete record of the whole process (Bryman and Bell, 2017). Therefore, for the 





Confirmability in qualitative research, is the equivalent of objectivity in quantitative studies. 
Even though absolute neutrality is considered impossible in qualitative research, the 
researcher can demonstrate ‘to have acted in good faith’; by showing that her personal 
values were not allowed to impact the participants or the findings (Bryman and Bell, 2017). 
Therefore, the researcher made sure not to express personal opinions and ideas during the 
interviews – unless directly asked – to avoid influencing the participants’ answers. 





What it means 
How it is applied in this 
research 
Credibility Internal validity  Its basis is to ensure that the 
research was done according to 
‘the canons of good practices’ 
and supports submission of 
findings to the participants with 
the aim of confirming that the 
research has the correct 
understanding of what the 
participants intended, the latter is 
called ‘respondent validation’. 
Member validation or respondent 
validation allows the confirmation 
of a mutual understanding 
between the researcher and the 
participants and accordingly 
verify the internal validity. 
At different stages of the 
research, the researcher shared 
the analysis with the key 
informants to get their feedback. 
Transferability External validity  To allow the judgment of the 
transferability of the finding to 
other cases, qualitative 
researchers are always 
encouraged to provide ‘thick 
descriptions’ that can be 
explained as ‘rich accounts of the 
details of a culture’. 
The researcher paid attention to 
provide a clear description of 
each step in the research 
process. 
Dependability Reliability  It means that the researcher has 
to ensure the documentation of 
all phases of the research to 
obtain a complete record of the 
whole process including problem 
For the sake of this research, a 
complete record has been kept 
and is available for review by 
authorized auditors; to protect the 





selection, fieldwork notes, 
interview transcripts, data 
analysis, and the like; this 
complete record should allow 
external audits to evaluate how 
far the appropriate procedures 
have been followed. 
non-identifiable data would be 
shared with auditors.  
Confirmability Objectivity  Even though absolute neutrality 
is considered impossible in 
qualitative research, the 
researcher can demonstrate ‘to 
have acted in good faith’; by 
showing that the researcher’s 
personal values and opinions 
were not allowed to impact the 
participants or the findings. 
The researcher paid attention not 
to express personal opinions and 
ideas during the interviews – 
unless directly asked – in order to 
avoid influencing the participants’ 
answers and opinions. 
 
Source: Author, after (Bryman and Bell, 2017)  
Furthermore, Yin (2017) identified some tactics that are specifically valid for case study 
research quality testing as explained in table 9. The table clarifies the definition of each of 
the four tests, the case study specific tactics to inspect each of them, and how they were 
applied in this research. As shown in the table, according to the guidance from Yin (2017), to 
ensure construct validity, key informants in this research were invited to review the draft 
case study report. To ensure internal validity, the researcher used thematic analysis to 
match patterns, and build explanations. To ensure external validity, the researcher aimed to 
reach analytic generalization by using a replication logic with the different cases. And to 
ensure reliability, she made sure to follow the protocol, provide a thick description of each 
step taken in the research and keep a chain of evidence by documenting all procedures in 










Table 9: Tactics to ensure design quality in case-study research after Yin 





operational procedures for 
the studied concepts  
- Use multiple sources of 
evidence 
- Ask the key informants 
to review the draft case 
study report  
Key informants in this 
research were invited to 




(For explanatory or causal 
studies only and not for 
descriptive or exploratory 
studies): seeking to establish 
a causal relationship, where 
specific conditions are 
believed to lead to other 
associated conditions, as 
distinguished from spurious 
relationships  
- Do pattern matching 
- Do explanation building 
- Address rival 
explanations 
- Use logic models 
 
The researcher used 
thematic analysis to match 




Showing whether and how a 
case study’s findings can be 
generalized  
- Use theory in single-
case studies 
- Use replication logic in 
multiple-case studies 
 
The nature of the research 
question addressing whether 
HCP adoption to mHealth 
tools impacts social 
practices and “how” helps in 
reaching analytic 
generalization by using a 
replication logic with the 
different cases 
Reliability Establishing that the 
processes of the study—such 
as its data collection 
techniques—can be 
repeated, and achieving the 
same results  
- Use case study protocol  
- Develop case study 
database 
- Maintain chain of 
evidence 
The researcher made sure to 
follow the protocol, provide a 
thick/detailed description of 
each step taken in the 
research and keep a chain of 
evidence by documenting all 
procedures in order to allow 
the readers to follow the 
derivation of evidence from 
research questions to 
findings 




Fundamentally, just like in quantitative research, the best strategy to guarantee rigor in 
qualitative research, and accordingly its quality, is to use meticulous and precise methods 
across every step of the research methodology, starting with the research design, the data 
collection methods, analysis and interpretation, and till communicating the insights (Mays 
and Pope, 2000). 
3.6 Ethical considerations 
There are ethical issues that should be considered in any qualitative research; those include 
the respect for the participants’ privacy, to respect their voluntary involvement, to preserve 
data confidentiality and not to cause any pain on the participants; it is very important to 
prevent any harm that might be caused to participants; harm can have different forms, such 
harm to participant’s development or self-esteem, stress, or harm to career prospects or 
chances for future employment (Bryman and Bell, 2017; Creswell and Poth, 2018; Clarke 
and Braun, 2013). 
Table 10 explains in detail the different types of ethical issues that researchers might face in 
the different phases of their research and how to address each of them as described in 
Creswell (2018).  
Table 10: Ethical issues in qualitative research and how to address them 




- Seek university approval 
- Examine professional association 
standards 
- Gain local access permissions 
- Select a site without a vested interest in 
the outcome of the study 
- Negotiate authorship for publication 
- Seek permission for use of unpublished 
instruments and procedures that other 
researchers might consider to be theirs 
- Submit for institutional review board approval 
- Consult types of professional ethical 
standards 
- Identify and go through local approvals for 
the site and participants; find a gatekeeper to 
help 
- Select a site that will not raise power issues 
with researchers 
- Give credit for the work done on the project; 
decide on author order 
- Obtain permission for use of any material 





- Disclose the purpose of the study 
- Refrain from pressure for participants into 
signing consent forms 
- Contact participants and inform them of the 
general purpose of the study 





- Respect norms and charters of 
indigenous societies 
- Have sensitivity to needs of vulnerable 
populations (e.g. children) 
- Find out about cultural, religious, gender, 
and other differences that need to be 
respected 
- Obtain appropriate consent (e.g. parents as 
well as children)  
Collecting 
data 
- Respect the study site and minimize 
disruptions 
- Avoid deceiving participants 
- Respect potential power imbalances and 
exploitation of participants 
- Do not “use” participants by gathering 
data and leaving the site without giving 
back 
- Store data of materials (e.g. raw data and 
protocols) using appropriate security 
measures 
- Build trust and convey the extent of 
anticipated disruption in gaining access 
- Discuss the purpose and use of the study 
data 
- Avoid leading questions, withhold sharing 
personal impressions, and avoid disclosing 
sensitive information 
- Store data and materials in secure location 
for 5 years (APA, 2010)  
Analysing 
data 
- Avoid siding with participants and 
disclosing only positive results 
- Respect the privacy of participants 
- Report multiple perspectives, and also report 
contrary findings 
- Assign fictitious names or aliases, develop 
composite profiles  
Reporting 
data 
- Avoid falsifying authorship, evidence, 
data, findings and conclusions 
- Avoid disclosing information that would 
harm participants 
- Communicate in clear, straightforward, 
appropriate language 
- Do not plagiarize 
- Report honestly 
- Use composite stories so that individuals 
cannot be identified 
- Use language appropriate for audiences of 
the research 
- See APA (2010) guidelines for permissions 
needed to reprint or adapt the work of others 
Publishing 
study  
- Share reports with others 
- Tailor the reporting to diverse 
audience(s) 
- Do not duplicate or piecemeal 
publications 
- Complete proof of compliance with 
ethical issues and lack of conflict of 
interest 
- Provide copies of the report to participants 
and stakeholders 
- Share practical results, consider website 
distribution, and consider publishing in 
different languages 
- Refrain from using the same material for 
more than one publication 
- Disclose funders for research and who will 
profit from it. 
Sources: After (Creswell, 2014; Creswel, 2016; Mertens, Ginsberg and Lincoln, 2014; 
Mertens and Ginsberg, 2014; Decleene and Fogo, 2012)  as cited in (Creswell and Poth, 




The researcher followed these recommendations thoroughly at each phase of the research 
to ensure ethical conduct: 
- Prior to conducting the study: she went through the necessary ethics trainings, 
and obtained ethical approval as shown in appendix 2. She identified the relevant 
key informants, and signed the necessary confidentiality agreements when required.  
- At the beginning of the study: the researcher gave an introduction about the 
research topic both verbally and through the information sheet that was sent to all 
participants by e-mail prior to interviews, the sheet is included in appendix 3 for 
reference; the written approval of every participant was asked, and it was always 
clarified that the participant has the freedom to skip the questions that he or she 
would not feel comfortable answering or to withdraw from the study altogether, the 
consent form is included in appendix 4 for reference. 
- Collecting data: she built trust with the participants by being transparent and always 
reminding the participants of their right to drop out of the study or skip the questions 
that they do not wish to answer, she also avoided any leading or threatening 
questions. She will make sure to store the transcripts, recorded interviews and all 
collected data in a secure location for 5 years. 
- Analysing data: the researcher made sure to balance all findings and not to focus 
only on positives; and she kept all interviews recordings and transcripts confidential, 
only supervisors can have access to them. All quotes used in the research were kept 
anonymous to protect the privacy of the participants that declared them. 
- Reporting data: the researcher reported the findings fairly and avoided the inclusion 
of any data that would lead to the identification of any of the participants. She also 
used Turnitin software for plagiarism check to confirm authenticity of the thesis 
content. 
- Publishing study: she shared tailored reports with the key informant at different 
stages of the research, and published findings in peer reviewed journals. And this 
research is not funded or sponsored by any party and there is no conflict of interest 
to declare.  
3.7 Role of the researcher 
Researchers play a fundamental role in qualitative research, this is because they are 
considered the instrument of the research, and accordingly the analysis and findings are 
impacted by their approach and way of evaluating and understanding things (Bryman and 




background impact the way she makes meaning from data; this doesn’t mean that anything 
would be accepted in qualitative research as some critiques say, but rather that the 
researcher “tells one story among many” that could be told about this specific data (Clarke 
and Braun, 2013, p.20). 
The author of this research holds a M.Sc. in International Management, a B.Sc. in 
economics, a diploma in business administration, and a postgraduate degree in business 
research methods; she has over 18 years of professional experience, out of which 10 years 
in healthcare, mostly in digital strategy roles. She started her consulting firm back in 2016 
and works on digital health research, strategy, training and planning with some leading 
Global healthcare players. 
This background empowered her with a strong and wide network in healthcare and enabled 
her to access key people in the area of Digital Health. This helped her with access to 
participants, and also fostered a relaxed and mutually beneficial dialogue between her and 
the key informants. Her passion about digital health and strong belief in its potential 
motivated her to dig deeper and investigate the topic. She always did her best to stay 






This section presents the aggregated and comparative results of the three cases, given 
that the individual reports of case 1 and case 3 were published separately in peer reviewed 
journals, while case 2 was rather narrow because of the limited number of participants, and 
it remained confidential, its results are only aggregated within the overall results reported in 
this thesis. The results related to the tools’ specific most useful features and limitations can 
be accessed in the individual reports as follows:  
- The individual report for case 1 was published as Clinicians’ Role in the Adoption 
of an Oncology Decision Support App in Europe and Its Implications for 
Organizational Practices: Qualitative Case Study. JMIR Mhealth Uhealth 
2019;7(5):e13555. DOI: 10.2196/13555 
- The individual report for case 3 was submitted for publishing and is available as 
Factors impacting clinicians’ adoption of a clinical photo documentation app 
and its implications for clinical workflows and quality of care - A qualitative 
case study. JMIR Mhealth Uhealth 2020;8(9):e20203. DOI: 10.2196/20203  
The figures in this section are used in order to visualize the findings, not with the intention of 
quantifying the data but rather to highlight the occurrence by visually presenting which 
themes or sub-themes were brought up by more participants than others. The frequency 
shown in the figures, counts the theme only one time per participant and doesn’t accumulate 
if the same participant brought the same theme up more than once. The visualization 
primarily aims to improve the understanding of the findings especially when contrasting two 
factors such as mHealth utilities and limitations (Verdinelli and Scagnoli, 2013), and can 
provide a clear and simple visual of the central ideas, themes and sub-themes for lay 
readers (Henderson and Segal, 2013). 
4.1 Case study backgrounds and context  
This sub-section aims to give the reader more contextual information on the three apps 
subject of this multiple case study, including more details about their features, their visuals 
where applicable (when the NDA waiver was signed by the provider) and how long they had 
been used in practice prior to the study. 
The first case study, which also served as the pilot study, examined an oncology decision 
support app created in 2012, and had been in use for 6 years at the time of the interviews for 




at point of care, and it did not comprise a patient interface at the time of the research, 
however, a patient interface was under development at the time.  
Its key features include adjuvant tools that may be used to get an overall survival of patients 
with and without chemotherapy in an adjuvant setting, this helps clinicians inform their 
patients of their decision to prescribe chemotherapy or not. This prediction algorithm 
estimates survival rates for different types of cancer based upon risk factors and treatment. 
It also includes interactive formulas, also available offline, to allow clinicians to make the 
essential calculations at point of care. 
The tool also includes a feature that helps clinicians to check common toxicity criteria for the 
standardized classification of adverse effects of cancer therapy drugs, as well as drug 
information, and a drug interaction checker that allow them to check combinations of drug 
interactions to identify if they are safe to use. Furthermore, the tool includes prognostic 
scores that allow clinicians to, for example, predict survival in patients with a specific type of 
cancer based on a few questions and patient characteristics. And the AJCC TNM staging 
feature assists users in their cancer reporting and classification, for example tumour size, 
affected lymph nodes, and metastases.  
The following list explains the tool’s features at the time of writing this thesis in more detail, 
as per the provider’s information and in alignment with the examples shared by the 
participants (ONCOassist, 2018), and visualized in Figure 14. 
• Adjuvant tools: can be used to get a 5 and 10-year overall survival of patients with 
and without chemotherapy in an adjuvant setting, this helps them inform patients as 
to why they may or may not be prescribing chemotherapy (e.g. Prediction algorithm 
estimating survival rates for breast/lung/colon/GIST cancer based upon risk factors 
and treatment).  
• Formulas: over 20 interactive formulas including offline access to enable clinicians 
to make the necessary calculations at point of care (e.g. body surface area / 
chemotherapy dose calculator to adjust the chemo dosage if a patient loses or gains 
weight since the last prescribed dosage).  
• Prognostic scores: over 14 prognostic scores enabling clinicians to get the scores 
they are looking for based on a few questions and patient characteristics (e.g. 
predicting survival in patients with metastatic renal cell carcinoma).  
• Common Toxicity Criteria: a set of criteria for the standardized classification of 




• AJCC TNM Staging: enables an easy and quick feature to help clinicians in their 
cancer reporting and classification, e.g. Tumor size, Lymph Nodes affected, 
Metastases.  
• Drug Info: gives users access to a comprehensive list of oncology specific drugs 
information allowing them to jump in and out of specific sections quickly.  
• Drug Interaction checker: enables users to quickly search combinations of drug 
interactions to identify if they are safe to use.  
• ONCOnews: allows easy access to most up to date news and information in the field 
of oncology, personalized based on the user’s specialist interests.  
Figure 14: First Case Study App Visual 
 
Source: (ONCOassist, 2018) 
The second case study covered a clinical trial matching tool. It is an Artificial Intelligence (AI) 
powered platform mainly aimed at oncologists and oncology nurses, and it incorporated a 
patient interface in addition to the clinicians’ interface at the time of the research. It was 
launched in 2015, and had been in use for 4 years at the time of the interviews for this study.  
Virtual tumour boards and second opinion are among the tool’s key functionalities that aim at 
bridging the gap between community oncologists and their academic counterparts. The 
clinical trial matching system uses AI to pre-screen the patients to specific clinical trials and 
aims at helping the patients gain access to trials faster, easing the stress of clinical trial 




rather than searching the database through hundreds of trials. Additionally, the tool may be 
integrated into the hospital or clinic’s internal information system and Electronic Medical 
Record (EMR). It is not visualized here because this case remains confidential as the 
provider didn’t sign an NDA waiver, and therefore visuals and too detailed features cannot 
be included for confidentiality reasons.  
The third case study assessed a clinical photo and wound documentation app that was 
created in 2016, and had been in use for 3 years at the time of the interviews for this study. 
It has a solid user base in Europe, mainly in Switzerland and Germany, and it did not 
encompass a patient interface at the time of the research.  
The app’s key features include secure clinical photos and wound documentation, direct 
patient identification via barcode, precise measurement of the area (but also length, width, 
circumference) of wounds and specimens, timelines to better understand the patient’s 
progress, classification of images using hashtags to enable photo search, as well as team 
collaboration via the chat function for second opinions. 
The following list explains the tool’s features at the time of writing this thesis in more detail, 
as per the provider’s information and in alignment with the examples shared by the 
participants (imito AG, 2019), and visualized in Figure 15. 
• EMR integration: the app integrates into the hospital's existing application 
architecture to facilitate the exchange of patient data between the two systems. 
• Simplified login and patient identification: the app allows users to login via 
barcode or Radio-frequency identification (RFID) for impersonal devices and, and 
also enables direct patient identification via barcode 
• Wound measurement: automatic measurement of the area, length, width and 
circumference of wounds and specimens  
• Offline and emergency mode: the app allows clinicians to capture series offline or 
without patient identification and complete it later on any device. 
• Order-based: the app uses an order-processing-interface that allows integrated 
wound photography workflows based on tasks 
• Timeline: clinicians can use the app to browse through the timeline of one or more 
findings of a patient to better understand the progression. 
• Interdisciplinary communication: the app enables team collaboration via chat, e.g. 




• Intelligent search and hashtags: The categorization of images provides added-
value for research and education, enabling users to instantly find other photos with 
similar characteristics. 
• Melanoma Screening: clinicians can use the app to document melanomas with the 
Handyscope (iOS adapter) and save them standardized and automatically calibrated 
in the patient record. This last feature is provided in cooperation with Fotofinder 
Systems GmbH.  
Figure 15: Third Case Study App Visual 
 
Source: (imito AG, 2019) 
4.2 Accounting for the materials: utilities and limitations 
At first, the researcher explored each app’s mostly used features, their perceived value from 
the participants’ perspective, and any possible limitations or suggested improvements. Th is 




reflects the frequency of each theme (frequencies reflect the number of participants that 
mentioned that specific theme).  
Figure 16: Utilities and limitations 
 
The study participants were first requested to list the features that they use most in the 
studied app to help the researcher understand the technological artefacts that they find most 
helpful. These app specific features were published in the individual reports as they are too 
specific to the individual tools; however, the perceived utilities and limitations are aggregated 
here in the overall reports given the common patterns that emerged in all three cases.   
The researcher asked each participant to explain how the app helped her or him and their 




position. Most participants mentioned saving time and efficacy as a clear added value of the 
apps (n=27, 79%), this utility was reported in the three studied cases; enhanced patient 
safety and quality of care were also reported by a large portion of the participating clinicians 
(n=23, 68%), and was reported in the three cases too. Users in the three studied cases also 
saw value in the better accessibility and compact overview of medical apps (n=14, 41%), 
and users of the apps in the first and third case studies believed that the apps enhanced 
data security and validation (n=12, 35%).  
In the same way, participants were also asked to talk about any limitations or restraints they 
might be facing with the studied apps. Data related limitations were the most common and 
came up in all three cases (n=8, 24%), they varied between issues related to data 
completeness and accuracy, to information availability and personalisation. Design related 
constraints emerged in two of the studied cases (n=7, 21%), they were focused on potential 
information clutter and the lack of some specific features such as a patient interface. System 
related challenges also emerged in two of the studied cases (n=6, 18%), and mostly evolved 
around interoperability and connectivity issues. Lastly, resources related issues were 
mentioned in only one of the three cases (n=2, 6%) and focused on providers’ capacity and 
bandwidth to continuously develop and expand their mHealth tools to meet users’ evolving 
needs. Table 11 summarizes the prevalence of each theme in the aggregated sample, as 
well as its frequency in each of the three studied cases.  
Table 11: Utilities and limitations, theme prevalence per case study 
Theme Sub-theme Total n(%) Case1 n(%) Case2 n(%) Case3 n(%) 
Utilities Accessibility and 
compact overview 
14 (41%) 7 (54%) 1 (33%) 6 (33%) 
Patient safety and 
quality of care 
23 (68%) 8 (62%) 1 (33%) 14 (78%) 
Saving time and efficacy 27 (79%) 11 (85%) 1 (33%) 15 (83%) 
Security and validation 12 (35%) 3 (23%) __ 9 (50%) 
Limitations Data related 8 (24%) 5 (38%) 1 (33%) 2 (11%) 
Design related 7 (21%) 1 (8%) __ 6 (33%) 
Resources Related 2 (6%) 2 (15%) __ __ 




4.3 Accounting for materiality: constraints and affordances 
The second step was about examining each of the studied apps’ materiality by investigating 
the participants’ views on the constraints and affordances impacting each tool’s adoption 
from technical and social standpoints. Figure 17 visualizes the themes in the category 
technical and material factors and their corresponding sub-themes, reflecting the incidence 
of each of them in the aggregated data.  
Figure 17: Technical and material factors 
 
Usefulness was the most dominant theme in the technical and material factors. Most 
participants stated that the tool’s efficacy and the resulting time saving are key facilitators for 




time saving were sometimes translated in manpower reduction resulting from the tool’s 
usage as explained by P20 “So the way we do the analysis of this is we are basically 
decreasing half day of FTEs per site for patient matching”, but could also be time saving per 
individual patient as P30 mentioned “It created efficiency. Before it (photo documentation) 
took maybe three, four, five minutes, and now it takes 30 seconds”.  
The tool’s capability to enhance the quality of care was another important factor (n=17, 
50%), closely followed by general usefulness (n=16, 47%), with the two sub-themes coming 
up in all three cases; for example, P36 clarifies how the introduction of the app can improve 
the quality of care “In the operating room, the photos are not available. So, the clinician has 
to either just have a good guess what happened in his memory, or get to retrieve the photo 
somewhere else. (With the app) there is really benefits in the treatments because you have 
the things available when you need them”. Participants in the second and third cases also 
referred to the importance of an evidence base that supports the value of the tool to 
encourage clinicians’ adoption (n=3, 9%); some participants, such as P39 explained that the 
data generated by such apps can be very helpful for research and evidence generation “We 
also expected benefits in terms of scientific studies, simplification of treatment algorithms 
and networking of inpatient and outpatient treatment pathways”. 
The IT capability and compatibility factors were also central. Participants in all three cases 
highlighted the importance of the tool’s interoperability and integration for it to be accepted 
by clinicians (n=17, 50%), highlighting that it is usually a challenge as explained by P34 “The 
EMR integration in this regard is a challenge both from a cost perspective and the support 
availability perspective”; while technical and connectivity issues may also be a barrier to 
adoption (n=13, 38%) as per participants in two of the three cases. Monetary factors such as 
the tool’s licensing and integration costs were also vital for adoption and present in all three 
cases (n=17, 50%), as detailed by P39 “Barriers for establishing such tools are the 
investment costs, e.g., set up of a secure WLAN, equipment and licensing cost”. And ease 
of use was mostly seen as a facilitator in the first and third studied cases (n=19, 56%), 
participants such P12 explained that if they find an app not easy to use, they would usually 
abandon it “I've often downloaded apps and deleted them. But once I download that and see 
how easy it is, it stayed on my phone” P12.  
Data related factors, especially data privacy, security and liability came up in the second and 
third cases (n=14, 41%), while challenges related to data management and potential 
overload were only mentioned by participants in the third case study (n=3, 9%); for example, 




future because it is so well accepted that some users overdo it. And we are not limited in 
terms of data capacity, storage space”. User experience factors associated with the tool’s 
design and content reliability and neutrality were mentioned by participants in the first and 
second cases (n=7, 21%), as P12 explains the importance of factors such as content 
reliability for user experience “And so having that, that each time-- as standard, that each 
time before you're giving your dose that you have, you have this reliable - I suppose that is 
the word, reliable - calculator for calculating your dose”. Table 12 summarizes the 
prevalence of each theme in the aggregated sample, as well as its frequency in each of the 
three studied cases.  
Table 12: Technical and material factors, theme prevalence per case study 
Theme Sub-theme Total n(%) Case1 n(%) Case2 n(%) Case3 n(%) 
Data Related Data management and 
overload 
3 (9%) __ __ 3 (17%) 
Privacy, security, and 
liability 
14 (41%) __ 1 (33%) 13 (72%) 
Ease of Use 19 (56%) 6 (46%) __ 13 (72%) 




17 (50%) 1 (8%) 3 (100%) 13 (72%) 
Technical and 
connectivity issues 
13 (38%) 7 (54%) __ 6 (33%) 
Monetary factors 17 (50%)  9 (69%) 2 (67%) 6 (33%) 
Usefulness Efficacy and time saving 29 (85%) 12 (92%) 3 (100%) 14 (78%) 
Evidence base 3 (9%) __ 1 (33%) 2 (11%) 
Quality of care 17 (50%)  7 (54%) 2 (67%) 8 (44%) 
General Usefulness  16 (47%) 9 (69%) 2 (67%) 5 (28%) 
User experience Design, and content 
reliability/neutrality 
7 (21%) 6 (46%) 1 (33%) __ 
Table 13 shows some more participants’ quotes from the three cases about the technical 







Table 13: Technical and material factors sample participants’ quotes 
Technical and material factors 
Data Related Data management 
and overload 
“And the other thing we noticed is that it needs some kind of controlling in 
the future because it is so well accepted that some users overdo it. And 
we are not limited in terms of data capacity, storage space” P26 
“We have more pictures in this time we roll out the devices. So, I do not 
know if it is always good to have just more content, if it is also in the right 
context, and is it useful, and that stuff. But we have more” P30  
Privacy, security, 
and liability 
“The other major challenge is the data privacy, and all the things that 
come from the compliance, regulation and transfer” P18 
“the product needs to have a CE mark or a mark as a medical product. 
Then it needs to be GDPR compliant, of course” P34 
“And altogether you just have to still follow the hospital rules about data 
security and all that stuff” P33 
Ease of Use “I've often downloaded apps and deleted them. But once I download that 
and see how easy it is, it stayed on my phone” P12 
“It is very important to have an easy self-explanatory tool for nurses to 






“Our ability to access their EMR system without them needing to 
physically either send records or have somebody sending the records that 
they have to pay. Or having to do any additional work on their side. I think 
that that is a huge thing” P21 
“But there are barriers, mainly the IT integration requirement” P22 
“The EMR integration in this regard is a challenge both from a cost 




“I do not know about your hospital. A lot of hospitals, the way they are, for 
some reason the signal is never good. And therefore, that also has a 
bearing on how these apps work” P8 
“of course, an app like this needs a lot of battery. So, we have to load the 
battery two or three times a day” P32 
“I was too frustrated with the log-in process and now that we have the 
possibility to log in with face ID, it has proved to be a marvel” P37 
Monetary factors “I suppose cost is also a barrier for a few” P15 
“maybe one part of the team, one clinician would like to have it, but they 
do not have the means to be able to pay for it” P21 
“Barriers for establishing such tools are the investment costs, e.g., set up 
of a secure WLAN, equipment and licensing cost” P39  
Usefulness Efficiency and 
time saving 
“I mean, it is quicker, more efficient than taking out a ruler and a piece of 
paper and measuring and then go and double checking it” P13 
“So, the way we do the analysis of this is we are basically decreasing half 
day of FTEs per site for patient matching” P20 
“It created efficiency. Before it (photo documentation) took maybe three, 
four, five minutes, and now it takes 30 seconds” P30 
Evidence base “the physicians are there because they are more interested in the 
research and the outcomes” P18 
“We also expected benefits in terms of scientific studies, simplification of 





Quality of care “And the intention was to see if this app would help aide my day-to-day 
clinical decisions and looking after patients” P8 
“It eases the stress of clinical trial enrolment process and gives the HCPs 
more time to focus on other patient-related tasks” P21 
“In the operating room, the photos are not available. So, the clinician has 
to either just have a good guess what happened in his memory, or get to 
retrieve the photo somewhere else. (With the app) there is really benefits 
in the treatments because you have the things available when you need 
them” P36  
General 
Usefulness  
“Something I can use every day and that is fast” P6 
“The fact that it does actually have things that we do use and which are 
relevant to us” P8 






“And so having that, that each time-- as standard, that each time before 
you're giving your dose that you have, you have this reliable - I suppose 
that is the word, reliable - calculator for calculating your dose” P12 
“And we need to keep training it constantly for the machine learning so it 
actually works in the right way and adapting to the needs of each client or 
each patient” P20 
 
As for social and individual factors, they were focused on 6 key sub-themes. Figure 18 
visualizes the themes in this category and their corresponding sub-themes, reflecting the 

















Figure 18: Social and individual factors 
 
Personal characteristics such as users’ attitude towards change or technology, previous 
experiences and habits, awareness, and preferences for personal devices played a clear 
role in the tools’ adoption decision. Participants in the first and third cases clarified that a 
person’s attitude towards change or technology in general may impact their decision to 
adopt mHealth tools (n=6, 18%), as P7 explains that this can be an individual matter “But I 
know people, even people from my age that are somewhat challenged regarding apps in 
general. So I do not think they would obtain the benefit I do. But of course, this is personal”. 
Participants in the second and third cases explained that awareness (n=5, 15%), and 
previous experiences and habits (n=5, 15%) could also play a role; for example, some users 
may not choose to adopt a certain tool because they are not aware of how it can help them 




Yeah. Awareness”. Some participants also stated that some people’s preference for their 
personal devices may facilitate mHealth adoption (n=3, 9%).  
Social and cultural elements should also be taken into account. Participants in two of the 
three cases elucidated that local and organizational culture (n=4, 12%) can impact adoption, 
explaining that organization cultures that perceive mobile use at work as waste of time may 
have a negative impact on the widespread adoption of such apps, as P12 says “So I think 
definitely. Unless that you're taking a call, if you're scrolling on your phone, people will 
automatically presume that you're using it for social media purposes and not for research or 
education” P12. Endorsement and recommendations from peers or trusted sources (n=10, 
29%) may also influence users’ adoption decision; for instance, P9 explains that 
recommendations from trusted colleagues on social media platforms is what encouraged her 
to adopt the app “I went to Young Oncologists Facebook group and everybody was talking 
about it. And also, one of my colleagues that I really trust a lot for many years now and I 
decided to install it and download”. Table 14 summarizes the prevalence of each theme in 
the aggregated sample, as well as its frequency in each of the three studied cases.  
Table 14: Social and individual factors, theme prevalence per case study 
Theme Sub-theme Total n(%) Case1 n(%) Case2 n(%) Case3 n(%) 
Personal 
characteristics 
Attitude  6 (18%) 2 (15%) __ 4 (22%) 
Awareness  5 (15%) __ 2 (67%) 3 (17%) 
Experience and 
habits 
5 (15%) __ 1 (33%) 4 (22%) 
Preference for 
personal devices 
3 (9%) 2 (15%) __ 1 (6%) 
Social and cultural 
factors 
Culture 4 (12%) 1 (8%) __ 3 (17%) 
Endorsement 10 (29%) 9 (69%) 1 (33%) __ 
Table 15 shows some more participants’ quotes from the three cases about the social and 








Table 15: Social and individual factors sample participants’ quotes 
Social and individual factors 
Personal 
characteristics 
Attitude   “But I know people, even people from my age that are somewhat 
challenged regarding apps in general. So I do not think they would 
obtain the benefit I do. But of course, this is personal” P7 
“And now with electronic health record opening all of it come these 
changes that can be challenging for physicians that were not used to 
that or that are resistant to changes” P29 
Awareness  “they maybe do not understand yet how it (the tool) could benefit them. 
Yeah. Awareness” P21 
“It is more of an awareness and training topic than functionality… to take 
a picture, that is very easy, you are used from your own cell phone. But 
if you make a wound measurement, okay, how does it work? And the 
QR code and-- you have to have some information about this” P30 
Experience and 
habits 
“I think that there's a lot of old school doctors who do not want to be 
bothered by doing this. They think that they can do it on their own and 
that is fine” P21 
“they (users) could open up finally to this digital transformation because 
they experienced already one best practice or two or three” P28 
“the medical field, as well, has a new generation now, getting to work 
more with digital health like a tablet or a Smartphone” P32 
“And then the head of the dialysis found out that she really had people 
on her staff that didn't have a smartphone. But I think it is not the general 




“if I have my phone in my pocket. I wouldn't always have access to an 




Culture “So, I think definitely. Unless that you're taking a call, if you're scrolling 
on your phone, people will automatically presume that you're using it for 
social media purposes and not for research or education” P12 
“Maybe on this point of view that, if you ever have a phone in your 
hands, many people think, "Okay. You are gaming something, or you 
are on social media." But this is a working device. And we are in a 
change now that the patients-- they see, "Okay. I can do something with 
the doctor” P30 
Endorsement “So, I would say the encouragement from ESMO is definitely a factor 
because probably this endorsement in itself has its strength” P8 
“I went for me on to Young Oncologists Facebook group and everybody 
was talking about it. And also, one of my colleagues that I really trust a 
lot for many years now and I decided to install it and download” P9 
“…recommendations, they keep following us and recommend other 
patients. The physicians that have referred to us as well, they still use 
our tool and sometimes they become advocates for us” P20 
 
4.4 Accounting for materialization: organizational factors and implications 
As a third step, participants were asked about the organizational and policy factors that may 




reflect on how technology use influences the way users organize their work. Figure 19 
visualizes the themes in the category organizational and policy factors and implications, and 
their corresponding sub-themes, reflecting the incidence of each of them in the aggregated 
data.  
Figure 19: Organizational and policy factors and implications 
 
Five key themes dominated the discussions about organizational and policy factors and 
implications: workflow related factors topped the list, followed by factors relating to the 
specific inner setting of the organization, then patient related considerations, the importance 
of user engagement in the development and implementation of mHealth, and external policy 




Workflow related aspects revolved around seven key sub-themes. Workflow fit and location 
flexibility, that focus on how the app actually fits in clinicians’ daily work, were mentioned by 
half the participants and strongly present in all three cases (n=17, 50%); P11 gave an 
example of the location flexibility and enhanced workflow gained from the app use “for the 
specific information that I know I have on the apps, I do not have to go to the computer 
anymore, so I think it is better organized my work because I know that I have that resources 
there”, and P30 added “before, you had to go onto the station, take the camera. Now, you 
have it in your pocket right next to you. You can log in with the face ID, take a picture and 
send it”. 
The impact of mHealth use on team collaboration and transparency was also central and 
mentioned in two of the three cases (n=14, 41%), as P39 explains “The advantages lie in the 
improvement of the interdisciplinary cooperation of different medical disciplines and the 
closer link between inpatient and outpatient treatment pathways”. The influence on 
clinicians’ ease of work was clear and came up in all three cases (n=11, 32%), P33 gave a 
good example of how the app can make work easier “it is easier for the physician to see 
something in a picture than to read it out of some long description someone did before”. 
Participants in two of the three cases also discussed mHealth’s impact on clinical practice 
and infrastructure (n=10, 29%); for instance, P22 explained that some lacking infrastructure 
in the organization can make the widespread adoption more challenging “And in some of the 
hospitals, it is as well the lacking of mobile devices readiness or how to deal with mobile 
devices, etc. So, it is more an infrastructure or strategic issue there”.  
Factors relating to clinicians’ workload and the resources made available to them were 
mentioned by participants in all three cases (n=8, 24%); some participants such as P21 
believed that such apps can have a positive impact on existing workload “They could also 
limit the need to have record coordinators. So as we had talked about before, a half or a full 
FTE. And decrease the time that is lost in sending the records”, while other participants such 
as P38 explained that the higher efficiency may also increase the workload because the 
apps are helping them finish more work more quickly which results in a higher workload 
overall “Digitalisation is an aid, but it is currently exacerbating the speed and increasing the 
challenges to performance. It set a much bigger pressure on working forces by creating 
more demands and increasing speed of everything”. Participants in two of the three cases 
explained that mHealth use may also impact clinicians’ empowerment (n=7, 21%) as per the 
example from P29 “You have the power of data so it is a gift in who has the knowledge and 
often it is used by physician. Physician has the knowledge, has the information in his folder 




Participants in all three cases explained that the introduction of these new apps may also 
alter some of the current roles and responsibilities (n=5, 15%), this can be in the form of the 
creation of new roles as explained by P5 “having people like myself CCIOs, clinical 
information officers, to get involved with the IT side of service provision” P5, but could also 
be in the form of the elimination of some roles that became obsolete after the introduction of 
the app as P26 clarified “our professional patient photographer is consulted less frequently, 
this has changed… it (the app introduction) altered the role of the photographer, it 
diminished the role a little bit”.  
The specific inner setting of the organization was also central. The majority of participants 
mentioned the importance of the decision maker and the internal decision-making process 
for mHealth adoption, a sub-theme that came up in all three cases (n=20, 59%), the lack of 
clarity on the decision-making process and the people involved in the decision can be a 
challenge for adoption as P36 clarified “I think the problem is nobody's actually willing to 
make a decision. Everybody wants it. Everybody thinks this is great. But nobody actually 
says, Yes. This is going to be implemented". There were also many discussions in all three 
cases about how mHealth apps are currently replacing some of the traditional tools in the 
clinical practice (n=14, 41%); for example, P36 explained how one of the key gains of these 
novel tools is that they replace processes that used to be done manually “So, the main 
aspect, the main benefit, is that the manual process that was previously used, I mean, using 
a point-and-shoot camera and having to transfer the photos from the camera to the 
computer and then saving them to the right patient. This whole manual process is, yeah, 
completely replaced by the automatic process. So, it is a lot of time savings and quality 
improvements because of the no errors, manual errors, linking the wrong photo to a patient 
or not linking them at all”.  
The importance of incentives and reinforcement factors to encourage adoption was 
mentioned by participants in all three cases (n=4, 12%), as P18 expressed “So there has to 
be clear incentives, and there has to be very clear resource allocation”. Additionally, the 
importance of training and education was mentioned in one of the three cases (n=4, 12%), 
for instance P30 clarified the importance of training the users and informing them about the 
importance of the new tool in order to encourage adoption “You have to train the users and 
show them why it is important”. Participants in one of the three cases also explained the 
possibility to try and pilot the app before scaling it could encourage adoption (n=2, 6%), this 
is mainly due to the reduced risk of a pilot compared to a large-scale implementation, as 
clarified by P28 “One of the factors is simply pilot projects are available and recommended 




Patient related factors such as the implications for patient engagement and safety were also 
pretty vital and were mentioned by participants in all three cases (n=14, 41%); for example, 
P13 explained that the app usage can enhance patient safety “It is just a security feature 
when you need something to fall back on if you're giving a drug and want to ensure you're 
giving the right dose”, and P36 explained how the app usage can also enhance patient 
engagement in their own treatment “Especially in wound care, they often adapt a treatment 
because a treatment is not necessarily working. And when they have the photos on the 
smartphone, they can easily talk to the patient and show them that, they can be involved 
much, much more easily than before because everything is available”. mHealth impact on 
the accessibility and availability of patient care was mentioned by participants in two of the 
three cases (n=5, 15%), as it  cuts travel times and helps patients access services that they 
might not have been able to access otherwise, as clarified by P20 “patients get the state-of-
the-art science in front of them so they do not have to travel. They do not have to waste 
time. Time is golden in cancer”, and P21 “So it helps to gain more access to clinical trials 
more quickly”. User engagement was another vital factor that came up in all three cases, 
stressing the importance of involving the users in the development and implementation of 
mHealth tools (n=15, 44%). 
Many participants also mentioned health policies and regulations as key factors impacting 
adoption. Reimbursement and funding policies were specifically called out as important 
factors in two of the three cases (n=5, 15%), for instance, P34 explained how the lack of 
reimbursement for them of these tools can be challenging for the healthcare organizations 
“And there will be no compensation, currently, at least. There will be no compensation for 
digital solutions, since the federal states are not paying for that... We are working on that. 
So, we are in close contact with a couple of institutions in the government in order to find 
some kind of compensation for that kind of expenses”. Regulations in general were also 
mentioned as a fundamental factor by participants in one of the three cases (n=3, 9%), for 
example, regulations related to healthcare data privacy and security may pose a challenge 
to adoption as P39 clarified “The limitations and problems are rather in the legal area, as the 
sending of sensitive patient data is very restrictive.... Legal and technical requirements for 
secure data transfer must be dealt with”. Table 16 summarizes the prevalence of each 







Table 16: Organizational and policy factors and implications, theme prevalence per case study 
Theme Sub-theme Total n(%) Case1 n(%) Case2 n(%) Case3 n(%) 
Inner setting Apps replacing 
traditional tools 
14 (41%) 3 (23%) 1 (33%) 10 (56%) 
Decision maker 20 (59%) 4 (31%) 2 (67%) 14 (78%) 
Innovation and tension 
for change 
2 (6%) __ __ 2 (11%) 
Reinforcement 
factors/incentives 
4 (12%) 1 (8%) 2 (67%) 1 (6%) 
Training and education 4 (12%) __ __ 4 (22%) 
Trialability/piloting  2 (6%) __ __ 2 (11%) 
Workflow related  Clinical practice and 
infrastructure 
10 (29%) __ 2 (67%) 8 (44%) 
Collaboration and 
transparency 
14 (41%) __ 2 (67%) 12 (67%) 
Empowerment  7 (21%) 4 (31%) __ 3 (17%) 
Made the work easier 11 (32%) 3 (23%) 2 (67%) 6 (33%) 
Roles and 
responsibilities 
5 (15%) 3 (23%) 1 (33%) 1 (6%) 
Workflow fit and 
location flexibility 
17 (50%) 4 (31%) 1 (33%) 12 (67%) 
Workload and 
resources 
8 (24%) 1 (8%) 2 (67%) 5 (28%) 
Policy and regulations Regulations 3 (9%) __ __ 3 (17%) 
Reimbursement and 
funding 
5 (15%) __ 1 (33%) 4 (22%) 
Patient related Accessibility and 
availability 
5 (15%) __ 3 (100%) 2 (11%) 
Patient engagement 
and safety 
14 (41%) 1 (8%) 2 (67%) 11 (61%) 
User engagement  15 (44%) 6 (46%) 1 (33%) 8 (44%) 
Table 17 shows some more participants’ quotes from the three cases about the 





Table 17: Organizational and policy implications sample participants’ quotes 





“So, the main aspect, the main benefit, is that the manual process that was 
previously used, I mean, using a point-and-shoot camera and having to 
transfer the photos from the camera to the computer and then saving them to 
the right patient. This whole manual process is, yeah, completely replaced by 
the automatic process. So, it is a lot of time savings and quality 
improvements because of the no errors, manual errors, linking the wrong 
photo to a patient or not linking them at all” P36 
Decision maker “I think the problem is nobody's actually willing to make a decision. 
Everybody wants it. Everybody thinks this is great. But nobody actually says, 




“And I think competition with other healthcare providers is a topic” P26 
“the fact we use such an app can also be used in communication, that is 
something that we use as a tool to also kick-off the internal change process in 
the people and show that (our institution) is an enormous player and open to 
that kind of innovation” P34 
Reinforcement 
factors/incentives 
“So there has to be clear incentives, and there has to be very clear resource 
allocation” P18 
“think it made changes in a positive way because now we're helping them 
include structured data in a way that they measure success” P20 
Training and 
education 
“And when you have high fluctuation of personnel, then you have the 
problems. You always have to do the training” P26 
“You have to train the users and show them why it is important” P30  
Trialability/piloting  “One of the factors is simply pilot projects are available and recommended to 





“And in some of the hospitals, it is as well the lacking of mobile devices 
readiness or how to deal with mobile devices, etc. So, it is more an 
infrastructure or strategic issue there” P22 
Collaboration and 
transparency 
“It would just facilitate for one larger team I think than having everybody 
playing one certain role and not being able to budge from that” P21 
“The advantages lie in the improvement of the interdisciplinary cooperation of 
different medical disciplines and the closer link between inpatient and 
outpatient treatment pathways” P39  
Empowerment  “You have the power of data so it is a gift in who has the knowledge and often 
it is used by physician. Physician has the knowledge, has the information in 
his folder and is coordinating everything and it gives him big power” P29 
Ease of work “It is making the work a lot easier for us” P32 
“it is easier for the physician to see something in a picture than to read it out 
of some long description someone did before” P33 
Roles and 
responsibilities 
“having people like myself CCIOs, clinical information officers, to get involved 
with the IT side of service provision” P5 
“our professional patient photographer is consulted less frequently, this has 
changed… it (the app introduction) altered the role of the photographer, it 
diminished the role a little bit” P26 
Workflow fit and 
location flexibility 
“for the specific information that I know I have on the apps, I do not have to 
go to the computer anymore, so I think it is better organized my work 




“before, you had to go onto the station, take the camera. Now, you have it in 
your pocket right next to you. You can log in with the face ID, take a picture 
and send it” P30 




“They could also limit the need to have record coordinators. So as we had 
talked about before, a half or a full FTE. And decrease the time that is lost in 
sending the records” P21 
“Digitalisation is an aid, but it is currently exacerbating the speed and 
increasing the challenges to performance. It set a much bigger pressure on 




Regulations “The limitations and problems are rather in the legal area, as the sending of 
sensitive patient data is very restrictive.... Legal and technical requirements 
for secure data transfer must be dealt with” P39 
Reimbursement 
and funding 
“And there will be no compensation, currently, at least. There will be no 
compensation for digital solutions, since the federal states are not paying for 
that... We are working on that. So, we are in close contact with a couple of 
institutions in the government in order to find some kind of compensation for 
that kind of expenses” P34 
User engagement  “And then the second is that they realize we're not coming with a solution that 
we have to onboard the hospital, we do it reverse, we onboard into the 
hospitals, so they normally stay calm when they realize, aha, you come into 






“patients get the state-of-the-art science in front of them so they do not have 
to travel. They do not have to waste time. Time is golden in cancer” P20 
“So, it helps to gain more access to clinical trials more quickly” P21 
“The course of healing can be determined by means of photo documentation 
and information exchange with e.g., outpatient wound care providers and 
care facilities. For this, the patient does not necessarily have to be presented 
in the hospital or specialized facility. Unnecessary and long transport routes 




“It is just a security feature when you need something to fall back on if you're 
giving a drug and want to ensure you're giving the right dose” P13 
“Especially in wound care, they often adapt a treatment because a treatment 
is not necessarily working. And when they have the photos on the 
smartphone, they can easily talk to the patient and show them that, they can 
be involved much, much more easily than before because everything is 
available” P36  
 
4.5 Future vision and the role of clinicians 
To close the interviews, participants were asked about their anticipations for the future of 
mHealth, and the role that clinicians could play in this development. Generally, participants 
in all three cases agreed that the future of mHealth is quite promising and will have a 
substantial effect on healthcare. Figure 20 visualizes the themes future vision and the role of 
clinicians, together with their corresponding sub-themes, reflecting the incidence of each of 




Figure 20: Future vision and the role of clinicians 
 
 
The participants expect an increase in mHealth adoption and acceptance (n=18, 53%), 
especially with more spread and standardization of EMRs, allowing for better interoperability 
and integration of such new tools into the hospital’s IT system. Clinicians also believe that 
the efficacies enabled by mHealth use will allow them to adopt a more patient centric 
approach that better engages patients and empowers them (n=16, 47%). Furthermore, they 
foresee an immense value in the big healthcare data that such tools generate, and all the 
possible research using AI to achieve more proactive and predictive treatment model (n=11, 




more familiar with mHealth, and as the healthcare policies and regulations reach a higher 
level of maturity (n=4, 12%). 
Participants also anticipated that clinicians will play a more active role in development and 
co-creation of mHealth tools in the future (n=9, 27%), and that they will support its spread by 
being active advocates, taking the lead in mHealth awareness and education (n=7, 21%). 
Furthermore, they expect the creation of new digital roles for clinicians (n=3, 9%), such as 
clinical information officers (CCIOs), to get clinicians involved with the technological side of 
service provision at an early stage and through the whole implementation process.  
4.6 Section Summary 
The multiple case study results offered rich insights into the factors impacting clinicians’ 
adoption of different mHealth tools. It showcased how social and organizational factors are 
crucial for the understanding of users’ decisions to adopt an mHealth tool or not, and 
clarified that solely assessing the technical and material factors would not give a complete 
picture.  
The inter-case comparison showed that even though the vast majority of factors were 
mentioned in all three cases, there were some factors that were more prominent in one case 
or the other, reflecting the importance of understanding the specificity of each case, and the 
relative importance of each factor for this specific tool. For example, the factor data 
management and overload came up only in the third case, because the tool enabled users 
to create considerably more documents compared to before the tool’s introduction, which 
was not the case with the two other cases. Another example, the factor privacy, security, 
and liability did not come up in the first case study despite its clear importance in the 
literature and in the two other cases; this is mainly due to the fact that the tool studied in the 
first case didn’t involve the storage or transmission of any patient data, hence, this factor 
was not relevant in this specific case, not because it is generally irrelevant but because it 
doesn’t apply for this specific tool.   
The findings largely confirmed what the systematic literature review revealed, and the 
contrast between the study findings and what has been reported in the literature will be 




5 Findings and implications 
This section discusses the findings of the multiple-case study in contrast with the systematic 
literature review, and reflects on the theoretical frameworks review in the study context. 
Consequently, theoretical implications and practical recommendations are explained.  
5.1 Multiple case study findings 
5.1.1 Understanding mHealth utilities and limitations 
Studying technology adoption starts with an understanding of its material features, and a 
deeper look into its utilities and limitations as perceived by its users (Leonardi, 2018). 
Participants in the three case studies found the health app that they adopted quite useful, 
there were similarities in the utilities of the three tools that could be categorized into four 
main themes: the tool’s accessibility and compact overview, enhanced patient safety and 
quality of care, the potential for saving time and efficacy, data security and validation. The 
utilities were clearly more prominent in the participants’ input compared to limitations; these 
in turn had similarities in the three cases, with more divergence in the second case. The 
limited limitations data in the second case could be due to the fact that all interviewees were 
from the provider’s side, and this might have not completely reflected the users’ views, even 
though two of the participants were clinicians. The limitations could also be categorized into 
four key themes: data related, design related, resources related, and system related 
limitations.  
Most participants found the main utility to be the efficacy and time saving, explaining that the 
apps made their work quicker and easier, this aligns with previous studies that proposed that 
expected efficacy gains positively impacts intention to use (Charani et al., 2013; Duhm et al., 
2016; Putzer and Park, 2012; Sandholzer et al., 2015; Varsi et al., 2015a; Wilhelmsen et al., 
2014; Zhang, Cocosila and Archer, 2010). Better patient care and safety was another 
prominent utility that prevailed in all three cases as the participants explained how the tools 
help in treatment optimization, this is in accord with previous research that demonstrated 
how these tools can facilitate early symptom detection and documentation generating better 
patient safety (Bishop et al., 2013; Bramley, Mangan and Conroy, 2018; Giraldo et al., 2018; 
Kleinpell et al., 2016; Li and Cotton, 2018; Moharra et al., 2015; Penny, Bradford and 





The apps accessibility and their compact overview were perceived as a clear added value in 
the three cases; such features enable timeliness and facilitate team collaboration, and make 
them more convenient compared to their potential alternatives, as described in other studies 
that stressed how the portability of these tools allows the healthcare providers to easily 
access the relevant information and flexibly complete work tasks regardless of place and 
time (Nerminathan et al., 2017; Odnoletkova et al., 2016; Puszka et al., 2016; Sadoughi et 
al., 2017; Sezgin, Özkan-Yildirim and Yildirim, 2017). Participants in two of the three cases 
were very positive about the data security and validation features of mHealth tools, 
emphasising the importance of regulatory issues such as GDPR compliance and health data 
privacy; the absence of this theme in the second case could be due to the fact that all 
interviewees were from the provider’s side, and this might have not completely reflected the 
users’ views and priorities. This is a vital utility given the usual medico-legal issues related to 
health data anonymity, confidentiality, and potential inappropriate use (El Amrani et al., 
2017; Anderson et al., 2017; Ariens et al., 2017; Avey and Hobbs, 2013; Bailey et al., 2017; 
Brewster et al., 2014; Chang et al., 2017; Davis et al., 2014; de Souza et al., 2017; Hackl et 
al., 2014; Han, Subramanian and Cameron, n.d.; Hanna, May and Fairhurst, 2012; Hickson 
et al., 2015; Holderried et al., 2018; Jarvis-Selinger et al., 2011; Jetty et al., 2018; Jimbo et 
al., 2013; Koval, Kim and Makhlouf, n.d.; Lacasta Tintorer et al., 2018; Mishori et al., 2017; 
Moskowitz et al., 2010; Muigg et al., 2018; Penny, Bradford and Langbecker, 2018; 
Quanbeck et al., 2018; Radhakrishnan et al., 2016; Rogove et al., 2012).  
As for limitations, the four key categories of factors raised by the participants were similarly 
reported in former research tackling the topic of clinicians adoption of mHealth, these are 
typically related to health care data quality and management concerns (Brown et al., 2018; 
James et al., 2016), possible information overload (Levine et al., 2014; MacNeill et al., 2014; 
Öberg et al., 2017), in addition to system integration and exchange issues (Bidmead and 
Marshall, 2016; Catan et al., 2015; Chung et al., 2015; Loh, Flicker and Horner, 2009). This 
latter barrier related to technological interoperability confirms the idea that frequently it is the 
software itself rather than the tool’s features that can be restrictive to technology use 
(Leonardi, 2018), in the same way, clinicians sometimes resit tools with very useful features 
only because they do not integrate well with their hospital’s information system.  
It was also noteworthy to see that some of the features that participants wished to add to the 
mHealth tool that they are using were already available. This shows that users were not 
always informed about all existing functionalities, and highlighting the fundamental role of 
training. This thought was underlined by Oudshoorn and Pinch when they rationalised that 




features and their understanding of what they can accomplish them, expressing that “It has 
long been recognized that the most sophisticated and complex computer hardware and 
software will come to naught if users do not know how to use them” (Oudshoorn and Pinch, 
2003). Some of the additional features requested by the participants, are already under 
consideration by the respective mHealth providers but are occasionally hindered because of 
their elevated development costs. 
5.1.2 Understanding mHealth’s constraints and affordances 
Moving on now to consider what a technological tool can afford or constraint, it is important 
to examine how users essentially perceive and adopt these technologies in their daily life; 
this is usually where technology becomes entangled with social practices as users make 
sense of the tools that they use (Leonardi, 2018). Therefore, it was important to better 
understand how the participants believe that the tools they adopted helped them and their 
patients, this is of particular importance because as Gibson suggests, users might renounce 
a specific technical tool if they do not know what it is good for (Gibson, 1986). 
The findings showed that adoption decisions, and the related barriers and opportunities, are 
not solely based on the technical and material factors as the tool’s features, but also 
comprises some vital social and cultural elements. Factors related to users’ individual 
characteristics may impact their technology acceptance; for example, participants explained 
that people’s previous technology experience, and whether they have used mHealth before, 
may impact their decision, as formerly highlighted by other researchers (Puszka et al., 2016; 
Orchard et al., 2016; Lacasta Tintorer et al., 2018; Albrecht et al., 2017; Iacono et al., 2016). 
Users’ attitudes towards risk-taking and change is another factor, similar results were 
described in former studies (Abd Ghani and Jaber, 2015; Bidmead and Marshall, 2016; 
Bishop et al., 2013; Hines et al., 2015; Bramley, Mangan and Conroy, 2018). Moreover, 
people’s preference for their personal devices, bearing in mind that mobile health apps are 
sometimes use on one’s personal phone, may also play a role in the adoption decision.  
Cultural and social considerations, like people’s negative perceptions on the usage of mobile 
devices at the workplace may hinder widespread adoption (Alajlani and Clarke, 2013; 
Farrell, 2016; McNally, Frey and Crossan, 2017); however, this is gradually changing and 
people are slowly accepting these tools as the new normal. This is a good example that 
shows the entanglement of the social and the material, as some may perceive the use of a 
specific technology or device (the smartphone) at work as a non-professional action. While 
mobile apps that can be used professionally are not new anymore, the stigma associated to 




with negative cultural perceptions of mobile devices use at the workplace, validates 
Leonardi’s argument that “culture tells us what something affords”, implying that the barriers 
and opportunities influencing technology adoption are the combined result of the 
entanglement among the material and social aspects of technology, and confirming 
Gherardi’s notion that sociomateriality goes past material and social elements to also 
encompass the entanglement between cultural and natural factors (Leonardi, 2018; 
Gherardi, 2016). 
Other social factors, like peer endorsement may also influence the intention of use. 
Participants explained that clinicians typically trust technologies that are endorsed by their 
colleagues or dependable medical associations, demonstrating again how the social and 
material factors begin to become entangled, as it becomes clear that adoption does not 
solely depend on the technological features and abilities but also on social elements like 
trusted endorsement. This suggests that in the absence of some social factors like 
endorsement or peer recommendations some efficacious and capable tools might go 
unnoticed. 
From a material and technical perspective, usefulness was the most obvious factor; as 
reported in former studies, perceived usefulness was usually related to the time-saving and 
efficacy stemming from the tool’s use (Varsi et al., 2015b; Saigi-Rubió, Jiménez-Zarco and 
Torrent-Sellens, 2016; Steinschaden, Petersson and Astrand, 2009), its favourable effect on 
the quality of care (Mueller et al., 2014; Anderson et al., 2017; Carlisle and Warren, 2013; de 
Souza et al., 2017), and the possible advantage for scientific evidence generation and 
research because of improved data availability (Kleinpell et al., 2016; L’Esperance and 
Perry, 2016). Perceived ease of use of the tool is a respectively significant factor that was 
extensively reported in similar research (Adenuga, Iahad and Miskon, 2017; Bello et al., 
2017; Bhatta, Aryal and Ellingsen, 2015; de Vries et al., 2017).  
IT factors like the system interoperability and integration of the tool with the healthcare 
organization’s system were also emphasized by the participants, as this helps clinicians 
avoid the additional workload stemming from having to re-enter the same patient data once 
again in the hospital’s system and what it could entail from documentation mistakes. 
Interoperability, which means that the possibility for the app to function correctly in relation to 
existing hospitals information systems not only as stand-alone, is a recognised challenge for 
health technologies and has been acknowledged in several other studies (El Amrani et al., 
2017; Armstrong et al., 2011; Asua et al., 2012; Sharma and Clarke, 2014; Shaw et al., 




issues or poor internet connectivity that may obstruct adoption (Kayyali et al., 2017; Molleda 
et al., 2017; O’Connor and Andrews, 2018; Orchard et al., 2016; Radhakrishnan et al., 
2016). 
The highly regulated nature of healthcare sheds light on some delicate topics like health 
data privacy and security.  In the two cases that involve patient data in our study, this factor 
was perceived as a facilitator, as the two tools offer secure solutions for clinical data 
documentation and exchange, however, other researchers described this factors as a barrier 
in cases where data privacy and security is not warranted (Daniel et al., 2018; Loh, Flicker 
and Horner, 2009; El Amrani et al., 2017; Anderson et al., 2017; Bailey et al., 2017; Bidmead 
and Marshall, 2016; Holderried et al., 2018). Also, given the large amounts of data that these 
tools yield, participants raised some concerns around data management and interpretation, 
particularly as the ease of use of these tools significantly increases data capture and 
generation (Bramley, Mangan and Conroy, 2018; Brown et al., 2018; Chung et al., 2015; 
James et al., 2016; Öberg et al., 2017). 
The tool’s cost is also a vital factor; it can be considered a facilitator when the tool helps in 
saving costs by generating efficacies as described in similar readings (Armstrong et al., 
2012; Avey and Hobbs, 2013; Ayatollahi et al., 2018; Catan et al., 2015); nevertheless, it can 
also be perceived as a barrier (Gagnon et al., 2016; Jimbo et al., 2013; Jungwirth and 
Haluza, n.d.) considering direct and indirect costs in relation to the creation of a proper 
infrastructure, like providing mobile devices across the healthcare organization to facilitate 
the tool’s use. User experience and factors like the app’s design, and content reliability and 
neutrality also impact clinicians’ views of mHealth tools; for example, a cluttered design 
could discourage use. Factors such as app layout, interface, and culturally appropriate 
design, as well as the trustworthiness of the content were similarly reported in other studies 
(de Vries et al., 2017; Fairbrother et al., 2014; Gagnon et al., 2016; Jeon et al., 2014; Levine 
et al., 2014; Puszka et al., 2016; Radhakrishnan et al., 2016; Seto et al., 2012; Taylor and 
Coates, 2015; Taylor et al., 2016; Walker and Clendon, 2016).  
5.1.3 Understanding how mHealth technology materializes in the organizing process 
Let us now turn to the organizational and regulatory factors, to better understand 
implications for healthcare organizations, clinical workflow, and health policy aspects. 
Organizational and policy factors and implications were quite prominent in the three case 
studies, demonstrating that the interaction between technology users and the tools that they 
utilize produces the adoption patterns that we examine, and impacts the organizing process 




Participants agreed that mHealth use generated workflow advantages in many ways; for 
example, by facilitating location flexibility and consequently enhanced workflow fit, this is 
because mobile device enable clinicians to access the relevant data at the point of care, 
streamlining the patient’s treatment process, a result that is aligned with what similar 
researchers concluded, that the tool’s workflow fit boosts adoption (Bailey et al., 2017; Bello 
et al., 2017; Duhm et al., 2016). Additionally, better collaboration and transparency, as well 
as making clinicians’ work easier were further workflow advantages, as participants 
observed that the tools made the inter-disciplinary cooperation easier and offered more 
transparency thanks to the enhanced documentation of health data, in accord with what 
other researchers have reported regarding health apps impact on collaboration (Ariens et al., 
2017; Armstrong et al., 2012; Avey and Hobbs, 2013; Bello et al., 2017; Bramley, Mangan 
and Conroy, 2018; Brewster et al., 2014; Duhm et al., 2016), and streamlining workflow 
(Schneider et al., 2016; Williamson and Muckle, 2018; Zilliacus et al., 2010). The data 
availability resulting from the tools’ use empowers clinicians, as they become instantly 
equipped with all the relevant information to make informed decisions; this was also reported 
in other studies (O’Connor and Andrews, 2018). Conversely, there are studies that stated 
that these tools might instead be viewed as a threat to healthcare providers’ autonomy (Li 
and Cotton, 2018; Liu and Cheng, 2015; Ly et al., 2018; MacNeill et al., 2014). This, 
however, was not a concern amongst this study’s participants.  
Workflow disadvantages, on the other hand, were mainly caused by existing workload and 
resources shortages. Participants explained that the majority of healthcare practitioners are 
over-stretched and resources shortages may therefore hinder adoption, a point that has 
been described in former studies (Ariens et al., 2017; Bhatta, Aryal and Ellingsen, 2015; 
Bishop et al., 2013; Egerton et al., 2017; Ehrler et al., 2018). Additionally, the efficiencies 
resulting from these tools sometimes result in a higher overall workload, as clinicians gain 
the capacity to do more work in less time thanks to these app, resulting in an additional 
burden to the staff. The large scale introduction of these tools can also lead to changes in 
the roles and responsibilities, sometimes by eliminating some of the existing roles, or 
creating new ones that are more suited to the digital era, as observed in other studies 
(Molfenter et al., 2015; Penny, Bradford and Langbecker, 2018; Shaw et al., 2013; 
Sturesson and Groth, 2018). For example, we now start to see new roles such as ‘clinical 
information officers’ in some healthcare organizations to tackle not only the medical aspects 
but also the IT aspects like interoperability and software integration. Additionally, mHealth 
introduction may also require some changes of the hospital infrastructure to support its use. 




embraced by the healthcare organization, reinforcing the argument that the real influence of 
the materials and materiality on the organizing process may only be realized if something 
allows their materialization (Leonardi, 2018); meaning, that would only happen when the 
management enforces the infrastructure changes that support the implementation of a 
specific tool.    
The inner or internal setting of the healthcare organization is also central for mHealth 
adoption. For example, a decision making-process that is too complicated or not clear 
enough can very well hinder or even prevent adoption, this issue was also raised in other 
cases (Bhatta, Aryal and Ellingsen, 2015; Muigg et al., 2018; Odeh et al., 2014; Öberg et al., 
2017). Furthermore, many participants explained that it is often difficult to identify the staff 
members that should be responsible for deciding about bringing a new technological tool in 
their organization, and even when these people are identified the procedure can be quite 
difficult as the decision includes an inter-disciplinary group covering IT, medical informatics, 
finance, and medical. Given this complex decision making process, aspects such as the 
possibility to try and pilot the tool may support adoption as it allows the decision makers to 
test the new technology without risking the collapse of a broad rollout (Varsi et al., 2015b).  
Providing continuous and proper training is also key, especially where the staff turn-over is 
high, as confirmed by other researchers (Armstrong et al., 2011; Asua et al., 2012; 
Dünnebeil et al., 2012; Duplaga, 2016; Gagnon et al., 2012b), similarly, the presence of 
proper reinforcement factors such as incentives can foster adoption. Moreover, 
organizations that desire to be seen as innovative have more acceptability of new 
technologies, this is aligned with other research that exhibited that factors such as 
institutional innovation and openness for change can foster adoption (Casey, Shaw and 
Swinglehurst, 2017; Saigí-Rubió, Torrent-Sellens and Jiménez-Zarco, 2014; Varsi et al., 
2015b).  
Participants also pinpointed some crucial patient related factors;  for instance, tools that 
improve patient engagement and their safety are more accepted, as described in similar 
studies (Daniel et al., 2018; Hanley et al., 2013; L’Esperance and Perry, 2016; Miller et al., 
2017). Equally, tools that improve patients’ access to care also have higher chances of 
getting accepted and adopted (Armstrong et al., 2012; Avey and Hobbs, 2013; Bishop et al., 
2013). Also, the external setting of the healthcare organization including health policies and 
regulations can influence adoption, participants explained that fostering technology 
acceptance and adoption in healthcare necessitates more clarity and simplification of the 




particular importance (Anderson et al., 2017; Armstrong et al., 2011; Avey and Hobbs, 2013; 
Choi et al., 2018; Chung et al., 2015; Gagnon et al., 2016; Hickson et al., 2015), the 
absence or vagueness of such regulations can discourage adoption as they hinder the 
compensation of medical activities accomplished via mHealth. 
User engagement in the development and implementation was found to be a key success 
factor by the research participants as was the case in similar studies (Brewster et al., 2014; 
Davis et al., 2014; Jarvis-Selinger et al., 2011; Lord et al., 2016; Molleda et al., 2017; 
Schmeer et al., 2016; Varsi et al., 2015b; Cox et al., 2017). This is usually a joint 
responsibility of the technology provider as well as the healthcare organization as they need 
to partner together in the development and implementation processes of the new tools. 
Incorporating users’ feedback is not always easy though, essentially when the tool is 
completely integrated into the hospitals systems (which are mostly closed systems), 
obstructing the visibility of the tool’s usability statistics from the tool’s provider. The providers 
of the three tools studied in this research, however, successfully established different user 
input and feedback channels where they acquire users’ opinions and medical informatics 
experts’ input to ensure their tools remain relevant and useful. From their side, the 
participating clinicians showed strong interest in contributing to the development process of 
these new tools, as they expect an increase in digital roles for clinicians, not only in digital 
health start-ups but also in healthcare organizations.  
5.2 Theoretical implications 
From a theoretical perspective, the review of the most used framework in studying clinicians’ 
mHealth adoption showed that several of the frequently used frameworks such as TAM offer 
an oversimplified set of aspects that need to be addressed in more detail and specificity. 
While it is sometimes argued that it is simplicity that makes these frameworks useful 
(Shachak et al., 2015), even in the healthcare context (Harst, Lantzsch and Scheibe, 2019; 
Holden and Karsh, 2010; Garavand et al., 2016), it is important to note that most of these 
models were not developed within a healthcare context and consequently overlook the 
complexity of its organizational and regulatory setting (Ammenwerth, 2019; Holden and 
Karsh, 2010; Rahimi et al., 2018). Additionally, frameworks such as TAM and UTAUT do not 
fully cover socio-organizational and cultural factors either (Ammenwerth, 2019; Rahimi et al., 
2018). Another important point, is that many of the largely used models focus on tools that 
can be willingly used by individual users, unlike healthcare settings that usually involve an 
organizational-level resolution to implement specific tools that are released to all staff 




Researchers in most of the included papers expanded pre-existing technology acceptance 
models to be able to examine potentially significant additional factors; however, some 
academics have criticized such a method of subjectively adding constructs, as it can lead to 
an inconsistent use of established frameworks (Benbasat and Barki, 2007), highlighting the 
need for an aggregated framework that covers all these factors in one overview, and allows 
future researchers to have a more consistent approach to the topic, making sure that they do 
not overlook any of the important adoption factors. 
Therefore, the researcher proposes a consolidated model that aggregates all the most used 
frameworks and complementing them with the additional factors that emerged from the gap 
analysis discussed in section 2.3.2, leading to a shift towards an extended framework that 
takes into account the complexity of the healthcare landscape, its highly regulated nature, 
and the interdependence between its different stakeholders, as well as the active role of 
clinicians in influencing how these new tools are being used in their work situation. Other 
researchers have similarly discussed that many of the broadly used frameworks adopt a 
technology-centred view focusing on the tool itself (Ammenwerth, 2019; Ward, 2013; Rahimi 
et al., 2018), and proposed a move to multi-dimensional models that go past usability to also 
encompass the surrounding organizational settings and implementation challenges 
(Shachak, Kuziemsky and Petersen, 2019; Ammenwerth, 2019; Ward, 2013; Sittig and 
Singh, 2010; Riley et al., 2011; Karsh, 2004).  
Healthcare technology cannot be successfully adopted in isolation from the broader 
organizational context in which it is being used; therefore, we need to adopt theoretical 
frameworks that take into account implementation challenges in light of the complexity of the 
sociotechnical structure, and the interplay between the technical, social and organizational 
aspects. Accordingly, figure 21 represents a suggested consolidated framework that 
addresses the gaps in the most frequently used models, and complements them using a 
sociotechnical methodology that allows researchers to take into account all the contextual 
aspects, and, essentially, the interaction between them, when studying adoption. Figure 21 
aggregates all the factors from the most used frameworks and contributes to knowledge by 
complementing them with the healthcare specific factors that emerged from the data, such 
as reimbursement; these complementary factors emerged from the gap’s analysis discussed 
in section 2.3.2 and visualised in figure 9. This consolidated framework should help future 
researchers adopt a more consistent approach when studying the topic, and cover all the 




As shown in figure 21, the factors are categorized according to the sociotechnical approach 
to (technical and material), (social and personal), and (organizational and policy) factors.  
Figure 21: Consolidated framework of the factors impacting clinicians’ adoption of mHealth 
 
Source: initially published in (Jacob, Sanchez-Vazquez and Ivory, 2020b) 
From a methodological guidelines’ perspective, looking into the three steps in Leonardi’s 
(2018) methodological guidance in contrast with the findings of the current study, the 
researcher suggests the addition of a fourth step to the guidance to better account for user 
engagement. This addition would enable researchers to reflect in more depth on the active 
role of the users in the adoption process. Embedding the users in the constant technology 
design and development processes warrants a better consideration of user-specific 
affordances; these can in turn be made more observable to other users and expand the 
potential of such tools to go beyond their technological features and have a higher impact on 
workflow and the process of organizing (how people organize their work) as perceived by 




To account for user engagement and ensuring that user-specific affordances can 
successfully make their way back to the design, researchers need to identify feedback loops 
established by the technology provider, better understand which user-suggested features 
are picked for development, and how they are chosen (based on which criteria), and also 
who the decision makers are. These questions can support the capture of any processes 
that trigger the active role of the users and the realization of affordances that could occur as 
shown in figure 22, it reflects the three first steps as defined by Leonardi (2018), then adds a 
fourth step with suggested ideas on how to best capture users’ views and ensure that user 
engagement is imbedded in our research of technology adoption at the workplace. This 
expansion should help technology providers ensure the constant development of their tools 
in a way that keeps them useful and relevant based on active and constant user 
engagement.   
It is important to remember though that including the users in the continuous development 
and testing of new tools can be challenging, particularly bearing in mind the extremely 
competitive ecosystem that mHealth technology providers are operating in, making them 
quite protective of their innovations out of fear of their competitors, a situation that often 
results in most of the new tools’ design and testing being internally done without including 
any external stakeholders, including users (Oudshoorn, Rommes and Stienstra, 2004). This 
nevertheless, needs to change to allow the user-triggered affordances to make their way 
back to the design and to warrant that these new technologies will remain relevant in a 
continuously changing world. The desired balance between the recommended user 
engagement and the required confidentiality can be attained through some legal deals like 
non-disclosure agreements, advisory contracts, or the like.  
Figure 22: Accounting for user engagement 
 




5.3 Practical recommendations 
The findings of the multiple-case study are largely aligned with the results of the systematic 
literature review. The joint outcomes imply the importance of tackling specific technical, 
social, and organizational aspects so as to effectively encourage clinicians’ mHealth 
adoption. The practical implications can be categorized in three clusters to define the 
needed actions from three major stakeholder groups: healthcare policy makers, mHealth 
technology providers, and clinical decision makers in the healthcare organizations, as 
visualized in figure 23. 
Healthcare policy makers can positively impact mHealth adoption by properly addressing 
health data privacy and management concerns, and policies that streamline and enable the 
reimbursement of mHealth services. Tackle interoperability barriers by coordinating the 
fragmented healthcare landscape and streamlining technology would warrant a more 
effective implementation and integration of these tools. Upskill the healthcare workforce by 
integrating mHealth related capabilities in official health education to equip clinical staff with 
the essential skills to effectively run the tools. Integrate mHealth services in health insurance 
schemes may help address the cost issues and foster adoption for both patients and 
clinicians. Support scientific evidence generation through funding programs for studies that 
investigate mHealth benefits and added value. Help develop remote care protocols that can 
support clinicians streamline mHealth services and integrate them into their workflow. 
mHealth technology providers should involve the users (clinicians and patients) more 
proactively in their development process, starting with design, testing, then planning and 
implementation, to ensure that their tool will fit well into routine care and clinical practice. 
Ensure the usefulness, ease of use, and technical support availability to enable a smooth 
day-to-day use of their tools. Encourage user feedback to ensure the tool’s relevance and 
long-term sustainability. Deliver consistent training about their tools’ various features and 
benefits, as well as an explanation of workflow integration scenarios in order to support 
clinicians with the tool’s integration into their daily practice. Collaborate with the relevant 
stakeholders on solving EMR integration problems, to enable clinicians to harness the 
efficiency gains generated by these tools, and avoid any potential burden of double data 
entry when information systems are not properly integrated. Also, engage with dependable 
healthcare opinion leaders and medical associations to recommend the tool and help create 




Clinical decision makers in healthcare organizations need to facilitate training programs that 
can help their staff acquire the essential skills for a successfully mHealth implementation. 
Encourage a cultural shift that fosters the value of innovation and technology to inspire their 
staff to embrace the new tools and change their conventional ways of working. Encourage 
the foundation of multidisciplinary groups that combine digital and medical capabilities, and 
redefine the existing roles to reflect the additional required skills. In a few cases, the creation 
of new roles might be necessary to enable an effective implementation. Moreover, plan for a 
proper integration of the new tools into the workflow to avoid that mHealth becomes more of 
burden to the clinical staff.  
Figure 23: Practical recommendations 
 






The findings of this multiple case study provided an in-depth understanding of the technical, 
social and organizational factors impacting clinicians’ adoption of mHealth, highlighting that 
a tool’s technical features and capabilities alone are not enough to determine its successful 
adoption. These findings reinforce what the researcher found in the systematic literature 
review, where it was apparent that some non-technical factors such as the social context, 
users’ individual experience and skills, as well as organizational factors are crucial for the 
implementation and adoption of new technologies in healthcare. This confirms the suitability 
of the sociotechnical framework for studying healthcare technology adoption, as it goes 
beyond technology itself to encompass other contextual elements such as the social, 
individual, organizational, and policy factors. 
The theoretical frameworks review, and the gap analysis allowed the researcher to clearly 
see the factors that are not considered by existing frequently used frameworks, allowing her 
to suggest an aggregated framework that takes all the relevant factors into account, and 
complements any gaps in existing models. This consolidated framework should help future 
researchers adopt a more consistent approach when studying the topic, and cover all the 
relevant factors in their studies related to mHealth adoption and implementation. 
Furthermore, the researcher suggests an expansion to Leonardi’s methodological guidance 
to better incorporate the active role of users, the existing mechanisms to capture their 
experiences and input for each tool, and the processes that enable their prioritization and 
allow them to make their way back to the design. This expansion would enable the constant 
development of tools to help them stay relevant in an area that is constantly evolving. 
From a practical perspective, the rich insights gained from the multiple case study, and 
complemented by the extensive literature review findings allowed the researcher to give 
some actionable recommendations that detail the necessary actions to be considered by the 
key stakeholders in order to foster mHealth adoption. The recommendations include specific 
actions for regulators and policy makers, technology providers, as well as clinical decision 
makers. These practical recommendations show that mHealth success requires close 
collaboration between the different players in the healthcare sector and cannot be achieved 
by technology providers alone, given the considerable importance of the regulatory 
landscape, as well as the organizational context.  
The insights gained from this study could prove useful for policy makers, healthcare 




factors it is crucially important to recognize the complexity of the healthcare ecosystem, its 
interdependencies, and highly regulated nature. There is a need for further research on this 
topic to test and validate the findings of this study and previous research, in order to facilitate 
a better understanding of the factors impacting clinicians’ adoption of mHealth tools, and the 
implications for social and organizational practices. 
6.1 Limitations and recommendations for future research 
While this thesis contributes to the understanding of the social, organizational and technical 
factors impacting clinicians’ adoption of mHealth, some limitations must be acknowledged. 
This research is limited to three specific mHealth tools, and focused on a specific geography 
through a certain timeframe. Moreover, the sample size is relatively small and excluded non-
users because their recruitment showed to be very challenging. Furthermore, the constantly 
evolving nature of mHealth means that the context of the research might change very 
rapidly, requiring new research to update the findings and expand this work. Future 
researchers are highly encouraged to research the applicability of the findings in this thesis 
for different purposes and to adapt and extend them as needed. 
Also, the literature review may not have included relevant studies that were not indexed in 
the searched databases, written in a language other than English, and grey literature 
searches that could have also enabled the identification of further significant insights. 
Additionally, it only considered published studies, and no further contacts were made with 
the papers’ authors to obtain additional information or to validate the thematic analysis.  
In order to address some of these limitations, future research should include other mHealth 
tools, in other locations, timeframes and settings. It would also be very pertinent to include 
some non-users to the participants mix to cover their opinions too. Future literature reviews 
could also include studies in languages other than English to have a better grasp of any 
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Appendix 1: interview guides 
Interview guide – Clinicians v.1.3  
Background Questions  
1. Participant introduction 
- Tell me about your role in the organization 
- How long have you worked in healthcare? 
- How long have you been using Mobile Health? 
- How would you define your level of technical awareness  
2. How would you define “Mobile Health” in one sentence? 
Theme 1: “Accounting for materials” 
3. Tell me about the app 
- What are its main features? 
- Are there any limitations in its features? 
- If you would add one feature what would it be? 
4. How did it help you and your patients? 
Theme 2: “Accounting for materiality” 
5. Tell me about what you wanted to achieve when you decided to use the app 
6. What were the factors that influenced your decision to adopt the app?  
- Which would you consider a barrier and which an opportunity? 
7. Who made the decision to implement the app? And are there in 
assessment/selection criteria for such new technologies in your workplace? 




8. What influence did the app have on your work/the work of others (e.g Workflow)?  
- Did it improve it? 
- Was the previous practice better for some things? 
9. Have these solutions led to changes in how the organization works, its rules or the 
use of other tools / technologies? 
10. How have the uses of the app sustained, altered, or transformed the way that people 
interact in your organization? 
11. In your opinion, what does the future hold for mHealth? And what roles will HCPs 
play in shaping this future? 
 
Interview guide - Technology provider - v1.2  
Background Questions 
1. Participant introduction 
- Tell me about your role in the organization 
- How long have you worked in healthcare (or Healthcare Tech)? 
- How long have you been working on Mobile Health apps? 
- How would you define your level of technical awareness  
2. How would you define “Mobile Health” in one sentence? 
Theme 1: “Accounting for materials” 
3. Tell me about your app 
- What are its main features? What do the features do or not do?  
- Are there any limitations in the features? 




4. How is it intended to help HCPs/patients? 
Theme 2: “Accounting for materiality” 
5. Tell me about what you wanted to achieve when you decided to create the app 
6. Based on your experience with your customers: What are the factors that influence 
HCPs’ decision to adopt the app?  
- Which would you consider a barrier and which an opportunity? 
7. In your experience: Who usually makes the decision to implement mHealth? 
- How widespread is its use? 
- What do HCPs think? 
Theme 3: “Accounting for materialization” 
8. What do you think is the influence of the app on HCPs’ daily work? 
- Did it improve it? 
- Was the previous practice better for some things? 
9. Has your app led – or could it potentially lead - to any changes in how healthcare 
organizations work, their rules, or the use of other tools / technologies? 
10. How have – or potentially could - the use of your app sustained, altered, or 
transformed the way that people interact in healthcare organizations? 
11. How do you ensure that your users are involved in the constant development of your 
solution (e.g. feedback channels…etc.). 
12. In your opinion, what does the future hold for mHealth? And what will be the role(s) of 
HCPs in this development? 
 
Interview guide – Medical informatics expert v.1.3        




1. Participant introduction 
- Tell me about your role in the organization 
- How long have you worked in healthcare? 
- How long have you been working with Mobile Health tools? 
- How would you define your level of technical awareness, as a user (on a scale of 1 to 
10) 
2. How would you define “Mobile Health” in one sentence? 
Theme 1: “Accounting for materials” 
3. Tell me about the “app name” 
- What are its main features? 
- Are there any limitations in its features? 
- If you would add one feature what would it be? 
4. How did it help clinicians and patients in your clinic/hospital? 
Theme 2: “Accounting for materiality” 
5. Tell me about what you wanted to achieve when you decided to rollout the “app 
name” in your clinic/hospital 
6. What were the factors that influenced your decision to adopt the “app name”?  
- Which would you consider a barrier and which an opportunity? 
7. Who made the decision to implement the “app name”? And are there in 
assessment/selection criteria for such new technologies in your workplace? 
Theme 3: “Accounting for materialization” 
8. What influence did the “app name” have on your work/the work of others (e.g 
Workflow)?  




- Was the previous practice better for some things? 
9. Have these solutions led to changes in how the organization works, its rules or the 
use of other tools / technologies? 
10. How have the uses of the app sustained, altered, or transformed the way that people 
interact in your organization? 
11. In your opinion, what does the future hold for mHealth? And what roles will HCPs 















































Appendix 4: participant consent form 
 
 
